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“We live on an island surrounded by a sea of ignorance. As our island of knowledge 
grows, so does the shore of our ignorance.” 
John Archibald Wheeler 
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Resumen 
Los polímeros de glucosa constituidos por enlaces α-1,4 y ramificaciones en α-1,6 (α-
glucanos), constituyen una de las principales fuentes de reserva de carbono y energía 
en los organismos vivos.  Los polímeros más representativos son el glucógeno, en 
animales, hongos, bacterias y arqueabacterias, y el almidón en organismos 
fotosintéticos.  La ventaja de utilizar polisacáridos como compuestos de reserva es que, 
gracias a sus propiedades físicas y su alto peso molecular, representan una fuente 
osmóticamente neutra de glucosa dentro de las células. La principal diferencia entre 
ambos polímeros es su patrón de ramificación, el cual determina en última instancia la 
morfología y las propiedades físicas del gránulo resultante.  
 
La biosíntesis de glucógeno en bacterias, al igual que en eucariotas, puede 
dividirse principalmente en tres fases: iniciación, elongación y ramificación. A diferencia 
de las células eucariotas donde la iniciación de la síntesis de glucógeno se produce 
mediante la autoglucosilación y la posterior acción cebadora de la enzima glucogenina, 
en bacterias se ha postulado que la glucogeno sintasa (GS) sería la enzima responsable 
de ambos procesos. Esta enzima cataliza la transferencia del residuo glucósido de un 
nucleótido azúcar activado al extremo no reductor de una cadena preexistente, 
generando un enlace α-1,4-glucosídico. Posteriormente, la enzima ramificadora (GBE) 
cataliza la transferencia de un segmento de cadena de α-1,4-glucano a posición α-1,6, 
introduciendo de este modo las ramificaciones características de este polímero. El 
anabolismo del glucógeno, por el contrario, se produce mediante la acción del enzima 
glucógeno fosforilasa (GP) que cataliza la eliminación secuencial de residuos 
glucosídicos desde los extremos no reductores de la molécula de glucógeno y la enzima 
desramificante de glucógeno (GDE) que cataliza la hidrólisis de los puntos de 
ramificación.  
 
La síntesis de glucógeno requiere, por lo tanto, de un nucleótido azúcar activado 
que actúe como sustrato de la GS. En el caso de la síntesis de glucogeno en bacterias 
y almidón en plantas, evolutivamente se ha seleccionado el nucleótido azúcar ADP-
glucosa (ADP-Glc) para cumplir esta función. La síntesis de ADP-Glc se lleva a cabo a 
través de la condensación de glucosa 1-fosfato (G1P) y ATP en presencia del catión 
divalente magnesio, en una reacción catalizada por la enzima ADP-glucosa 
pirofosforilasa (AGPase) y que resulta en la liberación de pirofosfato. La generación de 
 ADP-Glc en bacterias y plantas supone un paso clave y limitante en la síntesis de 
glucógeno y almidón, respectivamente, y conlleva un importante gasto energético. Por 
estos motivos, evolutivamente AGPase ha adquirido propiedades alostéricas a través 
de metabolitos relacionados con el estado energético celular. La naturaleza de estos 
metabolitos puede variar en función del organismo, pero todos comparten la 
característica de ser intermediarios en las principales rutas energéticas de asimilación 
de carbono. Por consiguiente, los reguladores alostéricos positivos representarían 
estados de alto contenido energético mientras que los reguladores negativos reflejarían 
niveles metabólicos bajos de carbón y energía.   
 
Tanto en plantas como en bacterias AGPase es una proteína tetramérica; en el 
caso de plantas corresponde a un heterotetrámero compuesto por dos subunidades 
largas y dos cortas (α2β2) mientras que las AGPases de origen bacteriano son 
homotetrámeros constituidos por protómeros de aproximadamente 50 kDa. Estos 
protómeros, al igual que en otros miembros de la superfamilia de nucleotidil transferasas, 
están constituidos por un dominio catalítico α-β-α sándwich N-terminal y un dominio 
regulador hélice-β C-terminal. Previamente a este trabajo, solamente dos estructuras 
cristalinas de AGPase habían sido resueltas; (i) la de Agrobacterium tumefaciens y (ii) 
la de Solanum tuberosum. En este último caso, la estructura depositada corresponde a 
un homotetrámero no fisiológico conformado únicamente por subunidades pequeñas 
(α4). La ausencia de estructuras en complejo con reguladores alostéricos ha dificultado 
el estudio del mecanismo por el cual la unión de estos metabolitos regula 
alostericamente la actividad catalítica de la enzima. En este sentido, la identificación de 
los sitios alostéricos en AGPase ha sido uno de los principales desafíos en el campo a 
lo largo de las últimas décadas. La AGPase de Escherichia coli (EcAGPase) ha sido el 
principal modelo de estudio de AGPases, no solo en relación a su actividad catalítica 
sino también al entendimiento de sus propiedades alostéricas. Específicamente, los 
reguladores alostéricos fiosiológicos de EcAGPase son fructosa-1,6-bifosfato (FBP) y 
adenosina-difosfato (ADP), regulador alostérico positivo y negativo respectivamente. 
Diversos estudios bioquímicos sugieren que tanto el dominio N- como C-terminal 
estarían involucrados en la regulación alostérica de AGPase, sin embargo, el 
mecanismo a nivel molecular por el cual se produce esta regulación sigue siendo una 
incógnita.  
 
  
Con el objetivo de profundizar en esta dirección, hemos resuelto la estructura 
cristalina de EcAGPase en complejo con su regulador alostérico positivo 
(EcAGPase•FBP) y negativo (EcAGPase•AMP) a una resolución de 2.67 y 3.04 Å, 
respectivamente. La estructura cristalina de EcAGPase corresponde a un 
homotetrámero que puede considerarse un dímero de dímeros. Los sitios de unión de 
ambos reguladores se encuentran parcialmente superpuestos en una profunda fisura 
entre los dominios N- y C- terminales de protómeros vecinos. El regulador negativo AMP 
se encuentra enterrado en la hendidura alostérica, con el fosfato α orientado hacia una 
cavidad rica en residuos cargados positivamente. De las interacciones derivadas de la 
unión a AMP resalta la fijación del heterociclo de adenina a través de la cadena lateral 
del residuo Arg130. Este importante residuo se encuentra en la hélice α7 del protómero 
vecino, que conforma a su vez un dímero distinto, hecho que aporta claras evidencias 
de interacciones inter-protoméricas derivadas de la unión a AMP. Para comprobar esta 
hipótesis, dado que este tipo de interacciones podrían llevar a la estabilización de la 
estructura cuaternaria de EcAGPase en solución, decidimos estudiar su estabilidad 
térmica por dicroísmo circular. Gracias a estos ensayos biofísicos determinamos que 
EcAGPase en complejo con AMP es 4.6 ºC más estable que su forma apo, resultado 
que concuerda con las observaciones estructurales. Por otro lado, FBP se une a la 
misma hendidura, pero en una localización más expuesta al solvente donde la Arg130 
ha sufrido un importante cambio conformacional. Esta variación/modificación de las 
interacciones inter-protoméricas queda reflejada en los estudios de dicroísmo circular 
donde la unión del regulador positivo no induce la estabilización térmica de la enzima. 
Esta configuración estructural de EcAGPase en la cual ambos reguladores se unen en 
localizaciones parcialmente superpuestas, explica el hecho de que la sensibilidad a la 
inactivación por AMP se ve afectada por la concentración de FPB. En este trabajo 
pudimos determinar asimismo que la adición de FBP al complejo EcAGPase•AMP 
provoca una reversión de la estabilización térmica, lo que indica que FBP no solo es 
capaz de desplazar el AMP sino también de modificar el estado conformacional inducido 
por este regulador hacía una estructura menos estable.  
  
El estudio detallado de las estructuras cristalinas determinó que cada hendidura 
alostérica comunica con el correspondiente sitio activo del mismo protómero a través de 
un elemento estructural que denominamos “Sensory Motif” (SM). Este motivo estructural 
está constituido por el loop de unión al nucleótido (NBL), el cual incluye la secuencia 
consenso GGxGxR involucrada en la unión del ATP, y una región compuesta por 
 diversos elementos de estructura secundaria relativamente cortos. La presencia de un 
loop flexible en el mismo protómero, denominado “Regulatory Loop 1” (RL1), que 
interacciona tanto con el NBL como con los elementos de estructura secundaria en el 
SM, indica una posible participación en la modulación de la conformación adoptada por 
el SM. Como se ha comentado anteriormente, la unión de AMP involucra una fuerte 
interacción con la cadena lateral del residuo Arg130 localizado en un protómero vecino 
de un dímero distinto. La hélice en la que se encuentra este residuo, α7, conecta a su 
vez con un loop denominado “Regulatory loop 2” (RL2) que flanquea el sitio de unión de 
ATP en el sitio activo. Teniendo en cuenta toda la información estructural reportada, 
proponemos un modelo de regulación alostérica de EcAGPase en el que la unión de los 
reguladores alostéricos positivo y negativo modularían la actividad enzimática a través 
del SM y dos loop regulatorios, RL1 y RL2, mediante interacciones intra- e inter-
protoméricas.  
 
Con el objetivo de validar el sitio de unión de ambos reguladores alostéricos, diseñamos 
mutantes puntuales de residuos involucrados en la interacción con ambos moduladores, 
para posteriormente medir la estabilización térmica, actividad específica y contenido de 
glucógeno “in vivo” de cada una de las variantes. La mutación de residuos involucrados 
en la unión de AMP claramente impide la estabilización mediada por el inhibidor 
mientras que las mutantes de residuos implicados en la unión de FBP fueron incapaces 
de revertir el efecto estabilizador de AMP en presencia del activador. Las medidas de 
actividad específica mostraron que la mutante EcAGPase•R130A corresponde a una 
variante en la que la inhibición por AMP se encuentra desregulada, hecho que 
concuerda con la información estructural que indica un papel fundamental de este 
residuo en el mecanismo inter-protomérico de transducción de la señal alostérica. Al 
transformar una cepa E.coli inactiva para el gen de EcAGPase con las distintas mutantes 
puntuales, pudimos determinar que las actividades enzimáticas medidas para 
EcAGPase•R130A se traducen en un incremento de la cantidad de glucógeno 
acumulado por las bacterias transformadas con esta variante. Posteriormente, la 
estructura cristalina de EcAGPase•R130A se resolvió en ausencia de ligandos a una 
resolución de 3.09 Å. Al comparar esta nueva estructura con la correspondiente a los 
complejos EcAGPase•AMP y EcAGPase•FBP se observan claros cambios 
conformacionales en elementos implicados en el mecanismo alostérico propuesto. Parte 
del SM se encuentra en una conformación extendida invadiendo parcialmente el sitio de 
unión de AMP y tanto el RL1 como el RL2 adoptan conformaciones distintas a las 
  
observadas para la enzima salvaje. Curiosamente, la estructura de EcAGPase•R130A 
presenta una reorientación de los dímeros que conforman el homotetrámero, lo que 
indica una clara flexibilidad de la estructura cuaternaria de EcAGPase.     
 
Dado que diversos resultados experimentales apuntan a cambios de estructura 
cuaternaria asociados al mecanismo alostérico de EcAGPase, decidimos focalizamos 
en el estudio de la estructura cuaternaria de la enzima en solución. A través de HPLC-
SAXS determinamos que el complejo EcAGPase•AMP es más homogéneo y compacto 
que el correspondiente a FBP, observándose en este último una clara pérdida de 
globularidad. La comparación de las estructuras cristalinas de ambos complejos con los 
modelos ab initio obtenidos por SAXS sugiere que, la adición de FBP a EcAGPase en 
solución dispara un importante cambio conformacional a nivel de estructura cuaternaria, 
que no es observable por cristalografía. Con el objetivo de validar esta hipótesis 
resolvimos la estructura de ambos complejos por cryo-EM. Los modelos obtenidos 
apuntan de nuevo a cambios de estructura cuaternaria, observándose una reorientación 
de los dímeros en el complejo activado. Basándonos en estos resultados, la estructura 
cristalina del complejo EcAGPase•AMP correspondería a la conformación tensa (T) de 
baja actividad definida por el modelo Monod-Wyman-Changeux (MWC), mientras que 
la estructura cristalina del complejo EcAGPase•FBP representaría un primer evento de 
unión de FBP a este mismo estado. El estudio del estado relajado (R) de alta actividad 
en EcAGPase requerirá en un futuro la determinación de la estructura del complejo 
EcAGPase•FBP en solución a alta resolución.  
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1. INTRODUCCIÓN 
1.1. Glycogen as a Reserve Storage Compound 
 
The biosynthesis of α-1,4-linked and α-1,6-branched glucose polymers (α-polyglucans), 
defines the most widespread form of storage polysaccharides in living cells and 
represents a major carbon an energy reserve form in nature. The most representative α-
polyglucans are glycogen and starch (Jack Preiss, 2006; Wilkinson, 1963). Glycogen is 
found in a majority of animal, fungal, bacterial, and archeabacterial species as discrete 
cytoplasmic granules, whereas starch is only found in photosynthetic eukaryotes (Figure 
1.1; S. Ball et al. 1996; S. G. Ball and Morell 2003; Pfister and Zeeman 2016). The 
advantage of using polysaccharides as 
storage reserves is that they are 
osmotically neutral means to store glucose 
in cells due to their high molecular weights 
(Roach, Depaoli-Roach, Hurley, & 
Tagliabracci, 2012a).  
 
Figure 1.1. Glycogen accumulation in DglgP 
E. coli mutant. The arrows indicate the 
electron-transparent cytoplasmatic glycogen 
granules preferentially located in the periphery 
of the bacteria (Modified from Alonso-Casajús 
et al. 2006) 
 
Either the accumulation or deficiency of glycogen in humans causes glycogen 
storage diseases (GSDs). Commonly, GSD is produced by defective enzymes involved 
in glycogen metabolism and regulation, displaying distinctive phenotypes depending on 
the enzyme affected (Hicks, Wartchow, & Mierau, 2011). In this regard, inactivation of 
the muscle glycogen synthase, the enzyme involved in the α-1,4-linkages elongation, 
causes glycogen depletion in skeletal and heart muscle, resulting in muscle weakness 
and cardiomyopathy (Moslemi et al., 2010). On the other hand, deficiencies on the 
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enzyme responsible of the depolymerization of glycogen at the α-1,6 branching points, 
result in the accumulation of abnormal glycogen, impairing the function of certain organs 
and tissues (Cori disease; Zhai et al. 2016). 
 
Wilkinson proposed that for a compound to be classified as having energy-storage 
function, it must satisfy three criteria (Wilkinson, 1959): 
 
i. the compound should accumulate intracellularly under conditions in which the 
energy supply for growth of the organism is in excess, 
ii. it must be utilized when supplies of energy from exogenous sources are no longer 
available for maintenance of growth or other processes necessary to sustain 
viability,  
iii. the proposed storage compound must be degraded to an energy form used for 
some purpose which gives the cell a biological advantage to survive or attend 
better in the media or environment.  
 
The occurrence of glycogen-like reserves has been reported in over 50 different 
bacterial species including Gram-negative, Gram-positive, archaebacteria and 
photosynthetic bacteria, a number of these observed as inclusion bodies of variable 
diameter (Iglesias & Preiss, 1992; Leadbetter & Poindexter, 1989; Jack Preiss, 2014; 
Shively, 1974). Based on several experimental observations bacterial glycogen fits these 
criteria. Its biosynthesis usually occurs in the presence of an excess carbon source and 
under environmental conditions of slow growth or no growth. Thus, glycogen 
accumulation has been shown to occur preponderantly in the stationary phase of the 
growth cycle due to limitations in an essential nutrient such as sulphur, nitrogen, or 
phosphate (M. a Ballicora, Iglesias, & Preiss, 2003; J Preiss, 1984, 2010). In this regard, 
Escherichia coli B cultures having glucose as carbon source and limited with respect to 
nitrogen show an inverse relationship in the rate of growth and the quantity of glycogen 
accumulated (Holme, 1957).  
 
Mutants of different bacterial species, which are deficient in glycogen 
accumulation due to mutations in key enzymes involved on this polysaccharide synthesis, 
grow as well as their wild type parent strains indicating that glycogen might not be 
required for bacterial growth (Govons, Gentner, Greenberg, & Preiss, 1973; Steiner & 
Preiss, 1977). However, a more prolonged survival rate is observed in the cells 
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accumulating the polysaccharide compared with the glycogen-less mutants (Strange, 
1968). These observations suggest that under conditions of no available carbon source, 
glycogen is probably utilized to preserve cell integrity, providing the energy required by 
the bacteria for maintenance. This ‘energy of maintenance’ is the energy needed for 
processes such as turnover of proteins and RNA, maintenance of motility and 
intracellular pH, chemotactic response and osmotic regulation (Wilkinson, 1963).  
 
 
 
1.2. Bacterial glycogen structure 
 
According to the currently accepted model, bacterial glycogen is similar to mammalian 
glycogen; it is a very large branched water-soluble polymer consisting of α-D-glucosyl 
units, these units are connected together by α-1,4-glucosidic linkages to form linear 
oligosaccharide chains, with α-1,6-glucosidic linkages at branching points (Figure 1.2; 
Manners, 1991).  
 
 
 
Figure 1.2. Glycogen structure. Glycogen is a glucose homopolymer composed of 
approximately 90% of α-1,4-glucosidic linkages and 10% of branching α-1,6-glucosidic linkages. 
 
Glycogen isolated from biological sources is polydisperse, existing as a 
population of molecules of different sizes. In addition, α-1,6-linkages are localized in 
random positions and their percentage can vary depending on the bacterium and 
possibly on the stage of glycogen synthesis (Roach, Depaoli-Roach, Hurley, & 
 - 6 - 
Tagliabracci, 2012b). It has been observed that in Mycobacterium smegmatis the degree 
of branching decreases as the glycogen granules increase in size (Manners, 1991). The 
molecular weights of glycogen isolated from different bacteria can also vary. However, 
the particular method used to isolate glycogen can significantly affect its molecular 
weight. The common way to analyze the chemistry of glycogen molecules is to define 
molecular mass distributions, average chain lengths and average branching frequencies. 
In bacteria, these parameters can vary depending on the source but the average length 
of the chains is usually of 8–12 glucose units, the α-1,6-branches accounts for 7–10% 
of the linkages and the molecular size of glycogen has been estimated to be about 107–
108 Da (S. Ball, Colleoni, Cenci, Raj, & Tirtiaux, 2011; Leadbetter & Poindexter, 1989; 
Manners, 1991).  
 
The storage of high amounts of free glucose within the cell would create an 
osmotic imbalance, for that reason, glucose units must be densely packed to increase 
the solubility of this polysaccharide (Figure 1.3A). Structurally, its branching pattern 
allows for spherical growth of the particle leading to a progressively more packed 
structure towards the periphery (Figure 1.3B; S. Ball et al. 2011). The size and density 
of the glycogen granule is self-limited to allow the interaction of the glycogen chains with 
the catalytic sites of the enzymes involved in its metabolism (Shearer & Graham, 2002). 
Mathematical modelling predicts a 42 nm maximal diameter of the glycogen granule 
including 55 000 glucose residues (Figure 1.3A). A higher percent of this total number of 
glucose residues localizes in the outer (unbranched) shell and is thus readily accessible 
to glycogen catabolism without debranching. In vivo, glycogen particles are thus present 
in the form of these limit size granules (macroglycogen) and also smaller granules 
representing intermediate states of glycogen biosynthesis and degradation (proglycogen) 
(Shearer & Graham, 2002). Based on its physical properties, glycogen particles are 
entirely hydrosoluble and, therefore, define a state where the glucose becomes less 
active osmotically but easily accessible for rapid mobilization through the enzymes of 
glycogen catabolism as if it were in the soluble phase (S. Ball et al., 2011).  
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Figure 1.3. (A, B) The schematic representation of whole glycogen granule. (B) Enlarged 
views of the circled sections of the glycogen granule. The distribution of branches exemplified in 
(B), with two α-1,6 linkages per glucan, allows the exponential increase in the density of the 
particle. This leads to a predictable maximum of 42 nm for the glycogen granule displayed in (A) 
(Modifed from S. Ball et al. 2011). 
 
It is worth noting that glycogen and starch display the same chemical building 
unit, α-D-glucosyl units connected in both α-polyglucans by the same types of covalent 
bonds, displaying similar ranges of molecular mass (Manners, 1991). Starch is 
composed of two major polysaccharides, amylose and amylopectin. Amylose is an 
essentially linear α-1,4-glucan with very few α-1,6-branches (less than 1%) whereas 
amylopectin, the major compound, consists of α-1,4-glucan chains with approximately 
5% of α-1,6-branches (Figure 1.4; Iglesias and Preiss 1992; S. Ball et al. 1996). Despite 
the similarities between glycogen and starch, their morphology and physical properties 
are quite different; due to their differences in the branch structure and molecule shape, 
starch defines insoluble semi-crystalline granules with sizes ranging 0.1-100 µm (S. Ball 
et al., 2011).  
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1.3. Glycogen metabolism in bacteria 
 
In bacteria, the basic glycogen biosynthetic pathway involves the action of three 
enzymes: adenosine diphosphate-glucose pyrophosphorylase (AGPase; EC 2.7.7.27), 
glycogen synthase (GS; EC 2.4.1.21), and branching enzyme (BE; EC 2.4.1.18) (Jack 
Preiss, 2014). It is well established that the NDP-sugar donor for bacterial glycogen 
synthesis is adenosine diphosphate-glucose (ADP-Glc). ADP-Glc is synthesized from 
adenosine triphosphate (ATP) and α-glucose-1-phosphate (α-Glc-1-P; G1P), with the 
liberation of pyrophosphate (PPi), via a reaction catalyzed by the enzyme AGPase 
(Reaction 1) (M. a Ballicora et al., 2003). 
 
ATP + G1P ←→ADP-Glc + PPi                                                                       (1) 
 
The next step of bacterial glycogen synthesis consists in the transfer of the 
activated glucose to the nonreducing end of a growing α-1,4-linked glucan (Reaction 2). 
A specific glycosyltransferase, GS, catalyzes this reaction (Buschiazzo et al., 2004). To 
date, it has been postulated that GS is able to initiate de novo glycogen biosynthesis 
Figure 1.4.  Glycogen and starch components, amylopectin and amylose, structure. The 
degree of branching in glycogen is higher than in amylopectin, been practically inexistent in the 
case of amylose. The difference in branching pattern between glycogen and starch confers 
distinctive structural properties to these carbohydrate granules 
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from ADP-Glc or use a pre-existent α-glucan primer as substrate for further elongation 
(Ugalde, Parodi, & Ugalde, 2003). However, the proposed molecular mechanism still 
remains a major challenge in the field. 
 
ADP-Glc + (α-1,4-glucan)n → (α-1,4-glucan)n+1 + ADP                                    (2) 
 
As indicated before, 10% of the total linkages found in glycogen are α-1,6-
glucosyl bonds. They are formed in a reaction catalyzed by the BE (Reaction 3) which 
hydrolyzes an α-1,4-linkage within a pre-existing α-1,4-linked glucan and transfers a 
segment of chain in α-1,6 position generating a branch point (Feng et al., 2015). 
 
α-1,4-glucan → α-1,6-branched α-1,4-glucan                                                    (3) 
 
In contrast, glycogen degradation is carried out by glycogen phosphorylase (GP; 
EC 2.4.1.1), which functions as a depolymerizing enzyme, and the debranching enzyme 
(DBE; EC 3.2.1.-) that catalyzes the removal of α-1,6-linked ramifications.  
 
In bacteria, the presence of glycogen is associated with a minimum of one 
AGPase, one GS, one GP, one BE, and one GDE (Figure 1.5). These enzymes 
constitute the core pathway of glycogen metabolism and it is conserved among a broad 
range of bacterial species (Jack Preiss, 2014).  
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Figure 1.5. Bacterial glycogen metabolism. Bacterial glycogen biosynthetic pathway involves 
the action of three enzymes: adenosine diphosphate-glucose pyrophosphorylase (AGPase; EC 
2.7.7.27), glycogen synthase (GS; EC 2.4.1.21), and branching enzyme (BE; EC 2.4.1.18) 
whereas its degradation is carried out by glycogen phosphorylase (GP; EC 2.4.1.1) and the 
debranching enzyme (DBE; EC 3.2.1.-). 
 
 
In Escherichia coli, these enzymes are located in a cluster of 15Kb organized in 
two neighboring operons (Figure 1.6) (Jack Preiss, 2006; Romeo, Kumar, & Preiss, 
1988). A deep study of this cluster showed that the genes coding for GS (glgA), AGPase 
(glgC), BE (glgB), isoamylase (glgX) and GP (glgP), are transcribed as two different 
operons, glgBX and glgCAP (Figure 1.6). Specifically, a non-coding region comprising 
500pb is located between glgX and glgC genes and both operons are preceded by 
promotors regulated during the growth phase (Jack Preiss, 2014). 
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Figure 1.6. Genomic organization of E. coli glycogen metabolic enzymes in two 
neighboring operons; glgBX and glgCAP. 
 
Most of the glycogen accumulated in bacteria is mediated by the GlgC-GlgA 
(AGPase-GS) pathway. In this regard, several studies demonstrated that glycogen-
deficient or glycogen-excess mutants of several organisms are affected in AGPase, GS 
or BE activities (Jack Preiss, 2014).  
 
More recently, important progress have been made in determining the 
physiological function of bacterial α-glucan beyond the classical point of view of glycogen 
as a storage reserve compound. The existence of an alternative pathway to glycogen 
synthesis in Mycobacterium species, known as the GlgE pathway, has been 
demonstrated. Mycobacterium tuberculosis synthesizes intra- and extracellular α-
glucans, been the last the main constituent of the mycobacterial capsule thought to be 
involved in immune evasion and virulence (Mishra, Driessen, Appelmelk, & Besra, 2011). 
Specifically, capsular α-glucan has been identified as a novel ligand for the C-type lectin 
dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN), involved in host immune 
modulation (Geurtsen et al., 2017). Originally, three separate and potentially redundant 
pathways were implicated in mycobacterial α-glucan biosynthesis: (i) the GlgC-GlgA 
pathway for classical glycogen, (ii) the glycosyltransferase Rv3032 (iii) and the TreS-
Pep2-GlgE pathway for trehalose-to-glucan conversion (Figure 1.7; Kalscheuer et al., 
2010). However, recent studies have shown that α-glucan in mycobacteria is exclusively 
assembled intracellularly utilizing the building block α-maltose-1-phosphate (M1P) as the 
substrate for the α-1,4-glucan:maltose-1-phosphate maltosyltransferase  GlgE, with 
subsequent branching of the polymer by the BE GlgB. Some of this polysaccharide is 
then exported to form the mycobacterial α-glucan capsule. Interestingly, the 
mycobacterial GS GlgA is three orders of magnitude more efficient at transferring 
glucose from ADP-Glc to G1P than to glycogen making little or no glycogen via the 
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classical GlgC-GlgA biosynthetic pathway. GlgA is, therefore, a M1P-producing 
glucosyltransferase which generates the activated M1P substrate for the synthesis of 
linear α-glucan through the GlgE pathway. On the other hand, Rv3032 action appears 
to be restricted to the synthesis of specialized oligomeric α-glucan derivatives such as 
methylglucose lipopolysaccharides (MGLPs), as the deletion of Rv3032 gene has no 
significant impact on the levels of either intracellular or capsular α-glucans. These 
evidences support the fact that both cytosolic and capsular α-glucan polymers in 
Mycobacterium tuberculosis, Mycobacterium smegmatis and probably all other 
mycobacteria are predominantly, if not exclusively, synthesized by the 
maltosyltransferase GlgE together with the branching enzyme GlgB (Asención Diez et 
al., 2015; Koliwer-Brandl et al., 2016; Rashid et al., 2016). Several structures of the 
enzymes involve in mycobacterial α-glucan biosynthesis have been reported (Caner et 
al., 2013; Lindenberger, Kumar Veleti, Wilson, Sucheck, & Ronning, 2015; Pal et al., 
2010; Roy et al., 2013). 
Similarly, an unconventional α-glucan metabolic pathway from the food-borne 
pathogen Listeria monocytogenes has been recently described. It outcomes from the 
identification of cycloalternan (CA), a cyclic tetrasacharide bacterial product with 
alternating α-1,3- and 1,6-glucan linkages, and the related extracellular cycloalternan-
forming enzyme (CAFE) in this organism.  This specialized metabolic function allows the 
bacteria to extracellularly transform environmental α-glucans into CA, which is transport 
into the cell and hydrolyzed to glucose. This CA pathway is not essential for 
maltose/maltodextrin utilization, in fact, most bacteria directly take up prevalent α-glucan 
and/or secrete an amylase to digest them into mono- or disaccharides that can be 
imported via general transport mechanism. It is worth noting that L. monocytogenes must 
compete with the host and other members of the microbiota for limited nutrients. It has 
been proposed that this new pathway could be a way to convert extracellular α-glucans 
to a form that few competing cells can catabolically process been, therefore, involved in 
interspecies resource competition within the host gastrointestinal tract (Light, Cahoon, 
Halavaty, Freitag, & Anderson, 2016). 
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The characterization of novel biosynthetic pathways and functions for bacterial 
α-glucan which, in some cases, implies the overlap of the canonical GlgC-GlgA pathway 
enzymes, highlight the evolution of the field (Koliwer-Brandl et al., 2016). In the current 
work, we will focus our attention on the canonical GlgC-GlgA glycogen biosynthetic 
pathway not describing in the following sections the enzymes involved in alternative 
pathways.    
 
 
Figure 1.7. Model of GlgE-mediated intracellular and capsular α-glucan biosynthesis in 
mycobacteria. The M1P building block is synthesize via two alternative routes; the TreS-Pep2 
pathway which involves the isomerization of trehalose to maltose by trealose synthase (TreS, EC 
5.4.99.16) and the conversion to M1P by maltokinase (Pep2, EC 2.7.1.175) and the GlgC-GlgA 
pathway (blue lines). GlgA and the trehalose-6-phosphate synthase (OtsA, EC 2.4.1.15) connect 
both routes through the shared use of ADP-Glc and the α-1,4-glucan:maltose-1-phosphate 
maltosyltransferase  (GlgE, EC 2.4.99.16)  catalyzes the α-glucan polymerization with further 
addition of α-1,6-branch points by GBE GlgB (orange lines).    
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1.4. Molecular bases of bacterial glycogen biosynthesis  
 
The glycogen synthesis by the canonical GlgC-GlgA pathway is a three-step process 
including an initiation, elongation and branching step (J Preiss, 2010; Ugalde et al., 2003; 
Wilson et al., 2010). This section includes a detailed description of the bacterial enzymes 
and proposed mechanisms involved in each step of the pathway, providing only brief 
information regarding the analogous plant/mammal systems as reference.  
 
 
1.4.1. ADP-Glc Pyrophosphorylase 
 
ADP-Glc serves as NDP-sugar donor for bacterial and plant glycogen/starch 
biosynthesis and its formation is mediated by AGPase (Figure 1.8; (Recondo & Leloir, 
1961; Trivelloni, Recondo, & Cardini, 1962). The activity of AGPase was firstly 
determined by J. Espada in 1962 (Espada, 1962) and since then, the characterization of 
this enzyme has been a matter of intense research in the field of glycogen/starch 
biosynthesis and regulation. Specifically, AGPase catalyzes the reaction between ATP 
and G1P to produce pyrophosphate and ADP-Glc in the presence of the divalent metal 
cation Mg2+ (Figure 1.8; Ballicora, Iglesias, and Preiss 2003). AGPase activity displays 
cooperative behavior and a bi-bi mechanism with sequential binding of ATP and G1P, 
followed by ordered release of pyrophosphate and ADP-Glc (Paule & Preiss, 1971). This 
reaction is reversible when isolated but in vivo it is shifted to ADP-Glc synthesis because 
of the subsequent hydrolysis of released PPi by ubiquitous pyrophosphatases in the 
organism (Kornberg, 1962). Evolution has led AGPase to acquire allosteric properties to 
control this key rate-limiting step of the glycogen biosynthetic pathway by essential 
metabolites in the energetic flux within the cell (J Preiss, 1978). 
 
 
 
Figure 1.8. Chemical reaction catalyzed by AGPase. 
Doctoral Thesis – Natalia Comino 
 
 - 15 - 
AGPases from different sources have been studied in terms of their subunit 
composition. Plant AGPases are heterotetramers composed by small (α) and large (β) 
subunits (α2β2) (Crevillén, Ballicora, Mérida, Preiss, & Romero, 2003; Giroux et al., 1996; 
Jin, Ballicora, Preiss, & Geiger, 2005) whereas, the native enzymes from most bacterial 
sources are homotetramers of ∼50 kDa subunit (Cupp-Vickery, Igarashi, Perez, Poland, 
& Meyer, 2008; Haugen, Ishaque, Chatterjee, & Preiss, 1974; Ko, Kim, Lee, & Kim, 1996; 
Yung & Preiss, 1982). To date, only two crystal structures of AGPase have been reported, 
the apo state of Agrobacterium tumefaciens AGPase (AtAGPase; Figure 1.9; PDB: 
3BRK; Cupp-Vickery et al. 2008) and the potato tuber AGPase (StAGPase). In the case 
of StAGPase, the crystal structure corresponds to a non-physiological, truncated 
recombinant homotetrameric version of the small subunit (α4), and it was solved in the 
presence of (i) SO4 (PDB: 1YP2), (ii) ATP (PDB: 1YP3), and (iii) ADP-Glc (PDB: 1YP3; 
Jin et al. 2005).  
AtAGPase monomer comprises two different domains: a glycosyltransferase A (GTA)-
like domain containing the active site and a C-terminal regulatory domain constituted by 
a left-handed parallel β-helix (LβH). The GTA-like catalytic domain is composed of a 
seven-strand central β-sheet with only one β-strand oriented antiparalell in the center of 
the β-sheet. This feature is surrounded on both sides by 12 amphipathic α-helices, which 
interact through their hydrophobic faces with the hydrophobic side chains of the central 
β-sheet (Figure 1.9A). The C-terminal LβH domain comprised four β-strands stacked to 
form a small left-handed parallel β-helix that displays a triangular coil. This structural 
feature shows a short β-strand on the top and two small β-strands, mixed with two short 
α-helices, cover the bottom of the β-helix (Figure 1.9A). The dimerization of AtAGPase 
takes place by the antiparalell stacking of the LβH domains whereas the tetramerization 
appears from the interaction between the N-terminal domains (Figure 1.9B-C; Cupp-
Vickery et al. 2008). Despite the low sequence identity shared between AtAGPase and 
the StAGPase small subunit (31%), their overall fold is preserved and it is predicted for 
all bacterial and plant AGPases (Figure 1.9D; Cupp-Vickery et al. 2008; Singh, Phillips, 
and Thorson 2012). 
 
AGPases are members of the superfamily of sugar nucleotidyltransferases 
(SNTs) and the enzymes within this family share a similar domain organization and 
common structural features. The GTA-like catalytic domain is composed of an α/β/α 
sandwich reminiscent of the dinucleotide-binding Rossmann fold (Rao & Rossmann, 
1973) with a central β-sheet comprising seven β-strands flanked on both sides with 
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several α-helices tightly packed against the β-sheet. Often there are additional 
secondary structure insertions, sometimes known as subdomains, between strands β5 
and β6 and strands β2 and β3, depending upon the nucleotidyltransferase family (Singh 
et al., 2012). On the other hand, the C-terminal auxiliary domain corresponds to a LβH 
feature but, based on several structures reported within this family, the orientation and 
length of this β-helix domain can vary along with its function (Brown et al., 1999; 
Kanamaru et al., 2002; Kostrewa, D’Arcy, Takacs, & Kamber, 2001; Raetz & Roderick, 
1995).  
 
Crystal structures of several other sugar nucleotide pyrophosphorylases have 
been reported, including; (i) the E. coli and Streptococcus pneumoniae UDP-N-
acetylglucosamine pyrophosphorylase GlmU, a bifunctional enzyme that catalyzes the 
CoA- dependent acetylation of glucosamine-1-phosphate (GlcN-1-PO4) and the metal-
dependent condensation of the resulting GlcNAc-1-PO4 with UTP to form the activated 
nucleotide sugar UDP-GlcNAc involved in the bacterial cell wall synthesis (PDB: 2OI5; 
Brown et al. 1999; Kostrewa et al. 2001; Green et al. 2012), (ii) the Pseudomonas 
aeruginosa glucose-1-phosphate thymidylyltransferases RmlA, which catalyzes the 
formation of di-oxythymidine diphosphated-D-glucose (TDP-D-glucose) from 
deoxythymidine triphosphate (dTTP) and G1P, the first reaction in the L-rhamnose 
biosynthetic pathway  (PDB: 3ZLK; Blankenfeldt et al. 2000), and (iii) the E. coli glucose-
1-phosphate thymidylyltransferase RffH, that catalyzes the same reaction but forms part 
of a different operon and biosynthetic pathway, being involved in the synthesis of 
enterobacterial common antigen (ECA), a cell surface glycolipid found in Gram-negative 
enteric bacteria (PDB: 1MC3; Sivaraman et al. 2002). The structural information derived 
from the GlmU, RmlA, and RffH crystal structures and the strong homology shared with 
the catalytic domain of AGPase, suggest a similar mechanism of action for these 
enzymes. The catalytic mechanism of AGPases will be further discuss in chapter 4. 
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Figure 1.9. The crystal structure of AtAGPase. (A) The overall structure of an AtAGPase 
protomer showing the GTA-like domain (yellow) and the LβH domain (blue). (B) Two views of the 
AtAGPase dimer. (C) The structure of an AtAGPase homotetramer and its surface representation. 
(D) Superposition of AtAGPase protomer and StAGPase small subunit. 
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1.4.2. Glycogen synthase 
 
1.4.2.1. Initiation  
 
It is well known that in the case of yeast and mammals the initiation of glycogen 
biosynthesis involves the action of the enzyme glycogenin (GN), which is considered the 
first acceptor of glucose units from the NDP-sugar donor UDP-Glc, catalyzing an 
autoglycosylation reaction. Further self-glycosylation occurs up to an oligosaccharide 
chain containing 8–12 glucose units linked by α-1,4-glucosidic linkages. This 
oligosaccharide remains attached to GN and forms a primer for further elongation by GS 
and the action of BE. In addition, glycogen and lower molecular weight maltodextrins can 
also serve as primers for the GS reaction (Lomako, Lomako, & Whelan, 2004; Roach et 
al., 2012a). 
 
A major unresolved question of bacterial glycogen biosynthesis is the mechanism 
of initiation. Fully sequenced genomes of bacteria known to accumulate glycogen have 
failed to reveal the presence of glycogenin homologues (Fox et al., 1973). Initially, it was 
proposed the existence of an initiation reaction in bacteria based in the incorporation of 
glucose into a protein acceptor. These studies were based in the different solubility of 
protein and glycogen in trichloroacetic acid (TCA), which makes possible to differentially 
determine the incorporation of radio-activity from labelled NDP-sugar into protein or into 
glycogen (Barengo, Flawia, & Krisman, 1975). However, further experimental evidence 
demonstrated that this observation corresponded to the elongation of pre-existent 
contaminant α-1,4-glucans in the sample and not to a glycogen de novo synthesis 
phenomenon (Kawaguchi, Fox, Holmes, Boyer, & Preiss, 1978). More recently, it was 
observed that A. tumefaciens GS can not only elongate α-1,4-linked glucans, but also 
form the primer required for the elongation process by catalyzing its own glycosylation 
in a similar way as glycogenin. Interestingly, some differences between glycogenin and 
GS initiation mechanisms were observed. The oligosaccharides formed by GS were 
composed by 2-9 glucose residues and, in addition, this glycan is released from the 
enzyme whereas in the case of glycogenin, it remains covalently attached during the 
elongation and branching steps (Ugalde et al., 2003). It was proposed that, bacterial GSs 
use this de novo synthesis mechanism in the absence of available soluble α-1,4-glucans 
to provide itself with an initial substrate. Due to the high affinity of GS for soluble α-1,4-
Doctoral Thesis – Natalia Comino 
 
 - 19 - 
glucans, when a functional concentration of this substrates is reached within the cell, GS 
preferentially catalyzes an elongation reaction of this oligosaccharides inducing an 
apparent inhibition of the initiation reaction (Ugalde et al., 2003).  
 
 
1.4.2.2. Elongation 
 
The next step in the glycogen biosynthetic pathway is carried out by GS and consists in 
the elongation of the α-1,4-linkages by the successive addition of α-1,4-linked glucose 
residues to the non-reducing end of glycogen, using NDP-glucose as the donor substrate 
(Figure 1.10; J Preiss 2010).  
 
 
Figure 1.10. Chemical reaction catalyzed by bacterial GS. 
 
Based on amino acid sequence similarity, glycosyltransferases (GTs) have been 
classified into several families (Cantarel et al., 2009). This classification system, which 
presently counts over 103 families of GTs is available and continuously updated at the 
Carbohydrate-Active enzyme database (CAZYy: www.cazy.org). A feature that makes 
these families particularly useful is that they correlate with several structure-based 
properties of the enzymes, such as an essentially conserved fold and active site 
geometry. Glycogen and starch synthases are classified in two large protein families: 
mammalian/yeast GSs included into the glycosyltransferase family 3 (GT3) and 
bacterial/plant GSs, which form part of the glycosyltransferase family 5 (GT5; Sheng, Jia, 
et al. 2009). Mammalian and yeast synthases are »80kDa enzymes that use UDP-
glucose as sugar donor and are regulated by covalent phosphorylation and allosteric 
ligand binding, whereas bacterial and plant synthases have a smaller size (»50 kDa), 
prefer ADP-glucose as substrate and appear to be unregulated proteins (S. G. Ball & 
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Morell, 2003; Gibbons, Roach, & Hurley, 2002). Sequence similarity is marginal between 
the ADP-glucose- and UDP-glucose-requiring enzymes, on the other hand, bacterial 
GSs and plant SSs share significant (30–34%) sequence homology over most of their 
length, consistent with a similar overall fold and enzymatic mechanism (Coutinho, 
Deleury, Davies, & Henrissat, 2003).  
 
Two major structural folds have been described for the nucleotide sugar-
dependent (Leloir) GTs defined as GT-A and GT-B. GSs and SSs are members of the 
GT-B superfamily of glycosyltransferases, which shares a common double ‘Rossmann-
fold’ domain architecture. This ‘nucleotide binding’ or ‘Rossmann-fold’ domain contains 
two sets of β-α-β-α-β units (654123 topology), together forming a single parallel sheet 
flanked by α-helices. An extended interdomain linker peptide connects the N- and C-
terminal halves describing a typical feature of GT-B enzymes (Albesa-Jové & Guerin, 
2016; Urresti et al., 2012). The active site of all of these enzymes lies in the interdomain 
cleft and therefore, a proper relative orientation of the two domains is required for correct 
active site geometry and catalytic competence as demonstrated for MurG (Hu et al., 
2003), PimA (Guerin et al., 2007, 2009) or MshA (Vetting, Frantom, & Blanchard, 2008). 
It is generally accepted that in GT-B enzymes, the nucleotide-sugar donors mainly bind 
to the C-terminal domain of the protein, whereas the N-terminal domain is involved in 
acceptor substrate recognition. Since acceptors exhibit a marked diversity of chemical 
structures compared with nucleotide-sugar donors, the N-terminal domains reflect this 
variability by showing different rearrangements of secondary structural elements (Breton, 
Šnajdrová, Jeanneau, Koča, & Imberty, 2006). 
 
To date, there are two crystal structures reported of bacterial GSs, the one from 
A. tumefaciens (AtGS; Buschiazzo et al. 2004) and from E. coli (EcGS; Sheng, Jia, et al. 
2009; Sheng, Yep, et al. 2009). Both enzymes crystalized as monomers describing the 
typical GT-B fold mentioned above (Figure 1.11A). Besides, comparison of AtGS and 
EcGS crystal structures in complex with ADP (PDB: 1RZU, 3GUH) shows that the 
nucleotide binds in the interdomain cleft, mostly along the C-terminal domain wall, with 
the adenine ring stacked against the conserved Tyr355 (equivalent to AtGS Tyr354; Phe 
in animal GS and plant SS). The interaction with the N-terminal domain is restricted to 
Asp21, Lys15 and Gly18 all of which are conserved in both glycogen and starch 
synthases (Buschiazzo et al., 2004). These last residues, Lys15 and Gly18, form part of 
the Lys-Tyr-Gly-Gly-Leu (KTGGL) widely conserved motif loop among GSs and SSs. 
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This motif is located facing the nucleotide-binding pocket and is suggested to be involved 
in substrate binding and catalysis (Figure 1.11C; Furukawa et al. 1993; Furukawa et al. 
1994). The last three residues of this motif are highly conserved in many other GT-B 
enzymes, including glycogen phosphorylase (GP, family GT35), maltodextrin 
phosphorylase (MalP, family GT35), and trehalose-6-phosphate synthase (OtsA, family 
GT20) (Buschiazzo et al., 2004).  
 
Of particular interest is the EcGS active closed crystal structure of the catalytic 
inactive mutant Glu-377-Ala containing bound ADP, glucose and the acceptor analog 
HEPPSO ([N-(2-hydroxyethyl) piperazine-(2-hydroxypropanesulfonic acid)]) which 
results in a 15.2° domain-domain closure (PDB: 3COP; Figure 1.11B). This domain 
motion is also observed in the crystal structure of the wild-type enzyme bound to ADP 
and glucose (PDB: 2QZS), the one in complex with ADP and HEPPSO (PDB: 3GUH) 
and the Glu-377-Ala mutant in complex with ADP, glucose and maltohexaose (PDB: 
3CX4; Sheng, Jia, et al. 2009; Sheng, Yep, et al. 2009). Interestingly, the AtGS crystal 
structure in complex with ADP (PDB: 1RZU; Buschiazzo et al. 2004) displays an open 
conformation, supporting the idea of the glycan acceptor-binding requirement to achieve 
the competent closed state. This domain closure brings the N-terminal loop containing 
the KTGGL motif into the vicinity of the C-terminal domain to interact with both, the 
substrate ADP-Glc and the acceptor molecule (Figure 1.11C). 
 
GTs and glycoside hydrolyzes can be classified as either retaining or inverting 
enzymes depending on whether the anomeric configuration of the sugar donor is the 
same (retaining) or different (inverting) from that of the product. The reaction mechanism 
of inverting GTs follows a single displacement mechanism with an oxocarbenium ion-
like transition state and an asynchronous SN2 mechanism, analogous to that observed 
for inverting glycoside hydrolases (Lairson, Henrissat, Davies, & Withers, 2008). In 
contrast, the catalytic mechanism for retaining GTs is currently a matter of strong debate. 
It was proposed that some retaining enzymes would use a double displacement 
mechanism, where the attack of an enzyme nucleophile results in the formation of a 
covalent intermediate (Gómez, Lluch, & Masgrau, 2013; Rojas-Cervellera, Ardèvol, 
Boero, Planas, & Rovira, 2013). However, in the absence of a clear residue near the 
reaction center that could act as a nucleophile to form the glycosyl-enzyme intermediate 
in the majority of GTs, an alternative mechanism known as the SNi ‘internal return’, also 
called the SNi-like mechanism, has been suggested. In this mechanism, leaving group 
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departure and nucleophilic attack occur on the same face of the sugar (Lee et al., 2011) 
and involve either a short-lived oxocarbenium ion intermediate (SNi-like; Lairson et al. 
2008; Sinnott and Jencks 1980; Persson et al. 2001; Gibson et al. 2002) or an 
oxocarbenium ion transition state (SNi; Gómez, Lluch, and Masgrau 2013; Bobovská, 
Tvaroška, and Kóňa 2015; Ardèvol and Rovira 2011; Lira-Navarrete et al. 2014).  
 
 
Figure 1.11. (A) EcGS overall fold (PDB: 3D1J). (B) Structural comparison between the ‘open’ 
(schematic cartoon) and ‘closed’ (molecular surface representation) states of EcGS. (C) Close up 
view of EcGS active site in complex with ADP-Glc and HEPPSO (PDB: 3GUH) sowing only 
selected interactions. The conserved KTGGL motif is represented in orange. 
Based on its catalytic mechanism, GSs are retaining GTs. Glu377 (EcGS 
numbering; equivalent to AtGS Glu376) and its equivalents were thought/proposed to be 
either the catalytic nucleophile or the general acid/base catalyst for GS. It is the first 
residue in the E-X7-E motif of some retaining GTs, such as eukaryotic glycogen 
synthases (GT3), α-glucosyltransferase (GT4), starch synthases, and bacterial glycogen 
synthases (GT5) and its mutation per alanine result in a drastic reduction in the enzyme 
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activity (Yep, Ballicora, and Preiss 2004; Cid et al. 2002). However, further analysis 
based on the structural information available, support a different role; (i) it provides 
charge stabilization to Lys305, which in turn stabilizes the negative charge on the leaving 
group ADP among with Arg300, and (ii) it is critical in locating the acceptor glucose 
moiety (Sheng, Jia, et al., 2009). A similar situation can be observed for the equivalent 
acidic residue in MalP, OtsA (Asp), and GP where the side chain carboxyl group also 
makes a direct interaction with the glucose moiety and a lysine residue within the active 
site of these retaining GT-Bs (Gibson et al., 2002; Martinez-Fleites et al., 2006; Sprang, 
Goldsmith, & Fletterick, 1987; Watson et al., 1999; Watson, Schinzel, Palm, & Johnson, 
1997). Although the Glu-377 side chain is not far from the β-phosphate (3.9 Å in EcGS), 
positively charged Arg-300 and Lys-305 directly interact with the substrate phosphate 
group, and are therefore more likely to play the role of proton transfer agent (Figure 
1.11C) (Sheng, Yep, et al., 2009).  
 
 
 
1.4.3. Branching enzyme 
 
The BE (EC 2.4.1.18) catalyzes the formation of α-1,6-glucosidic branch points into 
glycogen/amylopectin polysaccharides (Figure 1.12). This branching increases the 
number of non-reducing ends, making glycogen more reactive to synthesis and digestion, 
and is also essential for assuring its solubility in the cell. The frequency and position of 
the branch points are important determinants for the structure and properties of starch 
in plants and of glycogen in animals and bacteria (J Preiss, 2010).  
 
The reaction catalyzed by BE proceeds in two steps: first, a preexisting α-1,4-
glucan chain is cleaved and the non-reducing portion of the donor chain is covalently 
attached to the carboxyl group of the catalytic residue at the active site of the enzyme 
(Uitdehaag et al., 1999). In a second step, the glucan moiety is then transferred to the 
C-6 hydroxyl group of the same or another glucan chain (the acceptor chain). Through 
this double displacement mechanism, the α-configuration of anomeric carbon is retained, 
resulting in the formation of α-1,6-linkage. If a water molecule instead of the C-6 hydroxyl 
group of a sugar is involved in the latter step of the reaction, the enzyme serves as a 
hydrolase rather than a transferase. Therefore, BE is mechanistically similar to amylolytic 
enzymes and, in addition, they share some conserved sequence regions (CSRs), thus 
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being grouped into the same family (although only a limited number of BEs show 
hydrolytic activity; MacGregor, Janecek, and Svensson 2001). 
 
 
Figure 1.12. Chemical reaction catalyzed by BE. 
 
Almost all sequence-annotated as BEs, belong to the GH13 family of glycoside 
hydrolases and fall either into subfamily 8 (eukaryotic BEs) or subfamily 9 (prokaryotic 
BEs).  BEs in animals, fungi, and plants show higher sequence similarity to each other 
than bacterial BEs. The GH13 family is the largest glucoside hydrolase family, and 
comprises α-amylases, pullulanase/isoamylase, cyclodextrin glucanotransferase (CGT), 
and branching enzymes (Abad et al., 2002; Pal et al., 2010; Sean Froese et al., 2015; 
Suzuki & Suzuki, 2016). GH13 BEs are multidomain enzymes consisting on: (i) a 
carbohydrate-binding module 48 (CBM48), (ii) a central (β/α)8-barrel catalytic domain 
(also known as TIM barrel) consisting of eight parallel β-strands surrounded by eight 
parallel α-helices and (iii) the C-terminal domain. In some GH13_9 BEs, CBM48 is further 
preceded by an N domain, which is generally absent from GH13_8 BEs. Indeed, GH13_9 
BEs are divided into group 1 and group 2, depending on the presence or absence, 
respectively, of this N domain. 
 
The crystal structure of GH13_9 BE has been elucidated from E. coli (EcBE; PDB: 
3K1D; Abad et al. 2002) and Mycobacterium tuberculosis (MtbBE; PDB: 1M7X; Feng et 
al. 2015) enzymes, both in their unliganded form (Figure 1.13). In the case of EcBE, it 
has also been reported the crystal structure in complex with maltoheptaose (PDB: 4LPC) 
and maltohexaose (PDB: 4LQ1; Feng et al. 2015). Based on the reported structures, the 
N domain, the CBM48, and the C domain consist of approximately 100 amino acid 
residues each, and all adopting a β-sandwich type fold (Abad et al., 2002; Noguchi et al., 
2011; Pal et al., 2010; Palomo et al., 2011; Sean Froese et al., 2015). The CBM48 
domain is related to the substrate specificity, recognition, and binding whereas the N 
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domain seems to be involved in determining the size of the chain transferred and thus 
the branching pattern. On the other hand, the C domain is suggested to participate in 
substrate preference and catalytic capacity (Tetlow & Emes, 2014). 
 
All members of the α-amylase family display an overall negatively charged surface which 
plays a crucial role in substrate binding. The crystal structures of EcBE in complex with 
maltoheptaose and maltohexaose, respectively, show several binding sites located a the 
surface. Interestingly, there is no evidence for oligosaccharide binding in the active site 
of EcBE. These binding sites can be regarded as surface/secondary binding sites (SBSs) 
in which oligosaccharides are bound at a certain distance of the active site. SBSs have 
been described for a wide range of glycoside hydrolases, and are particularly prominent 
in GH13 family (Cockburn et al., 2014).  The feature that distinguishes BE from all other 
GH13 enzymes is that its reactivity is only seen with large polymers such as glycogen or 
amylose and not short glucan chain. The presence of multiple SBSs could be a way to 
anchor a complex glycogen granule and determine the chain length specificity for the 
branching reaction as a ‘molecular ruler´. This agrees with the emerging concept of 
glycogen serving not only as the substrate and product of its metabolism but also as a 
scaffold for all acting enzymes (Feng et al., 2015). 
 
Structural data on the GH13 family has defined amino acid residues along the 
central (β/α)8-barrel catalytic domain whose positions are well conserved in all α-
amylases. Based on EcBE numbering these residues are: Tyr300, Asp335, His340, 
Arg403, Asp405, Glu458, His525, and Asp526. Biochemical studies support the role of 
these residues in α-amylases family substrate binding and catalysis, specifically, Asp405 
serves as a nucleophile in the reaction, whereas Glu458 is responsible for the 
protonation and deprotonation necessary on the leaving group and attacking oxygen 
(Tao, Reilly, & Robyt, 1989; Uitdehaag et al., 1999). In the case of EcBE and MtbBE the 
catalytic residues aspartate and glutamic acid are located in adjacent loops (Abad et al., 
2002; Pal et al., 2010). 
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Figure 1.13. Superposition of EcBE (blue) and MtbBE (green) crystal structures 
highlighting the conserved domain architecture. 
 
 
 
1.5. Molecular bases of bacterial glycogen degradation 
 
1.5.1. Glycogen phosphorylase  
 
Phosphorylases are key enzymes in the carbohydrate metabolism and are found in many 
organisms, including bacteria, yeast, plant and vertebrates. Glycogen phosphorylase 
(GP; EC 2.4.1.1) is encoded in the E. coli glycogen gene cluster glgBX-glgCAP being 
the expression product of the glgP gene and, along with the debranching enzyme (glgX), 
participates in the degradation of glycogen during extended periods of substrate 
deprivation. Specifically, GP catalyzes the cleavage of α-1,4-linkages at the non-
reducing ends of glycogen and branched polysaccharides with retention of configuration 
at the anomeric carbon, releasing G1P (Figure 1.14). The cofactor pyridoxal-5-
phosphate (PLP) is absolutely required for GP activity being the PLP-domain common 
to all α-glucan phosphorylases. This cofactor is covalently bound via a Schiff base to an 
active site lysine and catalysis is dependent on the ionizable phosphate residue of the 
enzyme-bound PLP (Kirby, 2007). This enzyme is unable to bypass or hydrolyze the α-
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1,6 linkages and therefore stops two, three, or four residues from the first α-1,6 branch 
encountered to generate the so-called phosphorylase-limit dextrin (Alonso-Casajús et 
al., 2006; J. T. Park et al., 2011; Jack Preiss, 2006). 
 
 
Figure 1.14. Chemical reaction catalyzed by GP. 
 
It is well stablished that mammalian GPs are subject to regulation by two mechanisms, 
allosteric regulation and covalent activation through phosphorylation. In contrast, 
bacterial phosphorylases show no apparent regulatory properties and are thought to be 
exclusively controlled at gene expression level (Buchbinder, Rath, & Fletterick, 2001; 
Newgard & Hwang, 1989; Wilson et al., 2010). In this regard, E. coli GP (EcGP) seems 
not to be allosterically regulated with respect to substrates of physiological relevance, 
such as AMP, ADP-Glc or glucose; however, GlgP could be allosterically modulated in 
E. coli as a result of its interaction with the histidine phosphocarrier protein (HPr). The 
HPr protein is an essential element in sugar transport by the bacterial 
phosphoenolpyruvate:sugar phosphotransferase system and it has been reported a 
highly specific binding with EcGP. Specifically, the phosphorylated form of HPr binds 
with higher affinity to GlgP than the dephosphorylated form and equilibrium 
ultracentrifugation analysis indicated that HPr allosterically regulates the oligomeric state 
of glycogen phosphorylase (Alonso-Casajús et al., 2006; Seok et al., 1997; Wilson et al., 
2010). 
 
All known phosphorylases share catalytic and structural properties being included 
into the GT35 family. Members of this family belong to the GT-B structural superfamily 
of GTs (Albesa-Jové, Giganti, Jackson, Alzari, & Guerin, 2014). Only one bacterial 
structure has been reported within the GT35 family, the E. coli maltodextrin 
phosphorylase (MalP). MalP catalyzes the phosphorolysis of maltodextrins, but is poorly 
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active against the more complex, branched glycogen molecule. It is a non-allosteric, 
dimeric enzyme shearing a 45% sequence identity with EcGP (Newgard & Hwang, 1989; 
Schinzel & Nidetzky, 1999). As expected from sequence comparison the overall 
structure of MalP shows a fold similar to that of GP from rabbit muscle, the 
phosphorylase study more in deep (Oikonomakos, Chrysina, Kosmopoulou, & Leonidas, 
2003). The bacterial enzyme is an α/β protein that exhibits a two-domain fold, the N-
terminal domain (residues 1–447) and the C- terminal domain (residues 448–797) 
separated by the catalytic site cleft. The dimeric structure is stabilized by inter-monomer 
contacts involving the central region known as the tower helices which mediates the 
allosteric transition between the active state (R-state) and less active state (L-state) in 
mammalian GP enzyme (Figure 1.15A). The active site lies between the N- and C-
terminal domains, at the center of the molecule, and is accessible to the solvent via a 
channel ~20 Å in length that forms the substrate-oligosaccharide binding site (Figure 
1.15B; O’Reilly, Watson, & Johnson, 1999; Oikonomakos et al., 2003).  
 
 
Figure 1.15. (A) Dimeric MalP overall structure indicating in one of the monomers the N-terminal 
domain (cyan) and C-terminal domain (yellow) (B) MalP monomer structure with the 
oligosaccharide located in the active site (PDB: 1E4O). The electrostatic surface representation 
of the monomer shows the entrance to the catalytic cleft.   
 
Several structures of MalP have been reported and interestingly, the one in 
complex with maltose provided the first phosphorylase structure featuring an 
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oligosaccharide bound at the catalytic site (PDB: 1AHP; O’Reilly et al. 1997). 
Comparison with the structure of the enzyme alone indicates that an induced-fit 
mechanism closes the N- and C-terminal domains over the oligosaccharide substrate. 
This phenomenon is caused mostly by the movement of the 380s loop (residues His377-
Trp387) which leads to the closure of the catalytic channel. (Figure 1.16A; O’Reilly et al. 
1997; Watson et al. 1997; Buchbinder, Rath, and Fletterick 2001). The crystal structures 
in complex with maltotetraose (G4; PDB: 1L5W), maltopentose (G5; PDB: 1E4O) and a 
non-hydrolysable thiopentasaccharide (GSG4; PDB: 1QM5) showed similar 
conformations of the 380s loop to the maltose complex (Watson et al., 1999). In addition, 
it was reported that the binding of G1P in sub-site -1 and a tris-
(hydroxymethyl)aminomethane (Tris) molecule coming from the crystallization buffer in 
sub-site +1, promotes the closure of the loop (Figure 1.16B; PDB: 1L5V; Geremia et al. 
2002). On the other and, the structure in complex with acarbose, an unnatural cyclitol 
that resembles a tetrasaccharide, was close to that of the native structure indicating that 
the shift of the 380s loop is likely to be a feature in substrate recognition (PDB: 2ECP; 
O’Reilly, Watson, and Johnson 1999).  
 
 
 
Figure 1.16. (A) Comparison between the MalP-acarbose complex (green; PDB: 2ECP) and 
MalP-maltose complex (cyan; PDB: 1AHP) showing the 380s loop shift and selected residues at 
the binding site. In the MalP-maltose complex a sulphate anion occupies the inorganic phosphate 
site. (B) Comparison between the MalP-acarbose complex (green; PDB: 2ECP) and MalP-G1P-
Tris complex (yellow; PDB: 1L5V) showing the 380s loop shift and selected residues at the binding 
site. Neither of the representations show the acarbose.  
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As the catalytic domain is highly conserved among phosphorylases a common catalytic 
mechanism has been suggested (Schinzel & Nidetzky, 1999). Based on the MalP–
GSG4-P ternary complex, it has been proposed that the α-retaining mechanism 
proceeds via a double displacement reaction with two steps (Figure 1.17); (i) the 5’-
phosphate of the cofactor PLP promotes general acid attack by the inorganic phosphate 
on the glycosidic oxygen. This oxygen is protonated leading to the cleavage of the C1-
O bond and formation of the oxonium-carbonium ion transition state, that is favored and 
stabilized by the now negatively charged phosphate; (ii) The inorganic phosphate acting 
as a nucleophile, attacks the carbonium oligosaccharide phosphorylase ion C1 carbon 
leading to formation of the product G1P with retention of configuration (Campagnolo, 
Campa, Zorzi, Wuerges, & Geremia, 2008; Geremia et al., 2002; Watson et al., 1999).  
 
 
 
Figure 1.17. Catalytic mechanism proposed for MalP. The oligosaccharide substrate binds in 
subsites -1 and +1 and subsequent sites across the catalytic cleft. His377, the first residue in the 
mobile region 380s loop, forms a hydrogen bound with O6 hydroxyl group of the sugar in sub-site 
-1 and Asp339 side chain interacts with O2/O3 hydroxyl groups of the sugar in sub-site +1. The 
phosphate substrate is stabilized by contacts with Arg569 and Lys574 whereas the 5´-phospate 
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group of the PLP cofactor is stabilized by interactions with water molecules (show as asterisks), 
Lys568 and Lys574. Note that not all of the substrates contacts are shown. the 5´-phospate group 
of the PLP cofactor promotes a general acid attack by the inorganic phosphate on the glycosidic 
oxygen leading to the cleavage of the C1-O bound and formation of the oxonium-carbonium ion 
intermediate. (B) The sugar in sub-site -1 is polarized by the interaction with the inorganic 
phosphate. (C) Nucleophilic attack by the inorganic phosphate at the C1 position of the carbonium 
ion leads to the formation of G1P. The position of G1P was inferred from the complex of GP with 
heptulose-2-phosphate (PDB: 6GPB). (Modified from Watson et al. 1999). 
 
 
1.5.2. Glycogen debranching enzyme  
 
Along with GP, glycogen debranching enzyme (GDE) constitutes the core of glycogen 
catabolism, being both codified within E. coli glycogen gene cluster glgBX-glgCAP (GDE; 
glgX; EC 3.2.1.196). As mentioned above, GP catalyzes the depolymerization of the α-
1,4-glucosidic linkages, however, due to the high degree of branching present in the 
glycogen molecule, a second type of enzyme is required to cleave the α-1,6-glucosidic 
bonds that remain uncleaved by GP (Figure 1.18; Jack Preiss 2006; Iglesias and Preiss 
1992).  
 
 
 
Figure 1.18. Chemical reaction catalyzed by GDE. 
 
Sequence analyses suggest all GDEs are glucan hydrolases, probably belonging 
to the glycoside hydrolase GH13 family in the CAZy database; however, important 
functional differences arise between eukaryotic and bacterial GDEs. Eukaryotic animal 
and yeast GDEs are bifunctional enzymes, which have α-1,4-transferase (N-terminus) 
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and α-1,6-glucosidase (C-terminus) activity, in contrast, most bacteria and plant 
debranching enzymes contains only α-1,6-glucosidase activity (Nakayama, Yamamoto, 
& Tabata, 2001; Woo et al., 2008). AS GP is not able to cleave the α-1,6-linkages, it 
generates phosphorylase-limit dextrins that consist of maltotriose or maltotetraose 
chains of three to four glucose residues branching from the linear glycogen strand. GDE 
in E. coli functions by cleaving the α-1,6-glucosidic linkage between these glucose 
subunits and the linear glycogen chain and rely on MalP and GP to cleave the remaining 
α-1,4-bonds in this short-released chain. In contrast, animal and yeast GDEs transfer 
the maltotriose unit from the branch to the nearby linear glycogen strand using α-1,4-
transferase activity and then cleave the α-1,6-glucosidic bond that connects the 
remaining glucose residue to the glycogen polymer (Figure 1.19; Dauvillée et al., 2005; 
Song et al., 2010).  
 
 
Figure 1.19. Schematic representation of the functional differences between eukaryotic 
and bacterial GDE (Modified from Lew, Guin, and Theodorescu 2015). 
Bacteria 
Eukaryote 
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Several crystal structures of GDEs have been reported, one bacterial enzyme 
corresponding to the E. coli GDE (GlgX; PDB: 2WSK; Song et al. 2010), the archeal 
Sulfolobus solfataricus tetrameric GDE (TreX; PDB: 2VNC; Woo et al. 2008), and the 
yeast Candida glabrata GDE (PDB: 5D06; (Zhai et al., 2016). The crystal structure of the 
monomeric GlgX shows an overall fold comprised by three major domains: (i) N-terminal 
CBM48 domain, (ii) a central catalytic domain and (iii) a C-terminal domain (Figure 
1.20A). Both the N- and C-terminal domains are composed by several β-strands forming 
a β-sandwich whereas, the central domain describes the GH13 family characteristic 
(β/α)8-barrel catalytic motif. GlgX is a retaining enzyme whose products maintain the 
stereochemical orientation of their substrates. The catalytic residues Asp336, Glu371 
and Asp443, within the central catalytic domain, act respectively as the nucleophile, 
proton donor and transition state stabilizer. (Song et al., 2010). The active site of GlgX 
shows an obvious cleft on top of the catalytic barrel motif with an approximate length of 
26 A˚ and width of 9 A˚. The residues composing the floor and sides of the groove show 
good alignment with residues involved in substrate binding in other members of the 
GH13 family, in fact, this groove overlaps well with the one observed in TreX crystal 
structure, except for the much shorter cavity dimension in GlgX (Figure 1.20B; Woo et 
al., 2008). This structural discrepancy between TreX and GlgX correlates with the 
different substrate specificity among these two enzymes; GlgX does not efficiently cleave 
substrates longer than four glucose residues, whereas TreX exhibits higher activity for 
branched substrates longer than 5 glucose residues (Dauvillée et al., 2005; J.-T. Park et 
al., 2008). At one side of the groove, a region stands out from the bottom of the substrate 
channel forming helix α4 which presents residues involved in substrate binding (Figure 
1.20A). This helix is only observed in GlgX and TreX crystal structures while it is missing 
in homologs within the GH13 family as isoamylases and pullulanases, suggesting that it 
could be a useful structural feature for distinguishing GDEs (Song et al., 2010). 
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Figure 1.20. Structural comparison between GlgX and TreX. (A) Schematic overview of GlgX 
superimposed on the TreX structure. N- and C- terminal domains are in blue and red, respectively. 
The catalytic domain of GlgX is in yellow whereas the TreX structure is in graywhite. The flexible 
loop above the active site containing the catalytic residue Glu371 is shown in green and the conserved helix 
4 in violet. (B) GlgX and TreX substrate binding grooves showing the catalytic residues (violet). Residues 
that constitutes the groove barrier in GlgX are shown in red (From Song et al. 2010).  
 
The high structural similarity between GlgX and TreX is of interest because this 
archaeal GDE exhibits both the transferase and the glucosidase activity in the same 
catalytic cleft. TreX exists in two oligomeric states in solution, as dimer and tetramer and 
exhibits two different active-site configurations depending on its oligomeric state. A 
flexible loop above the active site containing the catalytic acid/base Glu371 in the GlgX 
crystal structure displays the same conformation as that observed in TreX dimer 
structure, however, in the tetrameric form of TreX this loop is flipped to reveal a 
significantly different conformation (H.-S. Park et al., 2007; J.-T. Park et al., 2008; Song 
et al., 2010; Woo et al., 2008). The configuration of this structural lid above the substrate 
binding site in the tetrameric TreX is a common motif that has been found in enzymes 
with α-1,4-transferase activity. It has been suggested that the inability of catalyzing 
transglycosylation reaction in GlgX may be related to the absence of this structural motif 
that could be necessary to stabilize the acceptor molecule during the transglycosylation 
catalysis (Song et al., 2010). 
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1.6. Bacterial Glycogen biosynthesis regulation 
 
As mentioned in previous sections, plant starch and bacterial glycogen biosynthetic 
pathways share the initial step catalyzed by the enzyme AGPase that generates the 
NDP-sugar donor, ADP-Glc. The formation of ADP-Glc is consider the main regulatory 
step in glycogen and starch production in these organisms, and requires the investment 
of ATP resulting in an energetically expensive reaction. For this reason, evolution has 
led AGPase to acquire exquisite regulatory mechanisms based in a cooperative and 
allosteric behavior to control this key rate-limiting step (J Preiss, 1978). Almost all 
AGPases characterized so far are allosterically regulated by small effector molecules 
that bind to the enzyme in positions that differ from the catalytic site affecting its 
enzymatic activity. AGPase positive and negative allosteric regulators correspond to 
metabolites that can differ according to the source but they share the characteristic of 
being intermediates in the major carbon assimilation pathways within the organisms. 
AGPase activators are metabolites that represent signals of high carbon and energy 
content of a particular bacteria or tissue, while inhibitors of the enzyme indicate low 
metabolic energy levels (S. Ball et al., 2011; M. a Ballicora et al., 2003).  
 
Kinetic studies of several AGPases of a wide range of bacterial species have 
been performed to determine their specific positive or negative allosteric regulators and, 
based on this feature, AGPases have been grouped into nine different classes (Table 1; 
Ballicora, Iglesias, and Preiss 2003; J Preiss 1978). In general, glycolytic intermediates 
such as fructose 6-phosphate (F6P), fructose 1,6-biphosphate (FBP), and/or pyruvate 
enhance the activity of bacterial AGPases, whereas AMP, ADP, and/or inorganic 
phosphate (Pi) display inhibitory properties. In contrast, AGPases from photosynthetic 
organisms such as plants and cyanobacteria prefer 3-phosphoglyceric acid (3PGA) as a 
positive signal produced by the photosynthetic activity, and Pi as the inhibitory signal. 
The structural overlapping observed for the activators in the different AGPase classes 
suggests that activator sites for distinct groups are similar or related (M. a Ballicora et 
al., 2003; J Preiss, 1984, 2010; Jack Preiss, 2006; Ribéreau-Gayon, Sabraw, Lammel, 
& Preiss, 1971). 
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Table 1. Relationship between carbon metabolism and regulatory and structural properties 
of AGPases from different organisms (From Ballicora, Iglesias, and Preiss 2003). 
 
The identification of the allosteric binding sites in AGPase has been a matter of intense 
research in the field of glycogen/starch biosynthesis/regulation in the last decades. The 
absence of structural information reported for this enzyme in complex with allosteric 
effectors has led to the characterization of its regulatory mechanism through a 
biochemical and site-directed mutagenesis point of view. The paradigmatic E. coli 
AGPase (EcAGPase) has been the subject of deep study since 60’s. It is classified within 
class I of AGPases, which are mainly activated by FBP and inhibited by AMP (M. a 
Ballicora et al., 2003). Chemical modification studies of EcAGPase with PLP by reduction 
The enzymes placed in class IV are fro bacteria mainly utilizing the Entner–Doudoroff pathway, and the
ADP-Glc PPases are distinctively activated by Fru 6-P and pyruvate, with ADP, AMP, and Pi behaving as
inhibitors.123,124 Included in this group are Agrobacterium tumefaciens and Arthrobacter viscosus. Photosynthetic
Table 1 Relationship between carbon assimilation pathway and regulatory properties of ADP-Glc PPase of different
organisms
ADP-GIc PPase
Main carbon Allosteric effectors
Organism Utilization pathway Class Activator(s) Inhibitor(s)
Prokaryotes
Escherichia coli Glycolysis I Fru-1,6-bis-P AMP
Salmonella typhimurium
Enterobacter aerogenes
Aeromonas formicans Glycolysis II Fru-1,6-bis-P,
Fru-6-P
AMP, ADP
Micrococcus luteus
Mycobacterium smegmatis
Rhodopseudomonas viridis (þ Reductive carboxylic acid cycle)
Serratia marcescens Glycolysis III None AMP
Enterobacter hafniae
Clostridium pasteurianum
Agrobacterium tumefaciens Entner–Doudoroff pathway IV Pyruvate, Fru-6-P AMP, ADP
Arthrobacter viscosus
Chromatium vinosum
Rhodobacter capsulata
Rhodomicrobium vaneilli
Rhodobacter gelatinosa Glycolysis, Enter–Doudoroff pathway,
and reductive carboxylic acid cycle
V Pyruvate,Fru-6-P,
and Fru-1,6-bis-P
AMP, Pi
R. globiformis
R. sphaeroides
Rhodocyclus purpureus
Rhodospirillum rubrum Reductive carboxylic acid cycle VI Pyruvate None
Rhodospirillum tenue
Bacillus subtilis TCA cycle during sporulation VII None None
B. stearothermophillus
Cyanobacteria
Synechococcus PCC 6301 Oxygenic Photosynthesis
(Calvin cycle)
VIII 3-PGA Pi
Synechocystis Pcc 6803
Anabaena PCC 7120
Eukaryotes
Green algae
Chlorella fusca Oxygenic Photosynthesis
(Calvin cycle)
VIII 3-PGA Pi
C. vulgaris
Chlamydomonas reinhardtii
Higher plants
Photosynthetic tissues Oxygenic Photosynthesis (Calvin
cycle or Hatch–Slack pathway)
VIII 3-PGA Pi
Plant leaves; e.g.; spinach
wheat, pea, Arabidopsis, maize,
rice, etc.
Nonphotosynthetic tissues Sucrose catabolism and
gluconeogenesis
VIII 3-PGA Pi
Potato tuber, maize endosperm
Barley and wheat endosperm Sucrose catabolism and
gluconeogenesis
IX 3-PGA and Fru-6-P
reverses Pi
inhibition
Pi
Biochemistry and Molecular Biology of Glycogen Synthesis 437
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with NaBH4 pointed to Lys39 residue, located in the N-terminal domain by homology with 
other AGPases, as an important amino acid implicated in the binding of the activator 
FBP. This observation has been further supported by direct mutagenesis, where the 
substitution of this residue per glutamic acid caused variations in EcAGPase activation 
kinetics (Gardiol & Preiss, 1990; Parsons & Preiss, 1978a). The involvement of the N-
terminal portion of AGPase in the allosteric regulation was also observed by the 
truncation of 11 amino acids, which made EcAGPase insensitive to activation (C. M. 
Bejar, Ballicora, Iglesias, & Preiss, 2006; Wu & Preiss, 1998). On the other hand, the C-
terminal domain of heterotrophic bacterial AGPases is known to play an important role 
for the activator specificity; this hypothesis is supported by results from experiments with 
the EcAGPase (class I) and AtAGPase (class IV) C-terminal chimeric enzymes in which 
the activator specificity was modified according to the C-terminal domain source (M. A. 
Ballicora, Sesma, Iglesias, & Preiss, 2002). Based on all these results, it was postulated 
that the allosteric regulation of AGPase might involve a rearrangement between the N- 
and C-terminal domains (Jack Preiss, 2014).  
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2. Objectives and hypothesis  
Bacteria and photosynthetic eukaryotes evolutionary pathways have selected ADP-Glc 
as the activated glucosyl nucleotide donor for glycogen and starch biosynthesis, the most 
common carbon storage and energy reserve polysaccharides in nature (S. G. Ball & 
Morell, 2003; Recondo & Leloir, 1961). ADP-Glc biosynthesis is mediated by the enzyme 
AGPase, and is considered the main regulatory step in glycogen and starch production 
in these organisms (Espada, 1962; J Preiss, 1978). In this respect, evolution led AGPase 
to acquire allosteric properties to control this key rate-limiting step by essential 
metabolites in the energetic flux within the cell. In general, AGPase activators are 
metabolites that represent signals of high carbon and energy content of a particular 
bacteria or tissue, while inhibitors of the enzyme indicate low metabolic energy levels (S. 
Ball et al., 2011; Clarisa M. Bejar, Jin, Ballicora, & Preiss, 2006). The identification of 
AGPase allosteric binding sites has been a matter of intense research in the field of 
glycogen/starch biosynthesis/regulation in the last decades. To date, only two crystal 
structures of AGPase have been reported, that of the Agrobacterium tumefaciens 
(AtAGPase) and the potato tuber AGPases (StAGPase; Cupp-Vickery et al., 2008; Jin 
et al., 2005). Nevertheless, no crystal structure of AGPase in complex with allosteric 
regulators has ever been reported.  
 
In this work, we focused on the paradigmatic AGPase from Escherichia coli. Much effort 
has been made in the study of EcAGPase allosteric regulation; experimental evidences 
suggest that both N- and C-terminal domains are involved in EcAGPase allosteric 
regulation and it was postulated that this phenomenon might be determined by a 
combined arrangement between both domains (M. A. Ballicora et al., 2002; C. M. Bejar 
et al., 2006; Jack Preiss, 2014; Wu & Preiss, 1998). However, the absence of structural 
data has not allowed to delve into the regulatory mechanism of this enzyme at the 
molecular level.  
 
Our specific aims are:  
 
I) to solve the crystal structure of EcAGPase in complex with its naturally occurring 
and preferred allosteric negative regulator, AMP, and positive regulator, FBP. 
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II) to propose a model for the allosteric regulation of EcAGPase 
 
III) to validate the structural information by direct mutagenesis and 
biophysical/biochemical approaches.  
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3. EXPERIMENTAL TECHNIQUES 
In this section, an overview of Circular Dichroism (CD) and Electron Microscopy (EM) is 
given. A careful description of the materials and other techniques used during these 
studies can be found in the Materials and Methods sections of each chapter. 
 
 
3.1. Circular dichroism (CD) 
 
The interaction of circulary polarized light with chromophores in optically asymmetric 
environments is specific and, even though the changes are subtle, they can be measured 
and interpreted. This fact allows the study of proteins in solution for structural 
characterization and structural conformational changes. In this work, we focus our CD 
studies on the determination of the thermal stability of EcAGPase in complex with its 
physiologically preferred allosteric regulators. 
CD, by definition, is the difference between the left circulary polarized light absorption 
and the right one. Plane-polarized radiation comprises two circulary vectors of equal 
intensity, one right-handed (RCP) and the other left-handed (LCP). A chromophore in an 
optically symmetrical environment absorbs the two components. When they recombine, 
they result in radiation oscillating again in a single plane (Eq. 3.1). However, a 
chromophore situated in an optically asymmetric environment will absorb unequally each 
of the two components to a different extent, DA. 
 
DA = AL - AR                                                      eq.3.1 
 
As consequence, the resultant vector describes an ellipse, instead of circle. The ratio of 
the major and minor axes of the ellipse determines ellipticity (q). It should be noted that 
q = tan -1 (OL’/OR’) (Figure 3.1). 
The output of CD instruments, also known as spectropolarimeters, can be either 
measures of the difference in absorbance between the LCP and RCP or the ellipticity (q) 
in degrees. 
The numerical relationship between DA and ellipticity (in degrees) is: 
 
 - 48 - 
q = 32.98 DA                                                   eq.3.2 
 
 
 
Figure 3.1 Circular dichroism phenomenon. The relation of ellipticity to the differential 
absorption of circulary polarized radiation in an optically symmetrical environment (A) and in an 
optically asymmetrical environment (B) (From Pain 2005). 
 
 
In addition, those molecules can also present a different refractive index for the RCP and 
LCP components that rotate the plane of the polarized emitted light. This phenomenon 
is known as rotatory optic dispersion (ROD) and it is defined by the angle formed by the 
major axis of the ellipse and the original plane (Figure 3.1). As it was previously 
mentioned, this phenomenon depends on the absorption, and thus, it varies with the 
wavelength of the incident radiation. Generally, spectra represent CD signal (ellipticity) 
as a function of the wavelength. The bands of the spectra correspond to the electronic 
transitions happened due to either the electric field, the magnetic field or both of them 
above the vibrational levels of the ground state and the first excited level ones.  
 
 
3.1.1 Structural protein characterization by CD 
 
In structural studies, proteins in solution are the chromophores that absorb different 
energy photons. Generally, spectra are obtained from two regions of the electromagnetic 
radiation spectrum: Far UV (180nm - 250nm) and Near UV (250 nm – 350 nm). In the 
Doctoral Thesis – Natalia Comino 
 
 - 49 - 
Far UV region, the peptidic backbond is the main chromophore responsible for the signal. 
On the other hand, the aromatic residues and the disulfide bond are the chromophores 
involved in the CD signal coming from the near UV region. 
 
1. Peptidic backbone: the amide bond is rotation limited (O=C-NH) and the partial 
double bond character leads to an electron pair delocalization of the nitrogen atom. The 
two dihedral angles, phi and psi that define the secondary structure of proteins, confer 
the chirality. The peptidic bond can undergo two electronic transitions: 
 
n -> p*: Due to the generation of a magnetic dipolar moment during the transition. 
It is characterized by having low energy since the transition occurs from a non-
bonding orbital to an antibonding one. A negative peak at 220 nm is detected. 
  
p -> p*: Due to the electric dipolar moment transition. It involves more energy than 
the n -> p* transition. It is a linear transition from a bonding orbital to a antibonding 
p*. A broad positive signal at 190 nm is observed. 
 
2. Aromatic residues: The asymetry of the side chain of the residues and the hydrogen 
bonds generated due to the solvent polarity exposure are relevant. The extinction 
coefficient factors for the phenilalanine and the tyrosine are small and, as a result, the 
transitions give as results weak bands in the spectra. Tyrosine residues show a peak 
between 275 and 282 nm, with a shoulder at longer wavelengths. The phenilalanine 
residues exhibit weaker but sharper bands at 262 and 268 nm. Interestingly, the 
tryptophan residue presents higher side chain asimetry and extinction coefficient factor 
undergoing several transitions in the 240-295 nm range. In addition, the solvent polarity 
has a direct effect on the energy required for the transition. Indeed, the hydrogen bonds 
decrease the energy required for the transitions from the ground state to the excited 
state. It should be noted that the fine structure in these bands arises from vibronic 
transitions in which different vibrational levels of the excited state are involved. (Kelly, 
Jess, & Price, 2005). Weaker aromatic bands are also located in the far-UV region. They 
can be observed in case of low secondary structure content, i.e., when the n-pi band of 
the backbone is weak. 
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3. Disulfide bonds: the absortion happens between 250-300 nm and it is low. In addition, 
if the protein also contains aromatic residues, the corresponding band of the disulfide 
bonds can be masked. 
 
3.1.1.2. Thermal induced-unfolding process followed by Far UV CD 
 
The thermal-induced unfolding process can be followed by CD in the far UV region 
providing useful information about the cooperativity during the denaturation event and 
stability of the folded state of the native protein that might vary upon neither denaturing 
agents or stabilizating substrates addition (Kelly et al., 2005). In fact, spectra can 
represent ellipiticity at a given wavelength (generally at 222 nm, maximun of absorption 
for the peptide backbond) as function of the temperature or the fraction of unfolded-
folded protein as function of the temperature. The simplest model for a protein unfolding 
reaction is a two-state model, N < -- > U, where N is the native state defined by a 3D 
structure and biological function and U is the unfolded state. If N state is subjected to 
different conditions that might cause the unfolding process (high temperature, pH, 
pressure or high concentration of chemical denaturants) the organized native structure 
can be lost in a more or less cooperative manner to form the U state. Generally, the term 
“unfolded” state refers to that can refold to the native state if perturbing condition is 
removed, whereas “denaturation” is a process that yields an altered structure that cannot 
readily refold to the native state (Gore, 2000). The thermal-induced unfolding process 
data can be fitted in order to determine thermodynamic parameters as DHvH or Tm 
(Chenal et al., 2010): 
The fraction of native protein  that populated the native state, N, is given by: 
 
, 
 
where U is the concentration of protein in the thermal-unfolded state and K the 
equilibrium constant at the given temperature: .  
The free energy of unfolding ∆G at any temperature is related to the enthalpy ∆H 
and the entropy ∆S of the unfolding reaction 
 
 with  and ,  
  
fN
  
fN =
N
N +U =
1
1+ UN
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ 
= 11+ KT
  
KT =U N
  
ΔG = ΔH −TΔS
  
ΔH = ΔHvH + ΔCp T −Tm( )
  
ΔS = ΔSm + ΔCpln T Tm( )
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given 
,  
given the Gibbs-Helmholtz equation: 
 
 
where ∆Cp is the variation of heat capacity at constant pressure, Tm the temperature of 
half denaturation (where U=N), ∆HvH and ∆Sm the van't Hoff variation of enthalpy and the 
entropy at the melting point. 
 
 In the vicinity of the half-melting temperature ( ):  and . 
Then, the expression of the free energy of unfolding in the vicinity of the melting point 
∆Gm can be approximated to: 
 
 
The variation of entropy in the vicinity of the Tm can be replaced by the van't Hoff 
enthalpy variation. Indeed, at the melting temperature, U=N given . The 
equilibrium constant K being related to the free energy , at the melting 
point: . Hence,  from where  can be 
expressed as follows:  and used to express  only as a function of 
 : 
 
 
With the ∆Cp contribution, the expression is 
 
From the free energy expression related to the equilibrium constant K, 
, K is given by  
 
In the vicinity of the half melting point, ∆Gm replaces ∆G, ∆Cp term can be considered 
negligible (T-Tm -> 0 and Ln(T/Tm) -> 0) and K becomes 
  
ΔG = ΔHvH + ΔCp T −Tm( ) −T ΔSm + ΔCpln T Tm( )( )
  
ΔG = ΔHvH −TΔSm + ΔCp T −Tm −T ln T Tm( )( )
  
T ≈ Tm
  
T −Tm( ) ≈ 0
  
ln T Tm( ) ≈ 0
  
ΔGm = ΔHvH −TΔSm
  
KTm =1
  
ΔG = −RT lnK
  
ΔGm = −RT lnKm = 0
  
ΔGm = ΔHvH −TΔSm = 0
  
ΔSm
  
ΔSm =
ΔHvH
T
  
ΔGm
  
ΔHvH
  
ΔGm = ΔHvH −
TΔHvH
Tm
  
ΔGm = ΔHvH −
TΔHvH
Tm
+ ΔCp T −Tm −T ln T Tm( )( )
  
ΔG = −RT lnK
  
K = exp
−ΔG
RT
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ 
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Finally, the fraction of native protein is expressed as followed, providing an estimation of 
∆HvH and Tm: 
                                           eq. 3.3 
 
 
The determination of the Tm values of EcAGPase in complex with its allosteric regulators 
allow us to characterize the thermal stabilization/destabilization effect of this interaction. 
In combination with structural information, CD might provide insights into the allosteric 
regulation of EcAGPase.    
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3.2. Electron microscopy  
In this work, electron microscopy (EM) has been one of the principal techniques used for 
the determination of the quaternary structure of EcAGPase in solution. 
In the last decades, EM has become a major tool for structural biology over the molecular 
to cellular size range, overlapping with methods as light microscopy (LM), X-ray 
crystallography and nuclear magnetic resonance spectroscopy (NMR).  
There are different varieties of EM, that can be classified in the way the image is 
generated form the specimen, as SEM (scanning electron microscopy), REM (reflection 
electron microscopy) and TEM (transmission electron microscopy) which is the matter of 
discussion in this section.  
 
 
3.2.1. TEM components 
 
TEM is analogous in some aspects to LM where the light-visible photons serve as the 
source of radiation and, once they pass through the specimen, they are refracted by 
glass optical lenses to form an image. 
The main difference between LM and 
EM is that, in EM, the radiation is a 
beam of electrons emitted by a source 
that is housed under high vacuum. 
Electrons are then accelerated down the 
microscope column and, after passing 
through the specimen, scattered 
electrons are focused by the 
electromagnetic lenses to form an 
image which can be recorded. Thus, 
similar to a conventional light 
microscope, the TEM consists of (i) an 
electron source, (ii) a series of lenses, 
and (iii) an image detecting system 
(Figure 3.1; Milne et al. 2013) 
 
Figure 3.2 Schematic representation of a 
classical TEM. (From www.ufrgs.br). 
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Different types of EM electron sources are available; the usual one is a heated tungsten 
filament to 2000-3000 ºC, at this temperature, the thermally emitted electrons are later 
accelerated by an electric field between the anode and filament.  Another common 
electron source is a lanthanum hexaboride crystal (LaB6), which displays a low work 
function. This parameter describes the minimum energy needed to remove an electron 
from the source. For this reason, LaB6 allows lower temperatures than tungsten, leading 
to greater brightness and longer life of the source. In addition, LaB6 produces electrons 
from a smaller effective area of the crystal vertex, which means higher coherence of the 
electron beam. At present, field emission gun (FEG) is the most advanced electron 
source and is used in high performance microscopes. It is composed by a single crystal 
tungsten sharpened to give a tip radius lower than in the case of LaB6. The tip is coated 
with ZrO2, which lowers the work function. These characteristics allows the FEG beam 
to be smaller in diameter, more coherent, and ∼500X brighter, with a very small spread 
of energies. In all cases, thermally emitted electrons are extracted from the source by a 
strong potential gradient at the emitter surface (field emission), and then accelerated 
through voltages of 100-300 kV (Orlova & Saibil, 2011; Shimizu, Kataoka, Kawai, & 
Tanaka, 1975). 
The basic function of electron optical lenses is to deflect electrons, as crystal lenses 
deflects photons in LM. Since electrons are negatively charged particles of small mass, 
they can be oriented by an electro-magnetic field. This way, magnetic condenser lenses 
convert the diverging electron beam into a parallel one illuminating the specimen. The 
objective lens provides the primary magnification and is the most important optical 
element of the electron microscope, as its aberrations play a key role in imaging. An 
objective aperture is placed in the back focal plane of this lens allowing the absorption 
of scattered electrons, thus improving the image contrast. Intermediate and projector 
lenses further magnify the image before the electrons arrive at the detector (Figure 3.1; 
(Williams & Carter, 2009). 
Finally, the image can be view projecting the magnified electron image onto a fluorescent 
viewing screen coated with a phosphor or scintillator material, located within a chamber 
in the microscope (Figure 3.1). The image can be photographically recorded using a 
conventional photographic film composed by microscopic silver halide crystals. 
Nowadays, digital imaging has practically replaced recording on films and is widely used 
in TEM, allowing the specimen monitorization and image acquisition in real time. The 
most popular cameras are based on Charge-Coupled Device (CCD) or 
Complementary Metal Oxide Semiconductor (CMOS) sensors that convert the analogue 
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optical signal into digital format. However, the latest detection systems have been matter 
of important improvements, based on the incorporation of direct electron detectors 
(DEDs), which can directly count the image-forming electrons from the microscope. 
These latest advances have revolutionized the technique, allowing to reach the atomic 
resolution (Callaway, 2015). 
 
 
3.2.2. Interaction of electrons with the specimen 
 
Resolving power is one of the most significant differences between LM and EM. It is 
worth noting that resolution is directly influenced by the wavelength of the imaging 
radiation source by the next relationship, 
 
Resolution (r) = λ/ (2NA) 
 
where r is resolution, NA the numerical aperture and λ the imaging wavelength. Based 
on this equation, the shorter the wavelength, the higher the attainable resolution. In this 
regard, the resolution achieved with visible light (wavelengths ~ 4000–7000 Å; 1 Å = 
10−10 m) is significantly less than that accomplish with electron sources in a typical TEM 
(wavelength of ~ 0.02 Å for operation at 300 kV) (Milne et al., 2013). In EM, the 
wavelength of electron radiation itself does not impose a limit on the resolution that could 
be obtained when imaging biological macromolecules by EM, however, the limitation in 
this regard is the stability of the specimen position and the radiation damage that results 
from the strong interaction of electrons with the organic matter. The nature of this 
interaction depends on the electron energy and sample composition. In this regard, 
electrons can either pass through the sample without any interactions or can be deflected 
by the specimen. These last, can interact with the electrostatic field of the nucleus, 
screened by the outer orbital electrons of specimen atoms, and some electrons may 
collide or nearly collide with the atomic nuclei, suffering high angle deflections or even 
backscattering (Figure 3.2A). Of the interacting electrons, some are scattered without 
energy loss (elastic scattering), but others transfer energy to the specimen (inelastic 
scattering). This energy transfer can ionize atoms in the specimen, induce X-ray 
emission, chemical reactions or induce secondary electron scattering, all of which can 
change the specimen structure. Thus, radiation damage of specimens is a significant 
limitation in high-resolution imaging of biological molecules (Figure 3.2B). To reduce this 
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phenomenon during area selection, alignment, and focusing, special “low dose” systems 
are used to deflect the beam until the final step of image recording (Orlova & Saibil, 2011; 
Williams & Carter, 2009). 
 
 
Figure 3.3 Interaction of the electron beam with the sample. (A) Schematic representation of 
possible electron interactions with the specimen. (B) Effect of electron beam damage on a cryo 
image of a cell. The electron dose is shown on the images. Increasing dose causes damage to 
cellular structures (From Orlova and Saibil 2011). 
 
 
3.2.3.  Specimen nature  
 
Electron microscopy can be used to provide structural information on a range of 
biological specimens of different shapes, sizes, and biochemical states.  
Because electrons interact strongly with matter, the column of the microscope must be 
kept under high vacuum to avoid unwanted scattering by gas molecules in the electron 
path. Therefore, the EM specimen must be in the solid state for imaging, and special 
preparation techniques are necessary to either dehydrate or stabilize hydrated biological 
samples under vacuum. It is worth noting that organic samples are predominantly made 
of light elements, including hydrogen, carbon, nitrogen, and oxygen, thus, images will 
not contain much contrast. For this reason, structural information can thus be obtained 
either by, (i) acquiring images from electrons scattered by stained samples or (ii) the 
scattering of native specimens supported in vitreous ice. In this regard, an electron 
cryomicroscope (cryo-TEM or cryo-EM) is a TEM with a specimen holder capable of 
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maintaining the sample at liquid nitrogen or liquid helium temperatures. This allows 
imaging specimens prepared in vitreous ice (Milne et al., 2013; Thompson, Walker, 
Siebert, Muench, & Ranson, 2016).  
Two extreme sample groups can be performed according to its nature: biochemically 
purified, isolated complexes (single particles or ordered assemblies such as 2D crystals) 
and unique, individual objects such as tissue sections, cells, or organelles.  
The sample preparation protocol, along with the data processing method, will depend on 
the nature of the sample: (i) single particle analysis for purified, ‘homogenous’ protein 
complexes, (ii) helical reconstruction for protein assemblies with helical symmetry, (iii) 
tomography for ‘unique’ assemblies such as organelles and cells, and (iv) 2D 
crystallography for proteins, significantly smaller than 150 kDa that form ordered 2D 
arrays (Thompson et al., 2016).  
 
In this work, steps towards biological structure determination by EM are discussed, 
focusing on sample preparation and imaging of specimens for single particle analysis 
(single particle-EM), although many of the concepts and considerations discussed are 
transferrable. 
 
 
3.2.4. Sample preparation  
 
Single-particle EM depends on the computational averaging of thousands of images of 
identical particles, so the ideal single-particle specimen is a pure, homogenous sample. 
Compositional heterogeneity of the sample can be reduced biochemically using 
appropriate protein purification methods, however, structural arrangements and intrinsic 
flexibility may produce a broad range of conformations. Although novel imaging 
processing algorithms and detectors allows dealing with some heterogeneity in the 
dataset during the processing stages, the structural heterogeneity can be reduced by 
biochemical approaches to simplify structure determination. In this sense, solution buffer 
conditions can dramatically alter the appearance of a sample in the microscope being 
recommended to perform a throughput screening to identify optimal buffer compositions. 
Chemical crosslinking may also be a useful tool for reducing sample heterogeneity, 
however, this approach may introduce artefacts. Other way to reduce conformational 
flexibility include ligand-induced stabilization, where molecules such as a substrate, 
ligand, inhibitor or protein/nucleic acid binding partners can promote stable complex 
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formation, a strategy that is well established in X-ray crystallography (Cheng, Grigorieff, 
Penczek, & Walz, 2015; Egli, 2010).  
Optimizing the sample before attempting to image it remains vital, however, the most 
informative way to judge the quality of a protein sample is to visualize it by negative-
stain EM (see above). 
 
 
3.2.5. Grid preparation 
 
Most biological EM work is done on small support discs called grids, commonly made 
from a fine mesh of a metal (Cu, Ni, Ag or Au). The mesh size, or number of squares 
across the grid, is defined as the number of squares in one inch; 200–400 mesh grids 
(20-40 squares across in each direction) are the most commonly used for cryo-EM 
(Thompson et al., 2016).  
The metal grid supports a carbon film on top, which is going to be in contact with the 
sample. The surface features of this film can be altered by a variety of processes, 
including the modification of its charge properties. This is accomplished by glow 
discharging; the carbon-coated grids are placed inside a partly evacuated chamber 
connected to a power supply. When high voltage is applied between the cathode and 
anode at each end of the chamber, the electron potential ionizes the gas within the 
chamber (Baker, Olson, & Fuller, 1999) . These negatively charged ions then deposit on 
the carbon, giving the carbon film an overall hydrophilic surface. This technique can 
change the partitioning of the sample into the grid and has to be optimized for each 
sample. 
Once the specimen is ready, the grid must be prepared for imaging by TEM. The choice 
of preparation technique is ultimately determined by the nature of the sample but 
common methods include negative staining and vitrification, techniques that will be 
describe in detail through the next sections.  
 
3.2.5.1. Negative staining 
 
Negative stain is a common method for examining a specimen at room temperature. This 
protocol usually comprises three steps: (i) particle adsorption onto the grid, (ii) washing, 
and (iii) incubation with a solution of a heavy metal salt, commonly 1–2% (w/v) uranyl 
acetate or uranyl formate. The grid is finally blotted to ensure a thin layer of stain. The 
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staining process quickly dehydrates the specimen and envelops it in stain; where the 
sample is visualized by the absence of stain, negative staining occurs; where the sample 
itself becomes stained, positive staining occurs (Figure 3.3; Ohi et al. 2004).  
The resulting shell of heavy metal atoms generates high contrast and signal to noise 
ratio (SNR), however, it only provides surface topology information. Moreover, the 
dehydration process can affect the sample state and staining artefacts are also probable 
if the metal salt solution deposition is uneven. This method is thus restricted to a modest 
resolution (>20 Å), nevertheless, it can be improved varying the metal grain size, as this 
parameter determines how well the stain envelope reflects the structure of the particle. 
One of the principal advantages of negative stain is the high speed of sample preparation, 
which makes it ideal for assessing sample purity, concentration or heterogeneity. Low-
resolution 3D reconstructions from stained data can also provide starting models for 
higher resolution cryo-EM studies (Ohi et al., 2004; Orlova & Saibil, 2011; Thompson et 
al., 2016). 
 
 
 
3.2.5.2. Vitrification - Plunge freezing 
 
Imaging of cryogenically immobilized samples by EM is known as cryo-EM. The sample 
must be frozen extremely rapidly, at a rate of -106 ºC/s, to allow the formation of vitreous 
ice. If freezing occurs too slowly, or the specimen is subsequently warmed above the 
temperature at which water devitrifies (-137 ºC), crystalline ice is formed which degrades 
image quality as this type of ice diffracts electrons. (Thompson et al., 2016). Cryo-
immobilisation can be achieved following three steps: (i) particle adsorption onto the grid, 
Figure 3.3. Schematic representation of (A) negative stain and (B) positive stain 
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(ii) blotting to generate a thin film of liquid and (iii) rapidly freezing by plunging the grid 
into a cryogen (Figure 3.4). It is important to optimize the incubation time, sample 
distribution (blotting time) and ice thickness to achieve the best images. The most widely 
used cryogens are liquid ethane or propane, cooled by liquid nitrogen. The ice layer 
should be as thin as possible without distorting the specimen and avoiding ice 
contamination. Commercially available freezing apparatus offer different features that 
may be beneficial when working with certain samples. In this regard, the humidity control 
in the freezing chamber can reduce ice contamination during the process and improve 
the final image quality (Baker et al., 1999; Cheng et al., 2015; Milne et al., 2013; 
Thompson et al., 2016). One of the main advantages of this method is that cryo-
immobilisation leads to the visualization of the sample in a native-like state. In this 
approach, low electron doses are needed to prevent radiation damage, which results in 
poor contrast. However, processing of data can yield high-resolution, 3D structural 
information.  
 
 
 
 
 
3.2.6. Image processing  
 
In EM, the image suffers from aberrations that can be corrected by the contrast transfer 
function (CTF). The CTF mathematically describes how these aberrations modify the 
image of the sample and its accurate estimation is essential for both, the initial evaluation 
of micrograph quality and subsequent structure determination (Baker et al., 1999). The 
Figure 3.4. Schematic representation of plunge freezing and a vitrified layer with an 
example cryo-EM image (From Milne et al. 2013) 
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parameters that have to be known to calculate this function are: acceleration voltage, 
spherical aberration, defocus, astigmatism, and percentage of amplitude contrast. 
Voltage and spherical aberration are instrument parameters that are usually used without 
further refinement and the contribution of the amplitude contrast is typically assumed as 
5%–10% for cryo-EM images (Cheng et al., 2015). As has been mentioned before, 
samples are predominantly made of light elements, including hydrogen, carbon, nitrogen, 
and oxygen. This means that an in-focus image in cryo-EM will not contain much contrast 
(magnitude of variation between bright and dark features) as the electron transmission 
across a sample is approximately constant. The main method for generating contrast is 
to deliberately underfocus the objective to induce phase shifts in the scattered electrons 
and thus contrast in the images (Newcomb, Moyer, Lee, & Stupp, 2012). However, this 
approach leads to a systematic alteration of the image data and because of that, 
although the defocus is set during data collection, more accurate values for defocus and 
astigmatism have to be calculated for each micrograph. 
 
 
3.2.7. Particle picking 
 
Once a dataset has been collected, it is necessary to obtain individual particles from 
each micrograph. This process in known as particle picking and can be performed in a 
manual, semi-automated, and fully automated manner. The quality of the selected 
particles is a major factor in the subsequent analysis. 
 
 
3.2.8. Alignment and 2D classification 
 
The first step in single-particle EM structure determination is the alignment and grouping 
of the 2D image dataset into homogenous subsets. A micrograph often contains particles 
in multiple different orientations and/or conformations, and so to get more representative 
image averages, a method is required to group similar particle images. This is usually 
carried out using one of several data analysis and image classification algorithms, such 
as multi-variate statistical analysis and hierarchical ascendant classification, or K-
means classification (Orlova & Saibil, 2011). 
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The reason to start with 2D analysis is that (i) 2D datasets contain image artefacts, invalid 
particles, or simply empty fields that should be removed; (ii) the angular distribution of 
the particle views is unknown and if the set is dominated by just a few views, 3D analysis 
is unlikely to succeed; and (iii) computational ab initio 3D structure determination 
requires high-SNR input data, as is present in high-quality class averages. Is essential 
thus to have enough images to cover all the possible orientations of the particle. The 
degree of relatedness between individual particle images (Figure 3.4A) is used to identify 
clusters of similar images within the data set. Related images are averaged to obtain 
characteristic projection views of the complex at much higher signal-to-noise ratios than 
in the original images (Figure 3.4B). Iteration of this classification process, using 
characteristic views of the newly generated class averages as alignment references, 
improves the accuracy of alignment and permits visualization of finer structural features 
(Figure 3.4C; Cheng et al., 2015; Orlova & Saibil, 2011; Williams & Carter, 2009) 
 
 
 
Figure 3.5 (A) Part of a recorded micrograph, (B) isolated particles and (C) class 
averages of the 70S T. thermophiles ribosome. The scale bar corresponds to 20nm (From 
Bai et al. 2013). 
 
 
3.2.9. 3D reconstruction 
 
Generation of a 3D reconstruction from the 2D electron microscopic projection views of 
the molecular complex is dependent upon knowing the relative orientations of all of the 
particles. The steps involved in computational ab initio structure determination are 
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mathematically complex, and take advantage of the central projection theorem, which 
states that, for a 3D object, the Fourier transform of each 2D projection is a central slice 
through the 3D Fourier transform of the object (Figure 3.6; Milne et al. 2013; Bragg 1929). 
Thus, once the 3D Fourier transform is built up from a collection of 2D images spanning 
a complete range of orientations, Fourier inversion enables recovery of the 3D structure.  
Initial maps can be refined to higher resolution using projection-matching refinement 
strategies, which modifies the orientation parameters of single-particle images 
(projections) to achieve a better match with reprojections computed from the current 
approximation of the structure. If appropriate, available atomic coordinates of 
corresponding protein components derived from X-ray or NMR analyses can be then 
fitted into the final structure. Various software packages, including EMAN (Ludtke, 
Baldwin, & Chiu, 1999), FREALIGN (Grigorieff, 2007), and SPIDER (Shaikh et al., 2009), 
were successfully used for the near-atomic resolution structure reconstructions  
 
Figure 3.6 Schematic illustration of the EM 3D map reconstruction. Projection images of the 
object, each with a different orientation, have 2D Fourier transforms that correspond to sections 
(indicated by red arrows) through the 3D Fourier transform of the original object. Thus, once the 
3D Fourier transform is built up from a collection of 2D images spanning a complete range of 
orientations, Fourier inversion enables recovery of the 3D structure (From Milne et al. 2013). 
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4. Structural characterization of EcAGPase 
allosteric regulation.  
To advance in the comprehension of the molecular mechanism that governs AGPase 
allosteric regulation in bacteria, we focused in the paradigmatic AGPase from 
Escherichia coli (EcAGPase) and its physiologically preferred positive and negative 
allosteric regulators, FBP and AMP, respectively (Ghosh & Preiss, 1966). Specifically, 
the aim of this study was to identify the EcAGPase allosteric binding sites by X-ray 
crystallography and propose a model of allosteric regulation in combination with 
biophysical data.  
The references of this chapter are based on the publication, mentioned in “Publications” 
section, Structural Bases of Glycogen Biosynthesis Regulation in bacteria (Cifuente et 
al., 2016). 
 
 
 
 
4.1. Materials and methods 
 
EcAGPase cloning, expression and purification — The full-length glgC gene from E. 
coli BL21 was amplified by standard PCR using oligonucleotide primers glgC_NdeI_Fwd 
(5´ gggaattccatatggttagtt 3´) and glgC_XhoI_Rev (5´ ccgctcgagtcatcgctcctg 3), Phusion 
DNA Polymerase (New England Biolabs) and purified genomic DNA as template. The 
PCR fragment was digested with NdeI and XhoI and purified by agarose gel 
electrophoresis. The fragment was ligated to the expression vector pET29a (Novagen) 
using T4 DNA ligase, generating pET29a-EcAGPase. The recombinant EcAGPase has 
no additional amino acids when compared to the native enzyme. E. coli BL21(DE3) cells 
transformed with pET29a-EcAGPase were grown in 3,000 ml of LB medium 
supplemented with 25 mg/ml of kanamycin at 37°C. When the culture reached an OD600 
of 0.8, the EcAGPase expression was induced by the addition of 1 mM isopropyl b-
thiogalactopyranoside (IPTG) and further incubated at 18°C overnight. All EcAGPase 
purification procedures were carried out at 4°C. Cells were harvested by centrifugation 
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at 5,000 x g and resuspended in 40 ml of 50 mM Hepes pH 8.0, 5 mM MgCl2, 0.1 mM 
EDTA, 10% sucrose (w/v; solution A), containing protease inhibitors (Complete EDTA-
free; Roche) and 10 mg/l of lysozyme (Sigma). Cells were then disrupted by sonication 
(five cycles of 1 min each) and centrifuged for 15 min at 20,000 x g. The supernatant 
was dialyzed twice against solution A by using an 100,000 Da molecular mass cutoff 
dialysis membrane.  The solution was then applied to a DEAE FF column (5 ml; GE 
Healthcare) equilibrated with solution A. Elution was performed with a linear 0-0.5M NaCl 
gradient in 100 ml. Enzyme-positive fractions were pooled and precipitated with 
ammonium sulfate to 1.2 M (solution B). The resultant suspension was centrifuged for 
20 min at 20,000 x g and the resulting supernatant applied into a Phenyl Shodex HIC 
PH-814 equilibrated in solution B. The enzyme was eluted with a linear gradient of 100% 
solution B to 100% solution A, in 50 ml. The most active fractions were pooled, 
concentrated to 10 mg/ml by an Amicon-Ultra spin concentrator (Merck Millipore) with a 
100-kDa-molecular mass cutoff, and stored at -80°C.  
 
Gel filtration — Gel filtration chromatography was performed using a Shodex KW-802.5 
column equilibrated in 50 mM Tris-HCl pH 7.5, 100 mM NaCl at 0.5 ml min-1. The column 
was previously calibrated using gel filtration standards (Sigma) including b-amylase (200 
kDa), alcohol dehydrogenase (150 kDa), bovine serum albumin (66 kDa), carbonic 
anhydrase (29 kDa), and cytochrome c (12.4 kDa).  
 
EcAGPase Crystallization and Data Collection — Crystallization trials were carried 
out in sitting drop 96 well plates by using a mosquito crystal robot (TTP Labtech). 
Crystals of EcAGPase•AMP•SUC were obtained by mixing 0.25 m l of EcAGPase at 5 
mg/ml in 5 mM ADP, 6.6 mM HEPES pH 8.0, 50 mM MgCl2, 10 mM EDTA and 12 % 
(w/v) sucrose with 0.25 µl of mother liquor containing 16 % (w/v) PEG 10,000 and 100 
mM imidazole pH 7.8. Crystals of EcAGPase•FBP were obtained by mixing 0.25 µl of 
EcAGPase at 5 mg/ml in 3.6 mM FBP, 6.6 mM HEPES pH 8.0, 50 mM MgCl2, 10 mM 
EDTA and 12 % (w/v) sucrose with 0.25 µl of mother liquor containing 22 % (w/v) PEG 
4,000 and 200 mM ammonium sulfate. Crystals grew in 3-15 days and were transferred 
to a cryo-protectant solution containing 25% ethylene glycol and frozen under liquid 
nitrogen. Crystals screening were performed at Diamond Light Source (DLS) (Didcot, 
Oxfordshire, United Kingdom). EcAGPase•AMP•SUC complete dataset was collected at 
I04 beamline (DLS) with oscillation angle of 0.15° for a total of 1200 images using a 
Pilatus 6M-F pixel detector. EcAGPase•FBP dataset was collected at I04-1 beamline 
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(DLS) with oscillation angle an 0.10° for a total of 1200 images using a Pilatus 2M pixel 
detector. X-ray data were processed using the program XDS23. EcAGPase•AMP•SUC 
and EcAGPase•FBP forms crystallized in space group P 21 with 16 molecules in the 
asymmetric unit and diffracted to a maximum resolution of 2.67 Å and 3.04 Å, 
respectively. 
 
EcAGPase Structure Determination and Refinement — The crystal structure of 
EcAGPase•AMP•SUC was solved by molecular replacement with the program Phaser24 
using a tetramer from AGPase from A. tumefaciens, PDB atomic coordinates 3BRK 
(Cupp-Vickery et al., 2008) ⁠, as search model and followed by automated model-building 
using Phenix (phenix.autobuild) (Adams et al., 2010) ⁠. The EcAGPase•FBP crystal 
structure was solved by molecular replacement using the EcAGPase•AMP•SUC model. 
The complete models were obtained using alternate cycles of manual model-building 
using COOT (Emsley, Lohkamp, Scott, & Cowtan, 2010) ⁠ and Phenix (phenix.refine) or 
Refmac5 (Murshudov et al., 2011). NCS restraints were relaxed towards the end of 
refinement and differences between chains subsequently modeled. The ligands topology 
for AMP, FBP and SUC was refined using CIFs (Crystallographic Information File) 
generated using PRODRG server (Schüttelkopf & Van Aalten, 2004) or Grade web 
server (Global Phasing Ltd.). It is worth noting that the electron density observed for the 
connecting region between the two phosphate groups of FBP is poor, leading to two 
possible conformations (i) the furanose and (ii) the open chain forms. Based on our 
interpretation of the maps, the furanose form is shown. During the refinement, the 
structure geometry was validated using Molprobity (Chen et al., 2010) ⁠ and the ligands 
checked using pdb-care (PDB CArbohydrate REsidue check) (Lütteke & von der Lieth, 
2004) ⁠. Final sugar analysis and validation was performed using CCP4 package Privateer 
(Agirre, 2015). Atomic coordinates and structure factors have been deposited with the 
Protein Data Bank, accession codes 5L6V (EcAGPase•AMP•SUC) and 5L6S 
(EcAGPase•FBP). Molecular graphics and structural analyses were performed with the 
UCSF Chimera package (Pettersen et al., 2004). 
 
Location of the ATP and G-1-P binding sites in EcAGPase — The location of the ATP 
binding site in EcAGPase was determined by structural superposition with (i) the crystal 
structure of GlmU in complex with ATP (4K6R) (Vithani, Bais, & Prakash, 2014) ⁠ and that 
of StAGPase in complex with ATP and ADPG (1YP4) (Jin et al., 2005) ⁠. GlmU is an 
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essential bifunctional uridyltransferase that catalyzes the CoA-dependent acetylation of 
GlcN-1-PO4 to form GlcNAc-1-PO4 and its subsequent condensation with UTP to form 
pyrophosphate and UDP-GlcNAc. The G-1-P binding site in EcAGPase was determined 
taking into account the location of the glucose moiety of sucrose in the 
EcAGPase•AMP•SUC crystal structure. 
 
EcAGPase Structure Analysis — Analysis of the crystal structures was carried out 
using Chimera (Pettersen et al., 2004). Assignment of the secondary structural elements 
was performed automatically using Chimera implementation of DSSP with parameters 
“H-bond energy cutoff = -0.5 kcal/mol”, “minimum helix length = 3” and “minimum strand 
length = 2”. Contacts were analyzed using the default settings considering a Van der 
Walls overlap of -0.4 Å. Structure superimposition was perform using the tool 
MatchMaker. Multiple sequence alignments were performed using Promals3D (Pei, Kim, 
& Grishin, 2008).  
 
Circular dichroism thermal unfolding analysis — Thermal unfolding transitions were 
recorded on a J-810 CD spectropolarimeter (Jasco Corp., Tokio, Japan) at 222 nm by 
using Hellma 110-QS quartz cuvettes with a 1 mm optical path. Thermal unfolding was 
recorded at protein concentrations of 1 µM in 50 mM Tris-HCl pH 8,0, 150 mM NaCl 
between 20 °C and 90 °C with a heating rate of 1°C/min. Transitions were tentatively 
fitted according to equation 1 to obtain the apparent melting temperature (Tm) 
(Sotomayor-Pérez, Subrini, Hessel, Ladant, & Chenal, 2013). 
 
𝑦 = 𝑦𝑓 	+𝑚𝑓 	· 	𝑇 +	 𝑦𝑢 	+	𝑚𝑢 · 	𝑇 · 	e	 𝛥𝐻𝑚𝑅 · 1𝑇𝑚−1𝑇1	 +	e	 𝛥𝐻𝑚𝑅 · 1𝑇𝑚−1𝑇  
(Eq. 1)  
where y represents the observed CD signal at 222 nm, yf and yu are the y-axis intercepts 
and mf and mu the slopes of the pre- and post-transition baselines, respectively, T is the 
temperature in K, Tm is the melting temperature, and  DHm is the enthalpy change of 
unfolding at Tm. Curve fitting was performed with Prism GraphPad.  
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4.2. Results and discussion 
 
4.2.1. Overall structure of EcAGPase 
 
The paradigmatic EcAGPase was purified to homogeneity following the protocol 
described in Materials and methods section. It is important to emphasize that the 
EcAGPase construct has no additional amino acids when compared with the native full-
length enzyme (Figure 4.1A). SDS-PAGE and analytical gel filtration confirmed that 
EcAGPase displays the homotetrameric structure expected for bacterial AGPases in 
solution (Figure 4.2B; Jack Preiss 2014). 
 
 
Figure 4.1. Recombinant production of EAGPase.  (A) Amino acid sequence of EcAGPase 
construct used for heterologous production in E. coli. EcAGPase was expressed in E. coli as the 
native full-length protein without additional amino acids. (B) SDS-PAGE showing purified 
EcAGPase with an apparent monomeric molecular mass of ~50 kDa. The analytical gel filtration 
confirms that the enzyme is a homotetramer in solution. The retention time of 7.75 min observed 
for EcAGPase corresponds to an apparent molecular mass of 198.3 kDa, which agrees within the 
experimental error of gel filtration experiments with the calculated mass of the homotetramer of 
194.8 kDa. 
  
The crystal structures of EcAGPase were solved by molecular replacement using 
a tetramer of AtAGPase (PDB: 3BRK) in two different states, including the complexes 
with its naturally occurring and preferred allosteric negative regulator AMP 
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(EcAGPase•AMP•SUC) and positive regulator FBP (EcAGPase•FBP; Preiss et al., 
1966). In addition, the EcAGPase•AMP•SUC structure displayed sucrose (SUC) located 
in the active site of the enzyme. EcAGPase•AMP•SUC and EcAGPase•FBP forms 
crystallized in space group P 21 with 16 molecules (431 residues each) in the asymmetric 
unit and diffracted to a maximum resolution of 2.67 and 3.04 Å, respectively. EcAGPase 
crystallized as a homotetramer with each protomer (48.7 kDa) composed of two domains, 
the N-terminal glycosyltransferase A (GT-A)-like domain (residues 1–315) containing the 
active site, and the C-terminal regulatory domain (residues 316–431) containing a left-
handed parallel β helix (LβH; residues 316–396; Figure 1A). The GT-A-like domain 
consists of one Rossmann fold domain (residues 1– 315; Pelissier et al., 2010). The core 
is composed of a central β sheet comprising seven β strands (β5, β4, β1, β8, β14, β10, 
and β15, of which β14 is antiparallel) flanked on both sides with several α helices (Figure 
4.2). In contrast, the LβH domain (residues 316–396; Raetz and Roderick, 1995) is built 
of short β strands (β17-β30) oriented parallel to each other and describing a triangular 
prism (Figure 4.2).  
 
 
 
Figure 4.2. The structure of a EcAGPase monomer. Cartoon representation of EcAGPase 
showing the secondary structural elements, as defined by CHIMERA. β-strands and α-helices 
are shown as arrows and cylinders, respectively. The N-terminal GT-A like domain consists of 
one Rossmann fold domain (green; residues 1-315). The core is composed of a central β-sheet 
comprising seven β-strands (β5, β4, β1, β8, β14, β10, β15 of which β14 is antiparallel) alternating 
with α-helices. The N-terminus region (residues 1 to 10) has no electron density	 indicating 
conformational flexibility. The C-terminal domain comprises the LβH (orange; residues 316 to 
396), built of short β-strands (β17-30) oriented parallel to each other, and describing a triangular 
prism.  
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The EcAGPase protomers build into a physiological and functional 
homotetrameric structure (194.8 kDa) that can be viewed as a dimer of dimers (Figure 
4.3). The most important contribution to the dimer inter-face is the triangular base of the 
LβH prism of each protomer (strands β17, β18, and β19) resulting in two antiparallel β 
sheets.  
 
 
 
Figure 4.3. Structure of EcAGPase dimer. A-D. Cartoon representing the three-dimensional 
configuration of an EcAGPase dimer. The most important contribution to the dimer interface is 
the triangular base of the LβH prism of each monomer (strands β17, β18 and β19), resulting in 
two anti-parallel β-sheets.  
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In contrast, the tetramer assembles mainly by interactions between the N-
terminal GT-A-like domains from different dimers. Specifically, as depicted in Figure 4.4, 
three adjacent α helices, α1 (residues 10–19), α6 (residues 93–95), and α8 (residues 
149– 159) from the GT-A-like domain of protomer A interact with the equivalent structural 
elements of the GT-A-like domain of protomer D. Moreover, α5 (residues 78–87), α7 
(residues 117–131), and β5 (residues 98–103) interact with the equivalent structural 
elements of the GT-A-like domain of protomer C, strongly contributing to anchoring both 
dimers in a competent tetramer configuration. The resulting architecture allows the 
protomers to communicate with each other, from which cooperativity emerges.  
 
 
 
Figure 4.4. Structure of EcAGPase tetramer. The EcAGPase monomers (48,7 kDa) build into 
a physiological and functional homotetrameric structure (194.8 kDa). EcAGPase is a 
homotetramer that can be viewed as a dimer of dimers54, with the dimer mainly built by 
interactions between the LβH C-terminal domains, and the tetramer assembling mainly by 
interactions between the N-terminal GT-A like domains from different dimers. Specifically, three 
adjacent α-helices, α1 (residues 10 to 19), α6 (residues 93 to 95) and α8 (residues 149 to 159) 
from the GT-A like domain of monomer A (green) interact with the equivalent structural elements 
of the GT-A like domain of monomer D (black). Moreover α5 (residues 78 to 87), α7 (117 to 131) 
and β5 (98 to 103) interact with the equivalent structural elements of the GT-A like domain of 
monomer C (grey), strongly contributing to anchoring both dimers in a competent tetramer 
configuration.  
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4.2.2. The active site of EcAGPase 
 
The active site is located in a deep cleft of the GT-A-like domain, as observed in other 
nucleotide sugar pyrophosphorylases (Cupp-Vickery et al., 2008; Jin et al., 2005). The 
crystal structure of EcAGPase•AMP•SUC revealed the presence of SUC in the C-
terminal region of the active site (residues 163– 315). SUC is clearly visible in the 
electron density maps and is present in all four active sites of the EcAGPase 
homotetramer. The glucose moiety binds to a deep pocket (the ‘‘sugar binding pocket’’ 
according to Brito et al., 2011, defined by three β strands, β11 (residues 179–183), β12 
(residues 189–194), and β13 (residues 208–212), and four loops: β12-β13 (residues 
194–208), α9-β11 (residues 177–179), α9-α12 (residues 261– 280), and β8-α8 
(residues 140–149). The O2 and O4 atoms of the glucose ring make hydrogen bonds 
with the side chain of Glu194 and the main chain carbonyl atom of Ser212, respectively. 
The glucose O6 is hydrogen bonded with the lateral chain of His143. Importantly, the 
replacement of His143, Glu194, and Ser212 per alanine displayed lower apparent affinity 
for G1P compared with the wild-type EcAGPase (Clarisa M. Bejar et al., 2006). Several 
aromatic residues, including Phe178, Phe192, Tyr216, and Trp274, are important for 
building the walls of the cavity. Interestingly, the structural comparison of the 
EcAGPase•AMP•SUC complex with that of the glucose-1-phosphate 
thymidylyltransferase from Pseudomonas aeruginosa (PaRmlA) in complex with G1P 
(PDB: 1G0R; (Blankenfeldt et al., 2000) revealed that the glucose moieties superimpose 
very well (Figure 4.5A). According to this configuration, the phosphate group of G1P is 
bound to Lys195, a conserved and essential residue for the enzymatic activity (Hill, 1991). 
Recent studies in the human UDP-glucose pyrophosphorylase from Leishmania major 
showed that the equivalent residue Lys255 is affected during the catalytic cycle, being 
relevant for G1P stabilization (Führing et al., 2013). Taken into account all these 
experimental data, we clearly defined the location of G1P in the active site of EcAGPase.  
The ATP binding site is located in the N-terminal region of the GT-A-like domain 
(residues 20–162; Figure 4.5B). The crystal structures of EcAGPase•AMP•SUC and 
EcAGPase•FBP revealed the presence of PO4 and SO4 ions, respectively, in the ATP 
binding site. Both anions are bound in equivalent positions, making strong interactions 
with the lateral and main chains of Arg32 and the main chain of Thr31. The structural 
comparison of both EcAGPase complexes with that of the N-acetylglucosamine-1-
phosphate uridyltransferase from Mycobacterium tuberculosis (MtGlmU) in complex with 
ATP (PDB: 4K6R; Vithani, Bais, and Prakash 2014) and the GDP-Man 
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pyrophosphorylase from Thermotoga maritima in complex with GTP (PDB: 2X60; 
Pelissier et al. 2010) revealed that the anions superimpose with the ATP g-PO4. 
According to this configuration, ATP accommodates into the active site of EcAGPase, in 
close contact to the essential catalytic Lys42 and favorably positioned to receive the G1P 
(Figure 4.5B; Ballicora et al. 2005; Ballicora et al. 2007). 
 
 
Figure 4.5. The ATP and G1P binding sites in EcAGPase. (A) Structural superposition of 
EcAGPase•AMP•SUC complex with that of RmlA in complex with G1P (PDB: 1G0R) defining the 
position of G1P, and showing key interactions of SUC with selected residues of EcAGPase.(B) 
Structural superposition of EcAGPase•AMP•SUC complex with that of the GlmU in complex with 
ATP (PDB: 4K6R) defining the entry position of ATP.  
 
 
Based on the structural information reported here and the biochemical data 
regarding the involvement of these residues in EcAGPase catalytic mechanism, we 
proposed a model in which Lys42 and Lys195 polarize G1P and ATP anionic 
phosphorous groups. This polarization increases the nucleophilic nature of the sugar 
phosphate oxygen attacking the ATP α-phosphate group, leading to the liberation of PPi 
(Figure 4.6A). The condetation reaction is held in the presence of cation Mg2+ 
(magnesium-dependent activity), which minimizes the charge repulsion between anionic 
phosphorous groups and has been proved to induce nucleophile activation in other 
nucleotidiltransferases (Swift, Ong, & Amaro, 2012). In nature, the reaction is pull forward 
by the hydrolysis of PPi by inorganic pyrophosphatases, since the reaction have a ΔG~0, 
otherwise the reverse reaction could also occur (Figure 4.6B).  
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Figure 4.6. Proposed catalytic mechanism for EcAGPase. (A) The formation of the nucleotide 
activated donor ADP-Glc occurs as a condensation reaction between ATP and a G1P. (B) 
Reverse reaction leading to the formation of G1P. 
 
 
4.2.3. The AMP allosteric binding site 
 
The identification of the physiological positive and negative regulatory sites at the 
molecular level in AGPases has been a long-standing question and a matter of intense 
research in the field of glycogen/starch biosynthesis/regulation. In the 
EcAGPase•AMP•SUC crystal structure, AMP is clearly visible in the electron density 
maps and is present in all four allosteric sites located in the corresponding clefts between 
the N-terminal GT-A-like and C-terminal LβH domains of neighboring protomers from 
different dimers (Figures 4.7). Specifically, AMP is deeply buried into a cleft mainly 
defined by (i) the N-terminal β2-β3 hairpin (residues 46–52), a5, and the connecting loop 
a2-a3 (residues 37–42), (ii) the C-terminal a15 (residues 419–425) and the connecting 
loops β28-β29 (residues 384–388) and β25-β26 (residues 367–371), and (iii) the N-
terminal a7 from a neighboring protomer. The a-PO4 group occupies a cavity rich in 
positively charged residues including Arg40 (a3), His46 and Arg52 (β2-β3 hairpin), 
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Thr79 (a5), and Arg386 (LβH; Figure 4.7A). The adenine heterocycle is stabilized by a 
strong stacking interaction with Arg130 (a7) from the GT-A-like domain of the 
neighboring protomer and van der Waals interactions with Arg419 (a15) and Arg386 
from the LβH domain. The side chain of Glu420 (a15) forms an important salt bridge with 
Lys39, communicating the a2-a3 loop with a15. In addition, a strong hydrogen-bonding 
interaction of the adenine N6 nitrogen with the side-chain carboxylate group of Glu270 
(LβH domain) may account for the nucleotide specificity. Finally, the D-ribose O2 atom 
makes a hydrogen bond with the side chain of Arg130 being also at a van der Waals 
distance from the Lys39 side chain (Figure 4.7B) 
 
 
Figure 4.7. Location of the AMP binding site. (A) Surface representation of the EcAGPase 
tetramer in complex with AMP (yellow spheres) in which each individual monomer displays it 
surface colored by coulombic potential, revealing the positively charged nature of the allosteric 
site. (B) Close-up view of the AMP binding site, showing key interactions with selected residues. 
 
Interestingly, a crosstalk event between protomers from the same and different 
dimers suggests that AMP interactions might lead to the stabilization of the quaternary 
structure of EcAGPase in solution. Supporting this notion, thermal unfolding followed by 
the far-UV circular dichroism (CD) signal at 222 nm indicated important differences in 
protein stability between the apo EcAGPase and the EcAGPase•AMP complex. The 
apparent melting temperatures (Tm) of EcAGPase and EcAGPase•AMP were 71.2 ºC 
and 75.8 ºC, respectively, indicating that the AMP-complexed form is approximately 4.6 
ºC more stable than the unliganded form (Figure 4.8).  
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Figure 4.8. EcAGPase thermal unfolding transitions recorded at 222 between 20 °C and 
90 °C. Native fraction of EcAGPase plotted versus temperature for the apo state (green), and 
EcAGPase at different concentrations of AMP (in a blue scale), The corresponding fitted two-
state sigmoidal curves of the unfolding events are also shown. 
 
 
4.2.4. The FBP binding site: Partial overlapping with the AMP 
binding site 
 
The EcAGPase•FBP crystal structure reveals that FBP binds into the same cleft as AMP, 
but is located in a more solvent-exposed environment, with no evident interactions with 
neighboring protomers (Figures 4.9A). The FBP binding site comprises the last C-
terminal residues of the enzyme (residues 420–431), with the FBP making important 
interactions with positively charged residues located in one side of a15 (Figure 4.9B). 
Supporting the relevance of the C terminus in the recognition of FBP, a protein chimera 
containing the N terminus (271 residues) of AtAGPase, activated by fructose 6-
phosphate and pyruvate, and the C terminus (153 residues) of EcAGPase, retained the 
selectivity for FBP (M. A. Ballicora et al., 2002). Moreover, a variant of EcAGPase in 
which the two last C-terminal residues, Glu430 and Arg431, were removed, became less 
sensitive to FBP activation (Wu & Preiss, 2001). 
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Figure 4.9. Location of the FBP binding site. (A) FBP binds into the same cleft as AMP, but is 
located in a more solvent-exposed environment. (B) Close-up view of the FBP binding site, 
showing key interactions with selected residues. 
 
The structural comparison of the EcAGPase•AMP•SUC and EcAGPase•FBP 
crystal structures revealed that the AMP and FBP binding sites partially overlap. FBP 
binding promotes important local conformational changes in the allosteric site when 
compared with the AMP complex (Figure 4.10). Specifically, the Lys39 side-chain 
coordinates the O1 atom of the FBP PO4 group at position 6, whereas the side chain of 
Glu420 makes a hydrogen bond with the O3 of the fructose ring. Biochemical studies 
demonstrated the important role of Lys39 in the binding and the mechanism of activation 
of EcAGPase by FBP (Gardiol & Preiss, 1990). Interestingly, Lys39 showed protection 
to the covalent modification with pyridoxal-PO4 (PLP), by reduction with NaBH4, in the 
presence of FBP (Parsons & Preiss, 1978b). The modification of Lys39 with PLP resulted 
in an enzyme with a permanently enhanced activity, even in the absence of FBP. This 
result suggests that the Schiff base formed between Lys39 and PLP might result in 
binding of the PLP phosphate group to the allosteric site, mimicking FBP binding and 
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contributing to the permanent locking of the enzyme in the activated state. In addition, 
the side chain of Arg423 positions its guanidinium group in close contact with the O5 
atom of the FBP phosphate group at position 6, the O6 atom of which makes a strong 
hydrogen bond with the main chain of Gln429. This structural configuration allows the 
fructose to be positioned in close proximity to a15, allowing the side chain of Arg419 to 
make an important hydrogen bond with the sugar ring O2 atom. Moreover, the side chain 
of Arg130 from the neighboring protomer completely changes its conformation and the 
last two residues, Glu430 and Arg431, become structured in the EcAGPase•FBP 
complex.  
 
Figure 4.10. Structural superposition of the EcAGPase•AMP•SUC and EcAGPase•FBP, 
showing the partial overlapping of AMP and FBP binding sites. 
 
The prominent conformational change of Arg130 side chain suggests that FBP 
interactions might not lead to the stabilization of the quaternary structure of EcAGPase 
in solution. The Tm value of EcAGPase•FBP was 72.0 ºC, indicating the formation of a 
less-stable complex than that observed for EcAGPase•AMP (Figue 4.11A). Moreover, 
the addition of FBP to the EcAGPase•AMP complex triggered a clear reduction in the 
Tm values as revealed by the CD experimental data, indicating that FBP not only is able 
to compete with AMP but also to modify the structural arrangement of the 
EcAGPase•AMP complex, leading to the occurrence of a less-stable structure (Figure 
4.11B). The structural configuration of the EcAGPase regulatory site, in which the AMP 
and FBP binding sites partially overlap, accounts for the fact that sensitivity to inhibition 
by AMP is modulated by the concentration of the activator FBP (J Preiss, 1978). In 
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addition, the experimental data indicate that the EcAGPase•FBP complex is markedly 
less stable and more flexible/dynamic than the EcAGPase•AMP complex (Figueroa et 
al., 2011).  
 
Figure 4.11. EcAGPase thermal unfolding transitions recorded at 222 between 20 °C and 
90 °C. Native fraction of EcAGPase plotted versus temperature for the apo state (green), FBP (A, 
in orange and red scale), or AMP and FBP (B, in a purple scale). In (B), the curve for 
EcAGPase•AMP (where concentration of AMP = 0.5 mM) is indicated for reference in blue. The 
corresponding fitted two-state sigmoidal curves of the unfolding events are also shown.  
 
 
4.2.5. A model for EcAGPase allosteric regulation  
 
Close inspection of the EcAGPase•AMP•SUC and EcAGPase•FBP crystal structures 
revealed how the allosteric and active sites are connected each other. The AMP 
allosteric site communicates with the active site (Figure 4.12A) of the same protomer 
through a region comprised of 27 residues, which we have defined as the sensory motif 
(SM), located between β1 and a4 (residues 26–52; Figure 4.12B). The SM is constituted 
by (i) the nucleotide-binding loop (NBL) (residues 26–33) including the GGxGxR 
consensus sequence involved in ATP binding; followed by (ii) a segment rich in short 
secondary structure elements (residues 34–52) including a2 (residues 34–37), a3 
(residues 42–44), β2 (residues 46–47), and β3 (residues 51–52), the last arranged in 
the form of a β hairpin (residues 46–52). In addition to the NBL, two side-chain residues 
of the SM face the active site playing a prominent role in ATP recognition and catalysis: 
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Arg32 (a2) interacts with the g-PO4, whereas Lys42 (a3) is proposed to participate in the 
electrostatic stabilization of the transition state (Figure 4.5; Führing et al. 2013; Ballicora 
et al. 2005). In contrast, Arg40 (a3), His46, and Arg52 (β2-β3 hairpin) face the AMP 
allosteric site, strongly interacting with a-PO4. The flexible β4-a5 loop (residues 73–77; 
regulatory loop 1; RL1 thereafter) interacts with both the NBL and the segment rich in 
secondary structure elements located on the same protomer, likely modulating their 
conformations. This loop also connects with a helix 5 (residues 78–87), of which Thr79 
interacts with the a-PO4 of AMP. Strikingly, the AMP binding site not only connects with 
the active site by intra-protomer interactions, but also through inter-protomer crosstalk. 
The adenine heterocycle of AMP makes an important stacking interaction with the side 
chain of Arg130 from a neighboring protomer of a different dimer. This important residue 
is located inside a7 (residues 117–131) and further communicates with a long loop 
(residues 104–116; regulatory loop 2; RL2 thereafter) that flanks the ATP binding pocket 
in the active site (Figure 4.5). In addition, the β2-β3 hairpin directly interacts with the loop 
connecting the N- and C-terminal domains (residues 292–315) of the neighboring 
protomer of the same dimer. In contrast, the FBP allosteric site communicates with the 
active site mainly through the SM of the same protomer, involving a key interaction of 
Lys39 with the O1 atom of the FBP phosphate group at position 6. This interaction 
directly modulates the conformation of the catalytic Lys42 located in the same loop, 
which is essential for the reaction to take place (Figure 4.6; Ballicora et al. 2007). We 
propose a model in which the positive and negative energy reporters regulate AGPase 
catalytic activity via intra- and interprotomer crosstalk, with the SM and two critical 
regulatory loops RL1 and RL2 flanking the ATP binding site playing a prominent role.  
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Figure 4.12. Cartoon representing the key structural elements involved in EcAGPase 
allosteric regulation. Protomers A and C of the complex EcAGPase•AMP•SUC are shown in 
green and orange, respectively. AMP and the superimposed FBP molecules are shown in the 
allosteric site. The SM is shown in red, whereas the RBL1 and RBL2 loops are shown in cyan. 
G1P and ATP are shown in the active site. (B) Close view of the SM.  
 
 
4.2.6. The allosteric sites are essentially preserved in AGPases 
 
The crystal structure of AtAGPase has been solved in the presence of SO4 (PDB: 3BRK; 
Cupp-Vickery et al., 2008). The EcAGPase primary sequence shares a 55% identity with 
AtAGPase. The overall fold between EcAGPase and AtAGPase is essentially preserved 
with (i) a root-mean-square deviation (RMSD) of 2.77 A ̊ for the monomer and (ii) an 
RMSD of 2.92 A ̊ for the tetramer. Importantly, multiple amino acid sequence alignments 
among the bacterial AGPase family, weighted by structural alignment of EcAGPase and 
AtAGPase, strongly support a common mechanism for the regulation of the enzymatic 
activity (Figure 4.13). The positively charged residues Arg40, His46, Arg52, and Arg386, 
involved in the binding of the a-PO4 moiety of the negative regulator AMP, are highly 
conserved. Interestingly, close inspection of the AtAGPase crystal structure shows that 
SO4 superimposes well with the a-PO4 of AMP in EcAGPase (Cupp-Vickery et al., 2008). 
In addition, Thr79 and Arg130, involved in the nucleoside ring binding of AMP, are mostly 
conserved within the enterobacteria family. The C-terminal region 
419RxMLRKLxxKQER431, involved in FBP binding, and the key residue Lys39 are also 
Doctoral Thesis – Natalia Comino 
 
 - 85 - 
conserved among enterobacteria AGPases that use FBP as a positive regulator. 
Importantly, critical residues that participate in the SM and RL1 and RL2 loops are also 
preserved.  
 
StAGPase is composed of two a and two β subunits, also referred to as small 
and large subunits, respectively, to form an a2β2 heterotetramer. The a subunit of 
AGPases is highly conserved in higher plants (85%–95% identity), whereas the β subunit 
is less conserved (50%–60% identity). In the StAGPase, the a and β subunits share 53% 
identity (Jin et al., 2005). Importantly, the two subunits have different functions: a is the 
catalytic subunit, whereas β is the regulatory subunit. The crystal structure of a non-
physiological, truncated recombinant homotetrameric version of the small subunit (a4) 
of StAGPase was solved in the presence of (i) SO4 (PDB: 1YP2), (ii) ATP (PDB: 1YP3), 
and (iii) ADP-Glc (PDB: 1YP3; Jin et al. 2005). The EcAGPase primary sequence shares 
a 31% identity with StAGPase. Although the overall fold between EcAGPase and 
StAGPase is preserved, with (i) an RMSD of 4.35 Â for the monomer and (ii) an RMSD 
of 5.20 Â for the tetramer, clear differences can be found both in the GT-A-like and the 
LβH domains, as revealed by the structurally weighted alignment (Figure 4.13). The 
structural comparison of EcAGPase with StAGPase, an enzyme that is negatively 
regulated by Pi, shows that SO4 binds to equivalent residues Arg40 and Arg52 and to a 
lysine occupying an equivalent position to Arg486 (Jin et al., 2005). Thus, the positively 
charged pocket responsible for the binding of (i) the AMP a-PO4 in bacterial AGPases 
and (ii) the Pi in plant AGPases seems to be conserved in both families, being essential 
for the negative regulation of most AGPases. Interestingly, Lys39 was also observed in 
several plant AGPases that use 3-phosphoglyceric acid (3PGA) as a positive regulator, 
suggesting that the PO4 groups might be coordinated in a similar manner to FBP in 
EcAGPase.  
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(legend on next page)
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Figure 4.13. Structure-Weighted Sequence Alignment of EcAGPase with other AGPases.  
Structural alignment between the crystal structures of EcAGPase (PDB: 5L6V; UniProt: P0A6V1), 
AtAGPase (PDB: 3BRK; UniProt: P39669), and StAGPase (PDB: 1YP3; UniProt: P23509). The 
secondary structure elements corresponding to the GT-A-like domain are shown in yellow (a-
helices) and orange (b helices); and to the LbH domain in green (a helices) and blue (b helices). 
Residues with poor electron density are highlighted as full boxes. The SM and the RL1 and RL2 
loops are highlighted in yellow. Catalytic residues are highlighted as dotted boxes. The RMSD 
value is shown for each residue. Amino acid sequences of selected AGPases were aligned to the 
structure alignment: Mycobacterium smegmatis (class II; UniProt: A0R2E1), Serratia marcescens 
(class II; UniProt: A0A0U6P844), Rhodo- bacter sphaeroides (class V; UniProt: Q9RNH7), 
Rhodospirillium rubrum (class VI; UniProt: Q9ZFN4), Bacillus subtilis (class VII; UniProt: P39122), 
Synechococcus sp. (class VIII; UniProt: Q2JU94), Ostreococcus tauri (class VIII; UniProt: 
Q6PYZ7), Spinacia oleracea (class VIII; UniProt: Q43152), and Triticum aestivum (class IX; 
UniProt: P30523)  
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5. Mechanistic insights into EcAGPase allosteric 
regulation 
As it has been shown in the previous chapter, the report of EcAGPase crystal structures 
in complex with its physiologically preferred allosteric regulators, AMP and FBP, allowed 
us to identify the allosteric binding sites and propose a model of regulation for this 
paradigmatic enzyme. In this regard, we define four common allosteric clefts between 
the GT-A-like and LβH domains of neighboring protomers, in which both allosteric 
modulators bind to partially overlapping sites. This structural configuration of the 
EcAGPase regulatory site accounts for the fact that sensitivity to inhibition by AMP is 
modulated by the concentration of the activator FBP (Gardiol & Preiss, 1990; Gentner & 
Preiss, 1967). Specifically, each allosteric cleft is communicated with the corresponding 
active site of the same protomer through a region defined as the ‘Sensory Motif’ (SM), a 
complex structural element constituted by the nucleotide-binding loop NBL, including a 
G-rich motif involved in ATP binding, and a segment rich in short secondary structure 
elements. Based on this structural information, we proposed a model, in which the 
binding of the positive and negative energy reporters regulates EcAGPase catalytic 
activity through the SM and two critical regulatory loops RL1 and RL2 flanking the active 
binding site, via intra-protomer interactions and inter- protomer crosstalk.  
Considering the important structural information already available, the next step was to 
attempt to validate the allosteric binding sites and regulatory model proposed for 
EcAGPase. For this aim, we carefully explore the consequences of single point 
mutations in the allosteric cleft of EcAGPase, in key residues involved in FBP and AMP 
binding, looking for changes in the allosteric properties, stabilization and their impact in 
enzymatic activity. Finally, we explore how those mutations impact in the yield of 
glycogen in the physiological environment of the host.  
 
The references of this chapter are based on the publication, mentioned in “Publications” 
section, Mechanistic insights into the allosteric regulation of bacterial ADP-glucose 
pyrophosphorylases (Comino et al., 2017). 
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5.1.  Materials and methods 
 
Materials — The pET22b:EcAGPase•K39A, pET22b:EcAGPase•R40A, 
pET22b:EcAGPase•R40E, pET22b:EcAGPase•K42A, pET22b:EcAGPase•H46A, 
pET22b:EcAGPase•R130A, pET22b:EcAGPase•K195A, pET22b:EcAGPase•R386A, 
pET22b:EcAGPase•R419A and pET22b:EcAGPase•R423A plasmids carrying out the 
EcAGPase mutants were synthesized/sequenced by ATG:biosynthetics (Merzhausen, 
Germany) using the pET22b:EcAGPase clone as template (please see EcAGPase 
cloning section), and further expressed and purified to apparent homogeneity as 
described for the recombinant EcAGPase enzyme.  
EcAGPase cloning, expression and purification — The full-length glgC gene from E. 
coli BL21 was amplified by standard PCR using oligonucleotide primers glgC_NdeI_Fwd 
(5 ́GGGAATTCCATATGGTTAGTT 3 ́) and glgC_XhoI_Rev (5 ́ CCGCTCGAGTCA 
TCGCTCCTG 3 ́), Phusion DNA Polymerase (New England Biolabs) and purified 
genomic DNA as template. The PCR fragment was digested with NdeI and XhoI and 
purified by agarose gel electrophoresis. The fragment was ligated to the expression 
vector pET22b (Novagen) using T4 DNA ligase, generating pET22b:EcAGPase. The 
recombinant EcAGPase has no additional amino acids when compared to the native 
enzyme. E. coli BL21(DE3) cells transformed with pET22b:EcAGPase or the 
corresponding mutants were grown in 2,000 ml of LB medium (5 g yeast extract, 10 g 
peptone tryptone, 10 g NaCl) supplemented with 100 μg/ml carbenicillin at 37°C. When 
the culture reached an OD600 of 0.8, EcAGPase expression was induced by the addition 
of 1 mM isopropyl β-thiogalactopyranoside (IPTG) and further incubated at 18°C for 20 
h. Cells were harvested by centrifugation at 5,000 x g and resuspended in 40 ml of 50 
mM Hepes pH 8.0, 5 mM MgCl2, 0.1 mM EDTA, 10% sucrose (w/v; solution A), 
containing protease inhibitors (Complete EDTA-free; Roche) and 10 mg/l of lysozyme 
(Sigma). Cells were then disrupted by sonication (24 cycles of 10 s each) and centrifuged 
for 20 min at 20,000 x g. The supernatant was dialyzed twice against solution A by using 
a 100,000 Da molecular mass cutoff dialysis membrane. The solution was then applied 
to a Q Sepharose packed column (30 ml; GE Healthcare) equilibrated with solution A. 
Elution was performed with a linear 0-0.5M NaCl gradient in 100 ml. Enzymatically active 
fractions were pooled and incubated with 1.2 M ammonium sulphate final concentration 
(solution B). The resultant suspension was centrifuged for 20 min at 32,000 x g and the 
supernatant applied into a Phenyl Shodex HIC PH- 814 equilibrated in solution B. The 
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enzyme was eluted with a linear gradient of 100% solution B to 100% solution A in 50 
ml. The protein was dialyzed against solution A with a 100-kDa-molecular mass cutoff 
overnight, and stored at -80°C. All the mutants were purified following the same protocol.  
Thermal unfolding — Thermal unfolding transitions were recorded on a J-815 CD 
spectropolarimeter (Jasco Corp., Tokyo, Japan) equipped with a water-cooled Peltier 
unit. Measurements were carried out at 222 nm by using Hellma 110-QS quartz cuvettes 
with a 1-mm optical path length. Samples were 2 μM EcAGPase or EcAGPase mutants 
in 50 mM Tris-HCl pH 8.0, 100 mM NaCl. Thermal dependences of the ellipticity were 
monitored in a range from 30 to 90°C at 222 nm. Temperature was increased stepwise 
by 1°C/min. Ligands effects were assessed in the same conditions for the following 
concentrations: AMP 0.25 mM, 0.5 mM and 1 mM; FBP 0.5 mM and 2.5 mM. Transitions 
were normalized and tentatively fitted according to equation 1 to obtain the apparent 
melting temperature (Tm), (Sotomayor-Pérez et al., 2013).  
 
𝑦 = 𝑦𝑓 	+𝑚𝑓 	· 	𝑇 +	 𝑦𝑢 	+	𝑚𝑢 · 	𝑇 · 	e	 𝛥𝐻𝑚𝑅 · 1𝑇𝑚−1𝑇1	 +	e	 𝛥𝐻𝑚𝑅 · 1𝑇𝑚−1𝑇  
(Eq. 1) 
where y represents the observed CD signal at 222 nm, yf and yu are the y-axis intercepts 
and mf and mu the slopes of the pre- and post-transition baselines, respectively, T is the 
temperature in K, Tm is the melting temperature, and  DHm is the enthalpy change of 
unfolding at Tm. Curve fitting was performed with KaleidaGraph 4.5.2 (Synergy 
Software).  
EcAGPase enzymatic assay — The enzymatic activity of EcAGPase and EcAGPase 
mutants was monitored using a micro plate colorimetric end-point malachite green 
phosphate assay (Fusari, Demonte, Figueroa, Aleanzi, & Iglesias, 2006). EcAGPase 
catalyzes the reaction of ATP and G1P to produce ADP-Glc and PPi. This reaction is 
coupled with an inorganic pyrophosphatase (PPase), which catalyzes the hydrolysis of 
PPi to orthophosphate (Pi). Pi dosage is determined by the formation of a 
phosphomolybdate- malachite green complex:  
 
 
1)  Enzymatic coupled reaction 
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α-Glucose-1P + ATP g ADP-glucose + P2O74-                                           (Eq. 2) 
P2O74- + H2O g 2 PO43- + 2H+                                                                                    (Eq. 3) 
 
2)  Stop reaction by complexation of Mg2+ with EDTA 
 
3)  Molybdate/Malachite Green (MG) reaction  
 
H3PO4 + 12 H2MoO4 g H3PO4(MoO3)12 + 12 H2O                        (Eq. 4) 
H3PMo12O40 + HMG2+ g [MG+](H3PO4(MoO3)12) +  2H+               (Eq. 5) 
 
4)  Addition of sodium citrate for reaction stabilization 
 
Specifically, samples contained 8 µg/ml of EcAGPase and 1 µg/ml of PPase (Sigma), 
0.5 mM ATP, 0.5 mM G1P, 50 mM Tris-HCl pH 7.5, 2 mM MgCl2 and 100 mM NaCl, with 
or without the addition of the allosteric regulators AMP, FBP or AMP/FBP at 0.5 mM, in 
a final volume of 60 µl. Reactions were incubated at 20°C and stopped at given time by 
the addition of 10 µl of 50 mM EDTA pH 8.0. 20 µl of molybdate solution (42 g/L 
ammonium molybdate tetrahydrate in 4N HCl; Fluka) were added to the reaction mixture, 
and incubated at 20°C for 3 min. Then, 60 µl of Malachite Green solution (0.52 g/L 
malachite green oxalate salt in water; Sigma) were added to the mixture and incubated 
at 25°C for 5 min. Finally, the solution was stabilized by the addition of 60 µl of sodium 
citrate (50 g/L in water; Sigma), and measured at 620 nm in a Spectra Max M2 plate 
reader. Measurements were performed in quintuplicates. EcAGPase and EcAGPase 
mutants were stored in 1 mg/ml aliquots in 50 mM Tris-Cl pH 7.5 and 100 mM NaCl at -
80 °C for single use. Specific activities were stable during a period of 6 months.  
 
Overexpression of EcAGPase mutants in a glgC knock-out E. coli strain — E. coli 
strain K-12 carrying out a glgC gene deletion (E. coli K-12 DglgC; kanamycin resistant 
strain; Keio collection; Dharmacon GE) was transformed with pTARA plasmid 
(chloramphenicol resistant plasmid; Wycuff and Matthews 2000; Addgene), to provide a 
controlled expression of T7 RNA polymerase. The resulting strain was subsequently 
transformed with pET22b:EcAGPase, pET22b:EcAGPase•K39A, 
pET22b:EcAGPase•R40A, pET22b:EcAGPase•R40E, pET22b:EcAGPase•K42A, 
pET22b:EcAGPase•H46A, pET22b:EcAGPase•R130A, pET22b:EcAGPase•K195A, 
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pET22b:EcAGPase•R386A, pET22b:EcAGPase•R419A or pET22b:EcAGPase•R423A 
mutants. E. coli K-12 DglgC cells transformed with pTARA and pET22b:EcAGPase or 
the corresponding mutants were further synchronized in 10 ml of LB medium 
supplemented with 34 μg/ml chloramphenicol, 25 μg/ml kanamycin and 100 μg/ml 
carbenicillin at 30°C (Richard H Baltz, Julian Davies, 2010). After two passages, bacterial 
cultures were diluted 1:50. 900 µl aliquots were removed every hour and kept on ice. 
After 4hs, protein expression was induced by the addition of 1 mM isopropyl β-
thiogalactopyranoside (IPTG) and 100 μg/ml arabinose. 900 µl aliquots were removed 
every hour and kept on ice for subsequent steps. 
 
Glycogen extraction — Glycogen was extracted as previously described with minor 
modifications (J Preiss, Greenberg, & Sabraw, 1975). 400 µl culture aliquots of the E. 
coli K-12 DglgC strain transformed with pTARA and pET22b:EcAGPase or the 
corresponding mutants, were centrifuged at 1200 x g for 10 min, and the supernatant 
discarded. Pellets were resuspended in 100 µl of 50% KOH, and further incubated at 
95°C during 30 min. 300 µl of ice cold 95% ethanol was added to the the sample and 
centrifuged 1200 x g for 30 min. The pellet was air-dried stored at -20°C.  
 
Glycogen measurement — The production of glycogen in the E. coli K-12 DglgC strain 
transformed with pTARA and pET22b:EcAGPase or the corresponding mutants was 
determined by two colorimetric methods (Archibald et al., 1961; Krisman, 1962). 
Glycogen pellets were resuspended in 100 µl of water by vigorous shaking during 5 min 
followed by the addition of 200 µl of 0.2 % anthrone (Sigma) in 95% H2SO4. Samples 
were then incubated at 95°C during 20 min. 200 µl aliquots were transferred to a 96 well-
plate and measured at 650 nm using a Spectra Max M2 plate reader. Glucose standards 
were treated in a similar manner in parallel. Since anthrona is a general reagent for the 
detection of sugars, a second less sensitive but specific assay was used. Glycogen 
pellets were washed with 20 µl of saturated NH4Cl and dry heated at 95°C to remove the 
excess of ammonia. 200 µl of freshly prepared iodine reagent, a modified Lugol’s iodine 
staining, obtained by mixing 20 µl of 2.6% I2 and 26% KI in water, with 5 ml of saturated 
CaCl2 were added. Samples were transferred to a 96 well-plate and measured at 450 
nm using a Spectra Max M2 plate reader. Measurements were performed in 4 and 5 
replicates for the iodimetric and anthrone methods, respectively.  
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EcAGPase Crystallization and Data Collection — Crystallization trials were carried 
out in sitting drop 96 well plates by using a mosquito crystal robot (TTP Labtech). 
Crystals of EcAGPase•R130A were obtained by mixing 0.25 µl of EcAGPase•R130A at 
6.3 mg/ml in 50 mM Tris-HCl pH 7.5, 100 mM NaCl with 0.25 µl of mother liquor 
containing 14% polyethylene glycol 3.350, 140 mM magnesium formate, 30% ethylene 
glycol. Crystals grew in 13 days and were frozen under liquid nitrogen. Crystals 
screening were performed at Diamond Light Source (DLS) (Didcot, Oxfordshire, United 
Kingdom). EcAGPase•R130A complete dataset was collected at I04 beamline (DLS) 
with oscillation angle of 0.15° for a total of 1200 images using a Pilatus 6M-F detector. 
EcAGPase•R130 form crystallized in space group P21 with 8 molecules in the 
asymmetric unit and diffracted to a maximum resolution of 3.09 Å. 
 
EcAGPase Structure Determination and Refinement — The crystal structure of 
EcAGPase•R130A was solved by molecular replacement with the program Phaser 
(McCoy et al., 2007) using a tetramer from the crystal structure of EcAGPase•AMP•SUC, 
PDB atomic coordinates 5L6V (Cifuente et al., 2016), as search model. The final 
structure was obtained using alternate cycles of manual model-building using COOT 
(Emsley et al., 2010) and Phenix (phenix.refine) or Refmac5 (Murshudov et al., 2011). 
NCS restraints were calculated automatically during refinement and differences between 
chains subsequently modelled. During the refinement the structure geometry was 
validated using Molprobity (Chen et al., 2010). Atomic coordinates and structure factors 
have been deposited with the Protein Data Bank, accession code 5MNI 
(EcAGPase•R130A). Molecular graphics and structural analyses were performed with 
the UCSF Chimera package (Pettersen et al., 2004). 
 
Enterobacterial AGPases alignment — A representative group of enterobacterial 
AGPase protein sequences from different species was obtained from UNIPROT 
database and sequence aligned using Clustal-Omega. Middle distance BLOSUM62 tree 
was performed using Jalview.  
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5.2.  Results and discussion 
 
5.2.1. Dissecting the structural determinants of EcAGPase 
allosteric regulation  
 
It was shown in the previous chapter that EcAGPase•AMP complex was ca. 4.6 °C more 
stable than the unliganded form of the enzyme. Moreover, the addition of FBP to the 
EcAGPase•AMP complex triggered a clear reduction in the Tm values, indicating that 
FBP is able to compete with AMP and to modify the structural arrangement of the 
EcAGPase•AMP complex, leading to a less stable structure. To further advance on the 
understanding of the molecular mechanism of EcAGPase allosteric regulation, we 
studied the contribution of a series of chemical derivatives of AMP and FBP to the 
stabilization of the enzyme. To this end, the ellipticity of EcAGPase in the absence and 
presence of AMP, orthophosphate, D-ribose 5-phosphate, adenine, FBP and fructose 6-
phosphate (F6P), was monitored at 222 nm as a function of temperature. The Tm of 
EcAGPase was 65.6°C (Figure 5.1A). Upon the addition of AMP, the Tm value increased 
to 73.6°C. In contrast, the presence of orthophosphate, D-ribose 5-phosphate, adenine 
did not significantly affect the Tm value of EcAGPase, with 69.0°C, 69.7°C and 69.5°C 
values, respectively (Figure 5.1A). These experimental observations correlate well with 
the structural configuration of the AMP allosteric site as visualized in the 
EcAGPase•AMP•SUC crystal structure (Figure 5.2). Specifically, the α-PO4 of AMP 
localizes in a pocket comprised by Arg40, His46, Arg52 and Arg386 of the same 
protomer, with no evident interactions with adjacent protomers of the homotetramer 
(Figure 5.2B). Similarly, the ribose moiety of D-ribose 5-phosphate provides two 
additional interactions with Lys39 and Thr79, also located in the same protomer. 
Interestingly, the EcAGPase•AMP•SUC crystal structure revealed that the adenine 
heterocycle is stabilized by a strong stacking interaction with Arg130 (α7) from the GT-
A-like domain of a neighbouring protomer (Figure 5.2A and 5.2B). However, the 
nucleobase alone did not provide any measurable stabilization effect.  
 
Different moieties of the AMP chemical scaffold have been studied regarding their 
modulatory effects on EcAGPase activity. Orthophosphate was characterized as a weak 
inhibitor of EcAGPase, requiring a much higher concentration to achieve similar 
inhibitory levels than AMP (Gentner & Preiss, 1967). Most of the AGPase crystal 
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structures reported to date revealed the presence of either orthophosphate or sulphate 
anions located in the corresponding binding pocket of the α-PO4 moiety of AMP in the 
regulatory site of EcAGPase (Cupp-Vickery et al., 2008). Interestingly, structural 
evidence also revealed (i) the presence of orthophosphate in the active site of EcAGPase, 
(ii) and sulphate, a phosphate mimic, in the active site of Solanum tuberosum AGPase 
(StAGPase), with the ATP substrate in a non-catalytically active conformation (PDB: 
1YP3; Jin et al. 2005). This structural information might suggest a competitive inhibitory 
effect of these anions with the EcAGPase substrates at high concentrations, however, 
an intra-protomeric inhibitory effect cannot be discarded. Finally, the presence of D-
ribose 5-phosphate or adenine did not alter the activity of EcAGPase (Preiss, Shen, and 
Partridger 1965; Ribéreau-Gayon et al. 1971).  
 
Altogether, these experimental observations indicate that the complete AMP 
scaffold is required for the stabilization of the enzyme, strongly supporting the notion that 
AMP inhibitory properties are inherently linked to the inter-protomer crosstalk in the 
negative allosteric mechanism of EcAGPase. Finally, the addition of FBP to the 
EcAGPase•AMP complex produced a clear reduction in the Tm value, whereas the 
presence of F6P did not significantly affect the Tm value of the EcAGPase•AMP complex. 
Taking into consideration that F6P does not modulate EcAGPase activity (Preiss 1978) 
together with its inability to alter EcAGPase•AMP stability, these observations points 
towards the PO4 group at position 1 of fructose as a key player to enhance the enzymatic 
activity, to modulate AMP inhibition and to reverse AMP stabilization effect (Figure 5.1B 
and 5.2C).   
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5.2.2. Design of EcAGPase single point mutants in the regulatory 
cleft and active site 
 
We carefully explored the consequences of single point mutations in the allosteric cleft 
of EcAGPase, in key residues involved in AMP and FBP binding, looking for changes in 
the allosteric properties, stabilization and their impact in enzymatic activity (Figure 5.2). 
Seven residues facing the allosteric cleft, Lys39, Arg40, His46, Arg130, Arg386, Arg419 
and Arg423, were selected and replaced by alanine. Residues Lys39, Arg40, His46, and 
Arg130 belong to the N-terminal GT-A-like domain, whereas Arg386, Arg419 and Arg423 
are located in the LβH domain (Figure 5.2). Specifically, Lys39, Arg40, His46 are located 
in the SM motif, Arg386 in the β25-β26 loop of the LβH domain, and residues Arg419 
and Arg423 in the C-terminal α15. The crystal structure of the EcAGPase•AMP•SUC 
revealed that (i) the α-PO4 group of the negative regulator AMP interacts with Arg40, 
His46, and Arg386, and (ii) the ribose moiety is at van der Waals distance of Lys39. In 
addition, the adenine heterocycle is stabilized by a strong stacking interaction with 
Arg130 and additional van der Waals interactions with Arg419 and Arg386 (Figure 5.2B). 
Figure 5.1. EcAGPase thermal unfolding transitions recorded at 222 between 20 °C and 
90 °C. (A) Thermal unfolding for the unliganded form of EcAGPase (green) and the 
EcAGPase•AMP (blue), EcAGPase•Adenine (black), EcAGPase•5RP (yellow) and 
EcAGPase•PO4 (red) complexes. (B) Thermal unfolding for the unliganded form of EcAGPase 
(green) and the EcAGPase•AMP (blue), EcAGPase•AMP•FBP (grey) and EcAGPase•AMP•F6P 
complexes.  
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Based on the EcAGPase•FBP crystal structure, residues Lys39, Arg419 and Arg423 of 
the same protomer interact with the PO4 group at position 6 of FBP, meanwhile Arg130 
in the neighbour protomer appears at salt-bridge distance (Figure 5.2C). It is worth noting 
that Lys39 proved to be essential for the FBP mediated enzymatic activation to take 
place (Gardiol & Preiss, 1990).Two single point mutants of the predicted catalytic 
residues, Lys42 and Lys195, were constructed by replacing them by alanine (Führing et 
al. 2013; Hill et al. 1991; Ballicora et al. 2005). The predicted catalytic residue Lys42 is 
located in a key region of the SM motif, at very close distance of several residues 
participating in both AMP and FBP regulators interactions, in the regulatory cleft. 
Moreover, the side chain of Lys42, is in closed contact with two aspartic residues, 
Asp142 and Asp276 (Clarisa M. Bejar et al., 2006; Cupp-Vickery et al., 2008; Frueauf, 
Ballicora, & Preiss, 2001), which were suggested to participate in the interaction of the 
divalent metal cation Mg2+ during catalysis, as observed in other nucleotidyltranferases 
(Steitz, Smerdon, Jäger, & Joyce, 1994; Swift et al., 2012). Finally, Lys195 is located in 
the β12-β13 loop of the sugar binding pocket, in the active site of the GT-A like domain, 
far apart from the allosteric cleft. Lys195 was proposed to interact with the β-PO4 group 
of ADP-Glc (Cifuente et al., 2016; Jin et al., 2005). It is worth noting that all EcAGPase 
constructs have no additional amino acids when compared with the native enzyme. They 
were expressed and purified to apparent homogeneity, following three main steps 
including anionic exchange, ammonium sulfate precipitation, and hydrophobic 
interaction criteria (see section 5.1. for details).  
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Figure 5.2. Localization of residues in the active and regulatory sites in EcAGPase. (A) 
EcAGPase protomer showing the GT-A-like and LβH domains. (B) Close view of the AMP 
regulatory site, showing the location of key residues involved in AMP binding, and its 
communication with the active site of EcAGPase. Selected/mutated residues are underlined. (C) 
Close view of the FBP regulatory site, showing the location of key residues involved in FBP binding, 
and its communication with the active site of EcAGPase. Selected/mutated residues are 
underlined.  
 
 
5.2.3. Single point mutants localized in the regulatory cleft 
impact EcAGPase stabilization  
 
The addition of AMP did not modify the Tm values of the EcAGPase•R40A, 
EcAGPase•R46A, EcAGPase•R130A and EcAGPase•R386A mutants, strongly 
supporting a role of these residues in AMP binding, as visualized in the crystal structure 
of the EcAGPase•AMP•SUC complex (Figures 5.2B and 5.3). In contrast, the addition of 
AMP to the EcAGPase•K39A, EcAGPase•R419A, and EcAGPase•R423A mutants, 
which are involved in FBP recognition, according to the EcAGPase•FBP crystal structure, 
triggered a clear increment in the Tm values as observed in the wild-type enzyme (Figure 
5.2C, Figure 5.3). As expected, the stabilization of EcAGPase•K42A and 
EcAGPase•K195A mutants, the predicted catalytic residues, was not affected by the 
addition of the negative regulator.  
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Figure 5.3. Thermal unfolding transitions of EcAGPase and selected EcAGPase variants in 
complex with AMP. Thermal unfolding transitions were recorded at 222 nm between 20ºC and 
90ºC. Tm value for the apo state of EcAGPase and selected EcAGPase variants are shown in 
green. AMP concentrations are shown in black.  
 
Interestingly, the addition of FBP to the EcAGPase•K39A and EcAGPase•R419A 
was unable to revert the stabilization of the enzyme variants mediated by AMP. In 
contrast, some reversion is observed in EcAGPase•R423A (Figure 5.4). As expected, 
EcAGPase•K195A displays a similar behavior. However, the Tm value of the 
EcAGPase•K42A mutant in the presence of AMP or AMP/FBP regulators remained 
equally stable. Since the side chain of Lys42 is in closed contact with two aspartic 
residues, Asp142 and Asp276 (Clarisa M. Bejar et al., 2006; Cupp-Vickery et al., 2008; 
Frueauf et al., 2001) this phenomenon might reflect the communication between the 
allosteric and active sites.  
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Figure 5.4. Thermal unfolding transitions of EcAGPase and selected EcAGPase variants in 
complex with AMP. Thermal unfolding transitions were recorded at 222 nm between 20ºC and 
90ºC. Tm value for the apo state of EcAGPase and selected EcAGPase variants are shown in 
green. AMP concentrations are shown in black.  
 
.  
5.2.4. EcAGPase•R130A deregulates AMP mediated inhibition of 
the enzymatic activity inducing the overproduction of glycogen 
in vivo  
 
In order to characterize the impact of the single point mutations on the allosteric 
properties of EcAGPase we measured their specific activities by the colorimetric end-
point Malachite Green Phosphate assay. This activity assay showed that 
EcAGPase•R130A doubles the specific activity compared to the wild-type EcAGPase, in 
the absence of allosteric regulators. As expected, wild-type EcAGPase is highly 
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activated by FBP but in contrast, most mutants failed to reach similar levels of activity 
compared to the EcAGPase•FBP active state (Figure 5.5A). Interestingly, 
EcAGPase•R130A was the only mutant activated by FBP, consistent with the 
requirement of an intra-protomeric signalling for the activation of the enzyme. 
Nevertheless, its activity does not reach the same levels of the wild type, which could be 
attributable to the lack of additional mechanism to reach full activation, the inter-
protomeric crosstalk (Figure 5.5B). 
 
In the presence of AMP, EcAGPase•R40A, EcAGPase•R40E and 
EcAGPase•H46A mutants (the mutated residues interact with the AMP α-PO4), along 
with the EcAGPase•R130A and EcAGPase•R386A mutants (the mutated residues 
interact with the adenine heterocycle and ribose moieties of AMP, respectively), display 
a similar behavior than that observed for the wild-type enzyme. Specifically, a partial 
inhibition was shown in all cases, pointing to a compensatory effect of the mutated 
residues. No inhibition was detected in the EcAGPase•K39A and EcAGPase•R419A 
mutants (the mutated residues interact with the ribose and adenine heterocycle moieties 
of AMP, respectively). The EcAGPase•R423A displays a behavior similar to the wild-
type enzyme, which is consistent with the lack of interactions between this residue and 
AMP (Figure 5.5C). The effect of the negative regulator AMP was also addressed in the 
presence of FBP, as sensitivity to inhibition by AMP is modulated by the concentration 
of the activator FBP (Figure 5.5D; Gentner and Preiss 1967; J Preiss 1978; Gardiol and 
Preiss 1990). Strikingly, EcAGPase•R130A displayed (i) a similar specific activity than in 
the presence of FBP and (ii) 7-fold higher than the wild-type enzyme in the presence of 
both AMP and FBP regulators, revealing a deregulation of the inactivation mediated by 
AMP for this mutant. Interestingly, the EcAGPase•K39A and EcAGPase•R419A mutants 
were unable to completely revert the slight activation induced by FBP in the presence of 
AMP, which is consistent with the results observed in the thermal unfolding transitions in 
the presence of both modulators (Figure 5.4). As expected, EcAGPase•K42A and 
EcAGPase•K195A mutants, the predicted catalytic residues, were inactive in all 
conditions tested.  
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Figure 5.5. Activity measurements of EcAGPase and selected EcAGPase variants. The 
enzymatic activity of EcAGPase and selected EcAGPase variants was measured in the absence 
of allosteric regulators (A), in the presence of FBP (B), in the presence of AMP (C), and in the 
presence of both positive and negative regulators FBP and AMP. 
 
To study the impact of the single point mutations in the in vivo glycogen content 
of E. coli, E. coli K-12 DglgC pTARA strain was transformed with pET22b:EcAGPase, or 
the corresponding mutants. The cultures were synchronized and aliquots were removed 
every hour before and after the induction for the determination of glycogen content. The 
growth curves of the different EcAGPase mutants confirmed that they were in the 
exponential growth phase in all cases (Figure 5.5A). After glycogen extraction, a 
standard anthrone assay was used for the detection of sugars (Figure 5.5B). As a 
complementary approach, a less sensitive but more specific iodimetric method was also 
used to measure glycogen content (Figure 5.5C). As expected, the EcAGPase•K42A 
and EcAGPase•K195A mutants carrying out the predicted catalytic residues were unable 
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to accumulate glycogen. Strikingly, EcAGPase•R130A mutant displayed an 
overproduction of glycogen in vivo, which correlates with the specific activities measured 
for this variant in vitro, supporting the idea of an hyperactive deregulated enzyme. 
Interestingly, EcAGPase•R40E mutant displayed a glycogen content similar to that 
observed with EcAGPase•R130A, although its specific activities did not show clear 
evidences of being a highly active enzyme. It is worth noting that EcAGPase is mainly 
activated by FBP, however, it can be also activated by other glycolytic intermediates (Ball, 
2011; Ballicora 2002). The change in the charge of EcAGPase•R40E in the regulatory 
cleft might therefore modify the effect of other regulators in vivo highlighting the 
complexity of the allosteric mechanism of this key enzyme.  
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Figure 5.6. Glycogen content in vivo. (A) Growth curve. (B) Glycogen content by using Lugol 
method (Krisman, 1962). C. Glycogen content by using anthrone method (Lodeiro, Di Lorenzo, 
Petruccelli, Molina-Ortiz, & Sorgentini, 1994).  
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5.2.5.  The crystal structure of EcAGPase•R130A  
 
The crystal structure of EcAGPase•R130A was solved in its unliganded form at 3.09 Å 
resolution (PDB: 5MNI). EcAGPase•R130A crystallized in space group P 21 with eight 
molecules in the asymmetric unit, representing two homotetramers of the enzyme. When 
compared with the EcAGPase•AMP•SUC and EcAGPase•FBP complexes, the crystal 
structure of EcAGPase•R130A revealed significant conformational changes. Firstly, the 
two dimers of the homotetramer were reoriented, strongly suggesting conformational 
flexibility of the quaternary structure of EcAGPase (Figure 5.7A and 5.7B). Moreover, 
conformational differences were also observed in key elements implicated in the 
proposed allosteric regulatory mechanism. Specifically, residues 26 to 41 of the SM motif 
displayed a new extended conformation, partially overlapping the α-PO4 and D-ribose 
binding sites of AMP, observed in the EcAGPase•AMP•SUC structure (Figure 5.7C). The 
side chain of Arg419 makes hydrogen-bonding interactions with the main chain carbonyl 
group of Leu34 and the side chain of Asn38. Interestingly, in the other seven protomers, 
this region of the SM was found partially disordered. The EcAGPase•AMP•SUC and 
EcAGPase•FBP crystal structures revealed that both AMP and FBP binding sites 
partially overlap pointing to an important role of dynamics and conformational changes 
of several structural elements located in the regulatory cleft, in the signal transduction 
mechanism. The replacement of Arg130 by alanine certainly affect the transduction of 
the negative regulatory signal to the active site, likely due to an inter-protomer cross-talk 
mechanism, as suggested by the EcAGPase•AMP•SUC crystal structure. However, the 
absence of Arg130 might also modify the rearrangement/dynamics of other structural 
elements located in the regulatory site of EcAGPase, most notably the SM motif, 
contributing to the activation/cooperativity of the enzyme.  
 
Similarly, the RL1 loop, which is in close contact with the nucleotide-binding loop 
(NBL) (residues 26–33) including the GGxGxR consensus sequence involved in ATP 
binding, was also observed to adopt different structural arrangements. Interestingly, the 
replacement of the highly conserved Tyr75 per alanine resulted in an inactive enzyme, 
suggesting a functional role for this residue in the modulation of the enzymatic activity, 
as reported for the Gln74Ala mutant (Figueroa et al., 2011). Finally, the RL2, could only 
be observed/partially modelled, in a different conformation with respect to the 
EcAGPase•AMP•SUC and EcAGPase•FBP structures. Taken together, the new crystal 
structure of EcAGPase•R130A provides evidence of conformational changes including 
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local flexibility, in key elements proposed to be involved in allosteric communication. It is 
worth noting that the transformation of plants with E. coli allosteric mutants on the glgC 
gene significantly increased starch content (Tuncel and Okita, 2013). Therefore, the 
identification of a EcAGPase hyperactive deregulated mutant provides exciting 
possibilities for industrial/biotechnological applications. 
 
 
Figure 5.7. The crystal structure of EcAGPase•R130A. (A-B) Two views of the structural 
superposition between the EcAGPase•R130A (yellow) and EcAGPase•FBP (orange) tetramers, 
based on the alignment of LβH domains pairs (arrow). The relative rotation of both domains is 
shown (curved arrow). C. EcAGPase•R130A structure (protomer D: yellow) centered at the 
sensory motif, superimposed with an EcAGPase•AMP•SUC protomer (orange), revealing the 
prominent conformational changes leading the SM motif to partially occupy the AMP binding site. 
The other EcAGPase•R130A protomers of the asymmetric unit appear superposed in grey scale, 
showing variability in the RL1, RL2 regions and the G-rich loop.  
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5.2.6. EcAGPase shares common sequence signatures for 
allosteric regulator binding with other enterobacterial AGPases  
 
Multiple primary structure alignment among members of the enterobacteriaceae family 
of AGPases revealed Lys42 and Lys195, the proposed catalytic residues, along with 
Arg40, His46, Arg386 and Arg130, residues involved in AMP binding, highly preserved 
(Figure 5.8). Several experimental data indicated that the C-terminal region of 
EcAGPase is involved in the recognition of the positive regulator and allosteric activation 
mechanism of the enzyme (Ballicora, 2002). Specifically, (i) the 
419RxMLRKLxxKQER431 sequence, and (ii) the key residue Lys39 which were 
observed to interact with the positive regulator FBP in the EcAGPase•FBP complex, are 
strictly conserved among enterobacterial AGPases known to use FBP as positive 
regulator (Cifuente et al. 2016; J Preiss 1978; Ballicora et al. 2002). Based on primary 
structure alignment, enterobacteria families, which have not been studied in terms of its 
allosteric activators and conserve this C-terminal region, are predicted to be also 
regulated by FBP (Shigella flexneri, Shigella boydii, Salmonella choleraesuis, 
Escherichia fergusonii; Figure 5.8 and 5.9). Interestingly, some enterobacterial AGPases 
not regulated by FBP (J Preiss 1978; Ballicora et al. 2002) displayed clear discrepancies 
in the C-terminal region (Serratia marcences, Serratia liquefaciens, Hafnia alvei), 
strongly suggesting that other enterobacteria AGPases lacking this region might have a 
different positive regulatory mechanism (Yersinia pestis, Pantoea vagans, Erwinia sp., 
Pectobacterium atrosepticum, Dickeya dadantii, Proteus vulgaris; Figure 5.8 and 5.9).  
Cell energy metabolism is inherently linked to the evolution of organisms, thus, 
enterobacterial glycogen synthesis ought to be study in this context. Based on our 
observations, AGPase seems to follow the same phylogenetic history of the 
enterobacteriaceae family, as described in the Pathosystems Resource Integration 
Center (Wattam et al., 2014). In this regard, the conserved use of FBP as positive 
allosteric regulator in EcAGPase seems to be a trait acquired by a sub-group of 
enterobacterial AGPases sharing the C-terminal 419RxMLRKLxxKQER431 sequence 
(Figure 5.9).  
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Citrobacter freundii P F P L S C V Q S D - - P E S E P Y W R D V G T L E A Y W K A N L D L A S V T P E L D M Y D Q D W P I R T H M E S L P P A K F V Q D R S G S H G M T L N S L V S G G C I I S G S V V258   345
Shigella flexneri P F P L S C V Q S D - - P D A E P Y W R D V G T L E A Y W K A N L D L A S V V P E L D M Y D R N W P I R T Y N E S L P P A K F V Q D R S G S H G M T L N S L V S G G C V I S G S V V258   345
Shigella boydii P F P L S C V Q S D - - P D A E P Y W R D V G T L K A Y W K A N L D L A S V V P E L D M Y D R N W P I R T Y N E S L P P A K F V Q D R S G S H G M T L N S L V S G G C V I S G S V V258   345
Salmonella choleraesuis P F P L S C V Q S D - - P Q A E P Y W R D V G T L E A Y W K A N L D L A S V T P E L D M Y D Q N W P I R T H M E S L P P A K F V Q D R S G S H G M T L N S L V S G G C I I S G S V V258   345
Escherichia fergusonii P F P L S C V Q S D - - P D S E P Y W R D V G T L E A Y W K A N L D L A S V V P E L D M Y D Q H W P I R T Y N E S L P P A K F V Q D R S G S H G M T L N S L V S G G C V I S G S V V258   345
Serratia liquefaciens P F T L S C V T S N - - P D L P P Y W R D V G T L E A Y W R A N L D L A S V T P E L D M Y D R A W P I R T H M E P L P P A K F V Q D R S G S H G M T M N S L V S G G C I V S G S V V258   345
Serratia marcescens P F P R S C V Q S D - - N N A E P Y W R D V G T L E A Y W K A N L D L A S V V P E L D V Y D R N W P I R T Y V E S L P S A K F V Q D R S G S H G M T M N S L V S G G C I I S G S V V258   345
Hafnia alvei P F T L S C V T S T D E H D V A P Y W R D V G T L D A Y W R A N L D L A S V T P E L D M Y D K R W P I R T Y M E S L P P A K F V Q D R S G S H G M T M N S L V S G G C I I S G S V V258   347
Cronobacter sakazakii P F P L S C V Q S D - - P N A E P Y W R D V G T L E A Y W K A N L D L A S V T P E L D M Y D Q D W P I R T H M E S L P P A K F V Q D R S G S H G M T L N S L V S G G C I I S G S V V258   345
Yersinia pestis P F D L S C V T S N - - A E L P P Y W R D V G T L D A Y W R A N L D L A S V T P E L D M Y D R A W P I R T H M E P L P P A K F V Q D R S G S H G M T M N S L V S G G C I V S G S V V258   345
Pantoea vagans S F A L S C V Q N D - - D N A P P Y W R D V G T L E A Y W R A N L D L A S V M P E L D M Y D V T W P I R T H M E P L P P A K F V Q D R S G S H G M T M N S L V S G G C I I S G S V V258   345
Erwinia sp. S F S L S C V Q Q D - - E T A E P Y W R D V G T L E A Y W K A N L D L A S V T P E L D M Y D A N W P I H T H M E P L P P A K F V Q D R S G S H G M T M N S L V S G G C I I S G S V V258   345
Pectobacterium atrosepticum P F T L S C V T S G - - E D E H Q Y W R D V G T L E A Y W R A N L D L A S V T P E L D V Y D R H W P I R S A I E S L P P A K F V Q D R S G S H G M T M N S L V S G G C I V S G S V V258   345
Dickeya dadantii P F T L S C V T S S - - D N A P P Y W R D V G T L E A Y W R A N L D L A S V M P E L D M Y D H N W P I R S A M A A L P P A K F V Q D R S G S H G L T M N S L V S G G C I V S G S V V259   346
Proteus vulgaris P F E L S C V S S D - - P S V A P Y W R D V G T I E A Y W S A N L D L A S V T P E L D M Y A K D W P I R T F M T P L P P A K F V Q D N H G E H G Q M M N S L I A D G C I I N G S T L258   345
Escherichia coli V Q S V L F S R V R V N S F C N I D S A V L L P E V W V G R S C R L R R C V I D R A C V I P E G M V I G E N A E E D A R R F Y R S E E G I V L V T R E M L R K L G H K Q E R - - - -346   431
Salmonella typhimurium V Q S V L F P R V R I N S F C N I D S A V L L P E V W V G R S C R L R R C V I D R A C I I P E G M V I G E N A E E D A R R F Y R S E E G I V L V T R E M L R K L Q V K Q E R - - - -346   431
Enterobacter aerogenes V Q S V L F P R V R V N S F C N I D S A V L L P D V W V G R S C R L R R C V I D R A C V I P E G M V I G E N A E E D A S R F Y R S E E G I V L V T R D M L R K L G H K Q E R - - - -346   431
Enterobacte cloacae V Q S V L F P R V R V N S F C N I D S A V L L P D V W V G R S C R L R R C V I D R A C V I P E G M V I G E N A E E D A R R F Y R S E E G I V L V T R E M L R K L Q V K Q E R - - - -358   443
Shigella dysenteriae V Q S V L F S R V R V N S F C N I D S A V L L P E V W V G R S C R L R R C V I D R A C V I P E G M V I G E N A E E D A R R F Y R S E E G I V L V T R E M L R K L G H K Q E R - - - -346   431
Klebsiella pneumoniae V Q S V L F P R V R V N S F C N I D S A V L L P D V W V G R S C R L R R C V I D R A C V I P E G M V I G E N A E E D A R R F Y R S E E G I V L V T R D M L R K L G H K Q E R - - - -346   431
Citrobacter freundii V Q S V L F P R V R V N S F C N I D S A V L L P E V W V G R S C R L R R C I I D R A C V I P E G M V I G E N A E E D A R R F Y R S E E G I V L V T R E M L R K L Q I K Q E R - - - -346   431
Shigella flexneri V Q S V L F S R V R V N S F C N I D S A V L L P E V W V G R S C R L R R C V I D R A C V I P E G M V I G E N A E E D A R R F Y R S E E G I V L V T R E M L R K L G H K Q E R - - - -346   431
Shigella boydii V Q S V L F S R V R V N S F C N I D S A V L L P E V W V G R S C R L R R C V I D R A C V I P E G M V I G E N A E E D A R R F Y R S E E G I V L V T R E M L R K L G H K Q E R - - - -346   431
Salmonella choleraesuis V Q S V L F P R V R I N S F C N I D S A V L L P E V W V G R S C R L R R C V I D R A C I I P E G M V I G E N A E E D A R R F Y R S E E G I V L V T R E M L R K L Q V K Q E R - - - -346   431
Escherichia fergusonii V Q S V L F S R V R V N S F C N I D S A V L L P E V W V G R S C R L R R C V I D R A C V I P E G M V I G E N A E E D A R R F Y R S E E G I V L V T R E M L R K L G H K Q E R - - - -346   431
Serratia liquefaciens V H S V L F P R V R V N S F C T I D S T V L L P D V N V G R S C R L R R C I I D R A C H I P E G M V I G E N A D E D S K R F Y R S E G G I V L V T R E M L S K L - - - - - - - - - -346   425
Serratia marcescens V Q S V L F S R V R I N S F C N I D S S V L L P G V W V G R S C R I R R C V I D R G C V I P E G T V I G E N A V E D A R R F Y R S E E G I V L V T K E M L N R L E L - - - - - - - -346   427
Hafnia alvei V H S V L F P R V R V N S F C T I D S S V L L P D V N I G R S C R L R R C I I D R A C V L P E G M V I G E N A E E D S K R F Y R S E G G V V L V T R E M L A R L - - - - - - - - - -348   427
Cronobacter sakazakii V Q S V L F P R V R V N S F C N I D S A V L L P D V W V G R S C R L R R C I I D R A C V I P E G M V I G E N A E E D A R R F Y R S E E G I V L V T R D M L A R L S A - - - - - - - -346   427
Yersinia pestis V H S V L F P R V R V N S F C T I D S S L L L P D V H V G R S C R L R R C I I D R A C H I P E G M V I G E N A D E D N A R F Y R S E G G G G V S D S G Y A G K V R G K I E P L G F L346   435
Pantoea vagans V N S V L F P R V R V N S F C N I D S T V L L P D V V V G R S C R L R R C V I D R A C E L P E G M V I G E N P D E D S R R F H R S D E G I V L V T R A M L A R L A K A G L - - - - -346   430
Erwinia sp. V N S V L F S R V R I N S F C N I E S S V L L P D V V V G R S C R L R R C V I D R A C V L P E G T V I G E N P D D D A R R F H R S E E G I V L V T T T M L A K L GW R - - - - - - -346   428
Pectobacterium atrosepticum T H S V L F P R V R V N S F C S I D S T V I L P D V N V G R S C R L R R C V I D R A C H L P E G M V I G E N A E E D S R R F Y R S E E G I V L V T R S M L E K L - - - - - - - - - -346   425
Dickeya dadantii T H S V L F P R V R I N S F C S I D S S V L L P D V N V G R S C R L H R C I I D R A C D I P E G M V I G E N A E D D S R R F Y R S E E G I V L V T R A M L A K L K S - - - - - - - -347   428
Proteus vulgaris Y S S I L F P L V R V E S F C H I E D S V I L P D V T V S H H C Y L K R C I I E R S C T I P E G T V I G M N A E D D A A R F H R T E E G I V L V T R E M L E Q L A H Q K K E N S I E346   435
Escherichia coli - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -431   431
Salmonella typhimurium - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -431   431
Enterobacter aerogenes - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -431   431
Enterobacte cloacae - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -443   443
Shigella dysenteriae - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -431   431
Klebsiella pneumoniae - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -431   431
Citrobacter freundii - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -431   431
Shigella flexneri - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -431   431
Shigella boydii - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -431   431
Salmonella choleraesuis - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -431   431
Escherichia fergusonii - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -431   431
Serratia liquefaciens - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -425   425
Serratia marcescens - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -427   427
Hafnia alvei - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -427   427
Cronobacter sakazakii - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -427   427
Yersinia pestis F V R L D L L I R L S L L I R L N L F I R M N L L I I L T L F F K L A S I Q A S H436   476
Pantoea vagans - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -430   430
Erwinia sp. - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -428   428
Pectobacterium atrosepticum - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -425   425
Dickeya dadantii - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -428   428
Proteus vulgaris K N E E Q K P Q N E - - - - - - E A F S - - - - - - - - - - - - - - - - - - - - -436   449
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Figure 5.8. Structure-Weighted Sequence Alignment of EcAGPase with other AGPases.  
Structural alignment between the crystal structures of EcAGPase (PDB: 5L6V; UniProt: P0A6V1), 
AtAGPase (PDB: 3BRK; UniProt: P39669), and StAGPase (PDB: 1YP3; UniProt: P23509). The 
secondary structure elements corresponding to the GT-A-like domain are shown in yellow (a 
helices) and orange (b helices); and to the LbH domain in green (a helices) and blue (b helices). 
Residues with poor electron density are highlighted as full boxes. The SM and the RL1 and RL2 
loops are highlighted in yellow. Catalytic residues are highlighted as dotted boxes. The RMSD 
value is shown for each residue. Amino acid sequences of selected AGPases were aligned to the 
structure alignment: Mycobacterium smegmatis (class II; UniProt: A0R2E1), Serratia marcescens 
(class II; UniProt: A0A0U6P844), Rhodo- bacter sphaeroides (class V; UniProt: Q9RNH7), 
Rhodospirillium rubrum (class VI; UniProt: Q9ZFN4), Bacillus subtilis (class VII; UniProt: P39122), 
Synechococcus sp. (class VIII; UniProt: Q2JU94), Ostreococcus tauri (class VIII; UniProt: 
Q6PYZ7), Spinacia oleracea (class VIII; UniProt: Q43152), and Triticum aestivum (class IX; 
UniProt: P30523)  
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Figure 5.9. Evolution of the FBP regulatory site within the enterobacteriaceae family of 
AGPases. Middle distance BLOSUM62 tree. The species known to use FBP are marked with an 
orange spot and those proposed to use it, based on the conservation of the C-terminus, with an 
empty orange spot. The species reported not to be regulated by this metabolite are marked with a 
grey spot and those proposed not to be with an empty grey spot.  
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6. Global structural quaternary rearrangements 
derived from EcAGPase allosteric regulation 
As it has been shown in chapter 4, no significant differences were observed in the 
quaternary structure of EcAGPase•AMP and EcAGPase•FBP crystal structures. 
However, the crosstalk event promoted by the residue Arg130 between protomers from 
the same and different dimers in EcAGPase•AMP structure suggests that AMP 
interactions might lead to the stabilization of the quaternary structure of EcAGPase in 
solution. Moreover, the differences on the Tm values between EcAGPase in its apo state 
(71.2°C) and EcAGPase•AMP complex (75.8°C) might point to the same hypothesis. In 
the case of EcAGPase•FBP complex, Arg130 side chain from the neighboring protomer 
changes its orientation, suggesting that FBP interactions might not lead to the 
stabilization of the quaternary structure. Interestingly, the addition of FBP to the 
EcAGPase•AMP complex triggered a clear reduction in the Tm values indicating that FBP 
not only is able to compete with AMP but also to modify the structural arrangement of 
the EcAGPase•AMP complex, leading to the occurrence of a less-stable structure. 
Changes in the quaternary structure of allosterically modulated enzymes have already 
been observed (Filippova et al., 2015; Fischer, Olsen, Nam, & Karplus, 2011; Lipscomb 
& Kantrowitz, 2012). To analyse whether the allosteric regulation of EcAGPase is 
associated with quaternary structural changes in solution we performed Small Angle X-
ray Scattering (SAXS) and cryo-EM studies on EcAGPase.  
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6.1. Materials and methods 
 
EcAGPase expression and purification – The recombinant EcAGPase has no 
additional amino acids when compared to the native enzyme. E. coli BL21(DE3) cells 
transformed with pET29a-EcAGPase were grown in 3,000 ml of LB medium 
supplemented with 25 µg/ml of kanamycin at 37°C. When the culture reached an OD600 
of 0.8, the EcAGPase expression was induced by the addition of 1 mM isopropyl b-
thiogalactopyranoside (IPTG) and further incubated at 18°C overnight. All EcAGPase 
purification procedures were carried out at 4°C. Cells were harvested by centrifugation 
at 5,000 x g and resuspended in 40 ml of 50 mM Hepes pH 8.0, 5 mM MgCl2, 0.1 mM 
EDTA, 10% sucrose (w/v; solution A), containing protease inhibitors (Complete EDTA-
free; Roche) and 10 mg/l of lysozyme (Sigma). Cells were then disrupted by sonication 
(five cycles of 1 min each) and centrifuged for 15 min at 20,000 x g. The supernatant 
was dialyzed twice against solution A by using an 100,000 Da molecular mass cutoff 
dialysis membrane.  The solution was then applied to a DEAE FF column (5 ml; GE 
Healthcare) equilibrated with solution A. Elution was performed with a linear 0-0.5M NaCl 
gradient in 100 ml. Enzyme-positive fractions were pooled and precipitated with 
ammonium sulfate to 1.2 M (solution B). The resultant suspension was centrifuged for 
20 min at 20,000 x g and the resulting supernatant applied into a Phenyl Shodex HIC 
PH-814 equilibrated in solution B. The enzyme was eluted with a linear gradient of 100% 
solution B to 100% solution A, in 50 ml. The most active fractions were pooled, 
concentrated to 10 mg/ml by an Amicon-Ultra spin concentrator (Merck Millipore) with a 
100-kDa-molecular mass cutoff, and stored at -80°C. 
 
Small Angle X-ray Scattering Measurements — HPLC coupled SAXS experiments 
were perform in beamline B21 at Diamond Light Source (Didcot, UK). Samples were 
injected in an in-line Agilent HPLC unit harboring a Shodex KW403-4F column, 
previously equilibrated in 50 mM Tris-HCl pH 7.5, 100 mM NaCl buffer for EcAGPase in 
apo state, the same buffer plus 0.5 mM AMP for the EcAGPase•AMP sample and 2.5 
mM FBP for EcAGPase•FBP sample. A sample volume of 45 µl at 4.5 mg/ml was injected 
in the column working at a flow rate of 0.16 ml/min at 15°C for each condition. X-ray 
scattering data were collected by illuminating 17 µl of sample at wavelength λ = 0.99 Å 
(12.4 keV) in different frames of 3 s exposure during the elution of the sample. Data was 
acquired using a Pilatus 2M detector at fixed distance configuration of 4.014 m, resulting 
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in a range of momentum transfer values of 0.0022 < q < 0.42 Å-1 (q = 4π sin(θ)/λ where 
2θ is the scattering angle).  
Diffraction data corresponding to each peak was integrated and buffer subtracted using 
SCATTER (Rambo & Tainer, 2011) and processed using PRIMUS (Konarev, Volkov, 
Sokolova, Koch, & Svergun, 2003). The forward scattering (I(0)) was evaluated using 
the Guinier approximation assuming the intensity is represented as I(q) = 
I(0)exp((qRg)2/3), with Rg being the radii of gyration, for a very small range of momentum 
transfer values (q < 1.3/Rg). The maximum dimensions (Dmax), the interatomic distance 
distribution functions (P(r)), and the Rg were computed using AUTOGNOM (Svergun, 
1992).  
 
Ab Initio shape determination and docking of the crystal structure— The low-
resolution structures of EcAGPase apo and in complex with AMP and FBP were 
calculated ab initio by using the program GASBOR (Svergun, Petoukhov, & Koch, 2001) 
using P 2 2 2 symmetry. The rigid body fitting of EcAGPase•AMP crystal structure into 
the SAXS ab initio model was performed using Chimera.  
 
Negative stain EM sample preparation and data acquisition – EcAGPase was diluted 
up to 0.05 mg/ml in 50 mM Tris pH 7.5, 100 mM NaCl to give good individual particle 
dispersion. CF200-Cu 200 mesh carbon grids were pre-treated by glow discharge for 40 
s at 40 mA. First, the sample was added placing the grid on a 6 µl drop of EcAGPase 
allowing the adsorption for ~2 min. Then, the grid was washed with ddH2O and blotted 
with filter paper. Filtered uranyl formate at a concentration of 0.75% was used as the 
contrast agent leading the grid on the top of a 6 µl droplet for 40 s. After blotting, a fast 
stain step was performed leading the grid dry for 20 min.  Micrographs were collected on 
a JEM-1230 TEM (JEOL,Japan) equipped with an Orius SC1000 (40008x2672 pixels) 
CCD camera (GATAN, UK) operating at 120 kV with a magnification of 50,000×.  
 
Cryo-EM sample preparation and data acquisition – Quatifoil-Cu R1.2/1.3 300 mesh 
grids were pre-treated by glow discharge for 30 s at 4.0 mA and EcAGPase samples 
were filtered using VIVASPIN 500 PES 1 MDa MWCO to avoid aggregates. Vitrified 
specimens were prepared by adding 4 µl of EcAGPase 0.30 mg/ml in 50 mM Tris pH 
7.5, 100 mM NaCl. Grids were blotted for 3 s after a 15 s pre-blotting time, then plunge-
frozen in liquid ethane using VITROBOT FEI instrument, with the chamber maintained 
at 15°C and 80% humidity. Same conditions were used to prepare EcAGPase samples 
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in complex with AMP (0.5 mM) and FBP (2.5 mM). Cryo-EM imaging was done on an 
JEM-2200FS/CR TEM (JEOL, Japan) operated at 200 kV, having Omega energy filter, 
in minimal dose mode at nominal magnification of 60.000 X. Images were acquired with 
a UltraScan 4000 SP (4008x4008 pixels) cooled slow-scan CCD camera (GATAN, UK) 
with a physical pixel sixe of 14 µm, resulting in image with a calibrated pixel size of 1.7 
Ǻ. Images were acquired using a defocus range between 2-5 µm with an exposition time 
of 35ms resulting in a dose of 30 e/ Ǻ2.  
 
Cryo-EM image processing – Micrographs in raw DM3 format were converted to MRC 
format using the program e2proc2d.py from the package EMAN2 and imported to the 
program RELION 2.0.3. Determination of the CTF was assessed using CTFFIND (Rohou 
& Grigorieff, 2015), through the package RELION 2.0.3. In parallel, raw DM3 format 
micrographs were converted to TIF format using the program ImageJ and afterwards, 
median filtering for noise reduction using the function ‘convert–median 8’ from 
ImageMagick was apply in order to facilitate particle picking in supervised mode using 
Xmipp3 through the package SCIPION (de la Rosa-Trevín et al., 2016). Using the 
particle coordinates from picking, single particle images were extracted using RELION 
2.0.3 with a final box size of 88x88 pixels, representing an image of 149x149 Ǻ2. In order 
to classify particles according to their quality, 2D class averages were perform in RELION 
2.0.3, and best classes were selected. Particles corresponding to the best 2D classes 
were used to perform 3D classification imposing D2 symmetry versus an initial model 
obtained from the crystal structure of EcAGPase tetramer calculated at 40 Ǻ resolution 
using RELION 2.0.3. The best 3D class was subsequently refined and post-processed 
leading to a final map for EcAGPase•AMP at 14 Ǻ resolution and for EcAGPase•FBP at 
16 Ǻ resolution  
The final resolution was estimated using the Fourier Shell Correlation criterion with 0.5 
cutoff. In all cases,  
Docking of X-ray crystal structures – The docking of X-ray structures into the cryo-
EM maps was made using Phenix real space refine (Afonine, Headd, Terwilliger, & 
Adams, 2013). First, a rigid body fitting was performed for the one tetramer of the 
EcAGPase•AMP crystal structure. In addition, a second rigid body fitting for each of the 
four GTA-like domains and the two stacked LβH corresponding to the dimer was perform 
for the EcAGPase•FBP complex. 
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6.2. Results and discussion 
 
 
6.2.1. Allosteric regulators modulate EcAGPase quaternary 
structure as visualized by SAXS 
 
SAXS belongs to the family of X-ray scattering techniques, providing information about 
the average particle sizes and shapes in solution. HPLC coupled SAXS (HPLC-SAXS) 
incorporates an HPLC unit harboring an analytical size exclusion column so that the data 
can be collected during the elution of the sample (Boldon, Laliberte, & Liu, 2015; 
Vestergaard, 2016). The resulting chromatograms of EcAGPase on its apo state and 
EcAGPase•AMP complex indicate that EcAGPase is most homogeneous/compact in the 
presence of AMP (peak Retention Time (TR) of 15.5 min and Full Width at Half Maximum 
(FWHM) of 0.5 min; Figure 1.6A) than the apo form (TR = 15.2 min and FWHM = 0.6 min; 
Figure 1.6A). Moreover, EcAGPase•AMP maintains a constant and low radius of gyration 
(Rg = 36.8 Å) for each consecutive frame in the SAXS signal plot (Figure 6.1C), indicative 
of sample homogeneity and compactness. In the apo state, EcAGPase is less compact 
(Rg = 39.2 Å) with some increase in heterogeneity, as indicated by the reduced values 
of Rg in consecutive frames in the SAXS signal plot (Rg range from 53.7 to 37.0) (Figure 
6.1B). These results are consistent with different Tm values observed for the apo state 
and the EcAGPase•AMP complex and the crosstalk event promoted by Arg130 in the 
presence of AMP (see chapter 4). Interestingly, in the case of transglutaminase type 2 
(TG2), a multifunctional allosterically regulated enzyme, the binding of the negative 
allosteric regulator guanosine triphosphate (GTP) also promotes the adoption of a 
compact, catalytically inactive conformation (Begg et al., 2006). In contrast, a clear gain 
in heterogeneity and hydrodynamic radius can be observed in the presence of FBP as 
indicated by (i) the chromatographic profile (TR=14.3 min and FWHM = 1.4 min; Figure 
6.1A), and (ii) the increase in Rg values and their variability along the SAXS signal plot 
(Rg range from 52.5 to 41.3 Å; Figure 6.1D). For EcAGPase•FBP peak, data were 
segmented in three parts for following data integration and analysis (FBP-1, -2, -3; Figure 
6.1D). The dimensionless Kratky analysis of the integrated data (Figure 6.1E) also 
indicates EcAGPase is in a less globular state in the presence of FBP when compared 
with the apo state or the AMP bound state, showing a large increase in particle 
asymmetry, which correlates very well with the increment in Rg values. Based on these 
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results, we propose that the competition of AMP and FBP regulators for the allosteric 
site modulates not only the dynamics of the SM element, and the RL1 and RL2 motifs, 
but also the compactness of the quaternary structure of the enzyme.  
 
 
Figure 6.1. SAXS biophysical analysis. (A) Size exclusion chromatograms recorded by 
absorbance measurement at 280 nm corresponding to EcAGPase apo (green), EcAGPase•AMP 
(blue) and EcAGPase•FBP (red) displaying relative changes in retention times. (B-D) Signal plots 
of HPLC-SAXS experiment corresponding to apo condition (B), AMP condition (C) and FBP 
condition (D). Per frame Rg values from buffer subtracted SAXS data are displayed inside the 
peak as black dots. For EcAGPase•FBP peak data were segmented in three parts indicated by 
yellow, orange and red dashed boxes for following data integration and analisys (FBP-1, -2, -3). 
(E) Dimensionless Kratky plot base on volume of correlation (Vc) using Guinier's approximation 
in which the maximum theoretical height for a sphere is 0.82, showing apo EcAGPase (green) 
the closer peak maxima to the value. Compared with the apo state the plots for EcAGPase•AMP 
(blue) evidence AMP triggered compaction as the curve is displaced downwards. Also, FBP-1, -
2, -3 data sets (red orange and yellow) displays a decrease in the surface-to-volume ratio as 
indicated by the curves shift upwards.  
 
The SAXS ab initio models were used to calculate the corresponding envelopes 
at 20 Å (Figure 6.2A). The shape of EcAGPase•AMP resembles to the EcAGPase•AMP 
crystal structure surface at low resolution, however, the apo state and EcAGPase•FBP 
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complex display notable differences. In these cases, a less globular quaternary structure 
can be observed, been this effect more pronounced in the FBP complex. This 
conformational change is more drastic on the FBP-3 sample which correlates with the 
Rg and TR values of this segment of the peak data (Figure 6.1D).  Comparison with the 
EcAGPase•AMP crystal structure envelope might suggest that this “enlargement” of the 
structure occurs between the GTA domains of EcAGPase with a correlation of 0.58 
(Figure 6.2B). 
.  
 
 
 
Figure 6.2. SAXS ab initio reconstructions of EcAGPase. (A) Average low resolution structure 
of EcAGPase on its apo state (green), in complex with AMP (blue) and FBP (red, orange and 
yellow). In the case of FBP, the ab initio reconstructions were done for the individual FBP-1, -2, -3 
data sets.  The crystal structure surface of EcAGPase•AMP complex is incorporated as reference. 
(B) Average low resolution structure of EcAGPase•AMP complex with the high-resolution crystal 
structure of EcAGPase•AMP fitted by rigid body docking. 
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6.2.2. Allosteric regulators modulate EcAGPase quaternary 
structure as visualized by cryo-EM 
 
To further advance in the comprehension of the conformational changes derived from 
the allosteric regulation of EcAGPase, we decided to perform EM for EcAGPase•AMP 
and EcAGPase•FBP complexes. This technique allows us to determine the structure of 
EcAGPase in a near-native state and corroborate the SAXS-based model in which we 
observe quaternary structural discrepancies between both complexes. The purity of the 
sample was confirmed by negative stain EM (Figure 6.3A). Cryo-EM structures were 
solved at 14 and 16 Å resolution for the EcAGPase•AMP and EcAGPase•FBP 
complexes, respectively. The crystal structure of EcAGPase•AMP fits to the cryo-EM 
density map with a correlation of 0,93 (Figure 6.3B) In contrast, EcAGPase•FBP cryo-
EM model highlights the conformational changes previously suggested by SAXS (Figure 
6.3C). Specifically, EcAGPase•FBP cryo-EM structure shows a relative rotation of the 
dimer LβH of 31.2º which results in an increment on the distance between the GTA-like 
and LβH domains of neighboring protomers, where the allosteric cleft is located (Figure 
6.3C).  
  
Altogether, both SAXS and EM approaches support a model in which allosteric 
regulators modulate EcAGPase quaternary structure. Interestingly, other enzymes of the 
central energy metabolism display similarities at structural and regulatory level to 
AGPase, as in the case of Pyruvate kinase (PK), Lactate dehydrogenase (LDH) and 
Glycerol kinase (GK; Fushinobu et al. 1996; Ormö, Bystrom, and Remington 1998; 
Valentini et al. 2000) ⁠. These enzymes are homotetramers with D2 symmetry that binds 
FBP as allosteric effector in some organisms. In all these enzymes, the allosteric 
phenomena is proposed to occur by a Monod-Wyman-Changeaux model (MWC; Monod, 
Wyman, and Changeux 1965) ⁠, where the symmetry of the tetrameric system must be 
preserved, and the catalytic properties are explained by conformational displacement 
between the so called “tense” low-activity/affinity state (T-state) and a "relaxed" high-
activity/affinity state (R-state) in a concerted fashion among protomers. These 
structurally distinct conformational states had been structurally observed bound to 
modulators (Ikehara et al., 2014; Jurica et al., 1998) ⁠. It is worth noting that whereas PK 
and LDH use FBP as positive allosteric modulators, GK is inhibited by this metabolite.  
Doctoral Thesis – Natalia Comino 
 
 - 125 - 
 
Figure 6.3. EcAGPase cryo-EM reconstructions. (A) Negative staining of EcAGPase on its apo 
state. (B) Cryo-EM model of EcAGPase•AMP with the crystal structure of this complex fitted into 
the cryo-EM density. (C) Cryo-EM model of EcAGPase•FBP with the crystal structure of this 
complex fitted into the cryo-EM density. (D) Structural superposition of the EcAGPase•FBP crystal 
structure (blue) and cryo-EM based model (yellow) showing the relative rotation of the dimer LβH 
(curved arrow). 
The experimental data reported in this work, suggest that the crystal structure of 
EcAGPase•AMP very likely represents the conformational state of the T-state, 
meanwhile EcAGPase•FBP also represent this low activity state, but complexed with the 
positive regulator FBP bound. In this sense, we speculate the crystal structure might 
represent the first binding event of the positive allosteric regulator into the inactive state 
of the protein.  
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7. Conclusions 
In this work, we focused in the study of the enzyme ADP-glucose pyrophosphorylase.  
This enzyme catalyzes the formation of the NDP-sugar donor ADP-Glc, the first 
committed reaction in the pathway of bacterial glycogen biosynthesis. Energy reporters 
within the cell allosterically regulate this key-limiting step modulating AGPase activity 
(Jack Preiss, Lammel, & Greenberg, 1976; Jack Preiss, Yung, & Baecker, 1983). 
Specifically, we studied the paradigmatic AGPase from Escherichia coli, and the 
interaction with its preferred allosteric negative regulator AMP and positive regulator FBP. 
Several experimental lines suggest that both N- and C-terminal domains are involved in 
EcAGPase allosteric regulation and it was postulated that this phenomenon might be 
determined by a combined arrangement between both domains  (M. A. Ballicora et al., 
2002; Clarisa M. Bejar et al., 2006; Jack Preiss, 2014; Wu & Preiss, 1998). However, the 
lack of structural information regarding AGPase allosteric binding sites has suppose a 
difficulty in the understanding of the molecular mechanism that governs AGPase 
allosterism. The main aim of this work was to advance in the study of EcAGPase 
allosteric regulation determining its structure in complex with AMP and FBP. The 
structural information derived from these complexes in combination with 
biophysical/biochemical evidences has placed us in an unprecedented situation to 
propose a suitable model for EcAGPase regulation. It is worth noting that the 
transformation of plants with E. coli allosteric mutants on the glgC gene significantly 
increased (i) the rate of starch synthesis in tubers of transgenic potato (Sweetlove, 
Burrell, & ap Rees, 1996) and (ii) starch content (Stark, Timmerman, Barry, Preiss, & 
Kishore, 1992; Tuncel & Okita, 2013). Therefore, the information reported herein 
provides exciting possibilities for industrial/biotechnological applications.  
 
Specifically, our new results concluded that: 
 
1) Based on EcAGPase•AMP•SUC and EcAGPase•FBP crystal structures, AMP and 
FBP bind to partially overlapping sites located in a deep cleft between GT-A like and 
LβH domains of neighboring protomers. Each allosteric cleft is communicated with 
the corresponding active site of the same protomer through a region defined as the 
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‘Sensory Motif’ (SM), a complex structural element constituted by the nucleotide-
binding loop (NBL), including a G-rich motif involved in ATP binding, and a segment 
rich in short secondary structure elements.  
  
2) EcAGPase•AMP complex is ca. 4.6 °C more stable than the unliganded form of the 
enzyme and the addition of FBP to this complex triggered a clear reduction in the 
apparent melting temperatures (Tm) values, indicating that FBP is able to compete 
with AMP and to modify the structural arrangement of the EcAGPase•AMP complex, 
leading to a less stable structure. 
 
3) Taking into account these experimental evidences, we proposed a model, in which 
the binding of the positive and negative energy reporters regulates EcAGPase 
catalytic activity through the SM and two critical regulatory loops RL1 and RL2 
flanking the active binding site, via intra-protomer interactions and inter-protomer 
crosstalk. 
 
4) Single point mutants on key residues of the AMP binding site decrease its inhibitory 
effect, but in addition, clearly abolish the overall stabilization effect mediated by this 
regulator in wild-type EcAGPase. On the other hand, single point mutants on key 
residues of FBP binding were unable to revert the stabilization mediated by AMP. 
 
5) EcAGPase•R130A deregulated mutant display a dramatic increase in the activity 
when compared with wild-type EcAGPase, which correlates with a significant 
increment of glycogen content in vivo. The crystal structure of EcAGPase•R130A 
revealed unprecedented conformational changes in structural elements proposed to 
be involved in the allosteric signal transmission.  
 
6) The determination of EcAGPase structure in solution by SAXS and cryo-EM indicate 
that its allosteric regulation also involves conformational changes in the quaternary 
structure, being the EcAGPase•AMP complex more compact than the 
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EcAGPase•FBP activated state. This experimental data suggests that 
EcAGPase•AMP crystal structure corresponds to the conformational state of the 
MWC model based T-state whereas we speculate the EcAGPase•FBP crystal 
structure might represent the first binding event of the positive allosteric regulator 
into the inactive state of the protein.  
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